0001493152-20-006856.txt : 20200421 0001493152-20-006856.hdr.sgml : 20200421 20200421170155 ACCESSION NUMBER: 0001493152-20-006856 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200421 DATE AS OF CHANGE: 20200421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kraig Biocraft Laboratories, Inc CENTRAL INDEX KEY: 0001413119 STANDARD INDUSTRIAL CLASSIFICATION: PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820] IRS NUMBER: 830459707 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-146316 FILM NUMBER: 20805848 BUSINESS ADDRESS: STREET 1: 2723 SOUTH STATE STREET STREET 2: SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: (734) 619-8066 MAIL ADDRESS: STREET 1: 2723 SOUTH STATE STREET STREET 2: SUITE 150 CITY: ANN ARBOR STATE: MI ZIP: 48104 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2020

[ ]	TRANSITION REPORT PURSUANT TO PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from_____ to _____

Commission File Number: 333-146316

KRAIG BIOCRAFT LABORATORIES, INC.

(Exact Name of Registrant as Specified in Charter)

Wyoming		83-0459707
(State or Other Jurisdiction of Incorporation)		(I.R.S. Employer Identification No.)

2723 South State St. Suite 150

Ann Arbor, Michigan 48104

(Address of Principal Executive Offices)

(734) 619-8066

(Registrant’s telephone number, including area code)

(Former name and address, if changed since last report)

Copies to:

Hunter Taubman Fischer & Li LLC

1450 Broadway, 26th Floor

New York, NY 10018

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
None		-		-

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and emerging growth company in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]			Accelerated filer [ ]
Non-accelerated filer [X]			Smaller reporting company [X]
			Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

As of April 21, 2020, there were 844,468,378 shares of the issuer’s Class A common stock, no par value per share, outstanding, 0 shares of the issuer’s Class B common stock, no par value per share, outstanding and 2 shares of preferred stock, no par value per share, outstanding.

TABLE OF CONTENTS

	Page

PART I FINANCIAL INFORMATION

Item 1. Unaudited Condensed Financial Statements:	3

Condensed Consolidated Balance Sheets as of March 31, 2020 (Unaudited) and December 31, 2019 (Audited)	3

Condensed Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2020 and 2019	4

Condensed Consolidated Statements of Stockholders’ Deficit for the three months ended March 31, 2020 and 2019 (Unaudited)	5

Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2020 and 2019	7

Notes to Condensed Consolidated Financial Statements (Unaudited)	8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	27

Item 3. Quantitative and Qualitative Disclosures about Market Risk	33

Item 4. Controls and Procedures	33

PART II OTHER INFORMATION

Item 1. Legal proceedings	34

Item 1A. Risk Factors	34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	34

Item 3. Defaults upon Senior Securities	34

Item 4. Mine Safety Disclosures	34

Item 5. Other information	35

PART I

ITEM 1. FINANCIAL STATEMENTS

Kraig Biocraft Laboratories, Inc. and Subsidiary

Condensed Consolidated Balance Sheets

(Unaudited)

	March 31, 2020			December 31, 2019
	(Unaudited)
ASSETS
Current Assets
Cash	$	37,411		$	125,024
Prepaid expenses		12,670			31,745
Total Current Assets		50,081			156,769

Property and Equipment, net		109,942			117,321
Operating lease right-of-use asset, net		444,514			473,242
Security deposit		3,518			3,518

Total Assets	$	608,055		$	750,850

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current Liabilities
Accounts payable and accrued expenses	$	482,435		$	560,948
Note payable - related party		942,000			642,000
Royalty agreement payable - related party		65,292			65,292
Accounts payable and accrued expenses - related party		4,320,170			4,145,465
Operating lease liability, current		113,764			110,678
Loan payable		60,000			60,000
Total Current Liabilities		5,983,661			5,584,383

Long Term Liabilities
Loan payable, net of current		170,244			185,244
Operating lease liability, net of current		339,548			369,281

Total Liabilities		6,493,453			6,138,908

Commitments and Contingencies

Stockholders’ Deficit
Preferred stock, no par value; unlimited shares authorized, none, issued and outstanding		-			-
Preferred stock Series A, no par value; 2 and 2 shares issued and outstanding, respectively		5,217,800			5,217,800
Common stock Class A, no par value; unlimited shares authorized, 844,468,378 and 844,468,378 shares issued and outstanding, respectively		16,757,079			16,757,079
Common stock Class B, no par value; unlimited shares authorized, no shares issued and outstanding		-			-
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively		22,000			22,000
Additional paid-in capital		4,966,968			2,412,969
Accumulated Deficit		(32,849,245	)		(29,797,906	)

Total Stockholders’ Deficit		(5,885,398	)		(5,388,058	)

Total Liabilities and Stockholders’ Deficit	$	608,055		$	750,850

Kraig Biocraft Laboratories, Inc. and Subsidiary

Condensed Consolidated Statements of Operations

(Unaudited)

	For the Three Months Ended
	March 31, 2020			March 31, 2019

Revenue	$	-		$	-

Operating Expenses
General and Administrative		2,792,781			117,967
Professional Fees		19,374			150,311
Officer’s Salary		144,562			118,155
Rent - Related Party		3,135			3,273
Research and Development		4,812			22,304
Total Operating Expenses		2,964,664			412,010

Loss from Operations		(2,964,664	)		(412,010	)

Other Income/(Expenses)
Interest expense		(86,675	)		(66,920	)
Interest income		-			1,184
Total Other Income/(Expenses)		(86,675	)		(65,736	)

Net (Loss) before Provision for Income Taxes		(3,051,339	)		(477,746	)

Provision for Income Taxes		-			-

Net (Loss)	$	(3,051,339	)	$	(477,746	)

Net Income (Loss) Per Share - Basic and Diluted	$	(0.00	)	$	(0.00	)

Weighted average number of shares outstanding during the period - Basic and Diluted		844,468,378			822,016,321

Kraig Biocraft Laboratories, Inc. and Subsidiary

Condensed Consolidated Statement of Changes in Stockholders Deficit

For the three months ended March 31, 2020

(Unaudited)

	Preferred Stock - Series A				Common Stock - Class A				Common Stock - Class B				Common Stock - Class A Shares To be issued						Accumulated
	Shares		Par		Shares		Par		Shares		Par		Shares		Par		APIC		Deficit			Total

Balance, December 31, 2019		2	$	5,217,800		844,468,378	$	16,757,079		-	$	-		1,122,311	$	22,000	$	2,412,969	$	(29,797,906	)	$	(5,388,058	)

Options issued for services		-		-		-		-		-		-		-		-		2,544,215		-			2,544,245

Imputed interest - related party		-		-		-		-		-		-		-		-		9,784		-			9,784

Net loss for the three months ended March 31, 2020		-		-		-		-		-		-		-		-		-		(3,051,339	)		(3,051,339	)

Balance, March 31, 2020		2	$	5,217,800		844,468,378	$	16,757,079		-	$	-		1,122,311	$	22,000	$	4,966,968	$	(32,849,245	)	$	(5,885,398	)

Kraig Biocraft Laboratories, Inc. and Subsidiary

Condensed Consolidated Statement of Changes in Stockholders Deficit

For the three months ended March 31, 2019

(Unaudited)

	Preferred Stock - Series A				Common Stock - Class A				Common Stock - Class B				Class A Shares To be issued						Accumulated
	Shares		Par		Shares		Par		Shares		Par		Shares		Par		APIC		Deficit			Total
Balance, December 31, 2018		2	$	5,217,800		816,883,910	$	15,145,798		-	$	-		1,122,311	$	22,000	$	2,043,235	$	(26,888,056	)	$	(4,459,223	)

Units issued for cash		-		-		14,797,278		1,000,000		-		-		-		-		-		-			1,000,000

Shares issued in exchange for accounts payable		-		-		4,052,652		281,659		-		-		-		-		-		-			281,659

Imputed interest - related party		-		-		-		-		-		-		-		-		4,947		-			4,947

Net loss for the three months ended March 31, 2019		-		-		-		-		-		-		-		-		-		(477,746	)		(477,746	)

Balance, March 31, 2019		2	$	5,217,800		835,733,840	$	16,427,457		-	$	-		1,122,311	$	22,000	$	2,048,182	$	(27,365,802	)	$	(3,650,363	)

Kraig Biocraft Laboratories, Inc. and Subsidiary

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	For the three months ended March 31,
	2020			2019
Cash Flows From Operating Activities:
Net Loss	$	(3,051,339	)	$	(477,746	)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense		7,379			6,665
Imputed interest - related party		9,784			4,947
Fair value of options issued for services		2,544,215			-
Changes in operating assets and liabilities:
Decrease in prepaid expenses		19,075			1,713
Operating lease right-of-use, net		28,728			10,737
Increase in accrued expenses and other payables - related party		174,705			162,725
(Decrease)Increase in accounts payable		(78,513	)		76,003
Operating lease liabilities		(26,647	)		(10,090	)
Net Cash Used In Operating Activities		(372,613	)		(225,046	)

Cash Flows From Investing Activities:
Purchase of Fixed Assets and Leasehold Improvements		-			-
Net Cash Used In Investing Activities		-			-

Cash Flows From Financing Activities:
Proceeds from Notes Payable - related party		300,000			120,000
Principal payments on debt		(15,000	)		(1,000	)
Proceeds from issuance of common stock		-			1,000,000
Net Cash Provided by Financing Activities		285,000			1,119,000

Net Increase in Cash		(87,613	)		893,954

Cash at Beginning of Period		125,024			13,697

Cash at End of Period	$	37,411		$	907,651

Supplemental disclosure of cash flow information:

Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-

Supplemental disclosure of non-cash investing and financing activities:
Settlement of accounts payable with note payable	$	-		$	265,244
Settlement of accounts payable with stock issuance	$	-		$	281,659
Adoption of lease standard ASC 842	$	-		$	167,867

Kraig Biocraft Laboratories, Inc.

Notes to Condensed Consolidated Financial Statements as of March 31, 2020 and 2019

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

(A) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations.

It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.

Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries.

(B) Foreign Currency

The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.

(C) Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.

(D) Cash

For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of March 31, 2020 or December 31, 2019.

(E) Loss Per Share

Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2020 and March 31, 2019, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.

The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

	March 31, 2020		March 31, 2019
Stock Warrants (Exercise price - $0.001/share)		55,995,917		58,595,917
Stock Options (Exercise price - $0.1150/Share)		27,340,000		-
Convertible Preferred Stock		2		2
Total		83,335,919		58,595,919

(F) Research and Development Costs

The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.

(G) Income Taxes

The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allows us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. Since the Tax Act was passed late in the fourth quarter of 2017, and ongoing guidance and accounting interpretation are expected over the next 12 months, we consider the accounting of the transition tax, deferred tax re-measurements, and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final year-end data and tax positions. We expect to complete our analysis within the measurement period in accordance with SAB 118.

Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2019 and December 31, 2017 there were no amounts that had been accrued in respect to uncertain tax positions.

Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.

Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.

(H) Stock-Based Compensation

The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations.

The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.

(I) Recent Accounting Pronouncements

In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As a result, the Company has recorded Right-to-use assets and corresponding Lease obligations as more fully discussed in Note 4.

All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

(J) Equipment

The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.

In accordance with FASB ASC No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

There were no impairment losses recorded for the three months ended March 31, 2020 and 2019.

(K) Fair Value of Financial Instruments

We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.

The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

	●	Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2020 and December 31, 2019.

	●	Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

	●	Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

	March 31, 2020		December 31, 2019
Level 1	$	-	$	-
Level 2	$	-	$	-
Level 3	$	-	$	-
Total	$	-	$	-

(L) Revenue Recognition

During the year ended December 31, 2019, the Company’s revenues were generated primarily from a contract with the U.S. Government. The Company performs work under this cost-plus-fixed-fee contract. Under the base phase of that contract the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017, to that original contract, the Company has worked to develop new recombinant silks.

Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

For the three months ended March 31, 2020 and 2019, the Company recognized $0 and $0 respectively in revenue from the Government contract. These revenues were generated for work performed in the development and production of the Company’s recombinant silks under the base and option period phases of our ongoing contract with the US Army.

On July 24, 2017, the Company signed a contract option extension with the US Army to research and deliver recombinant spider silk fibers and threads. This contract option increased the total contract award by an additional $921,130 to a total of $1,021,092 and added 12 months to the contract duration. This effort was scheduled to end on September 24, 2018, but the Company requested an extension of this contract option period through April 2019 to complete the work. The Company has been in communication with the contracting office and is working with them as they determine the best path forward; Management believes there is a possibility of securing a follow-up contract to complete the delivery of all materials for the contract. The Company is also continuing to pursue additional contract opportunities with the Department of Defense, Department of Energy and other governmental agencies.

(M) Concentration of Credit Risk

The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2020 and December 31, 2019, the Company had approximately $0 and $0, respectively in excess of FDIC insurance limits.

For the three months ended March 31, 2020 and 2019, the Company booked $0 and $0 for doubtful accounts.

NOTE 2 GOING CONCERN

As reflected in the accompanying financial statements, the Company has a working capital deficiency of $5,933,580 and stockholders’ deficiency of $5,885,398 and used $372,613 of cash in operations for three months ended March 31, 2020. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

NOTE 3 EQUIPMENT

At March 31, 2020 and December 31, 2019, property and equipment, net, is as follows:

	As of March 31, 2020			December 31, 2019
Automobile	$	41,805		$	41,805
Laboratory Equipment		96,536			96,536
Office Equipment		7,260			7,260
Leasehold Improvements		85,389			85,389
Less: Accumulated Depreciation		(121,048	)		(113,669	)
Total Property and Equipment, net	$	109,942		$	117,321

Depreciation expense for the three months ended March 31, 2020 and 2019, was $7,379 and $6,665, respectively.

NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITITY

Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $2,508 for conference facilities, mail, fax, and reception services located at our principal place of business.

On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $960. Rent expense – related party for the three months ended March 31, 2020 and 2019, was $3,135 and $5,760, respectively (See Note 9).

On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on September 30, 2019. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space.

On May 9, 2019 the Company signed a 5 year property lease with the Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. The adoption of the new guidance resulted in the recognition of ROU assets of $529,135 and lease liabilities of $531,462.

The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. In calculating the present value of the lease payments, the Company elected to utilize its incremental borrowing rate based on the remaining lease terms as of the January 1, 2019 adoption date. This rate was determined to be 8% and the Company determined the initial present value, at inception, of $559,568.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any.

The Company has elected the practical expedient to combine lease and non-lease components as a single component. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as right-of-use assets, current operating lease liabilities and non-current operating lease liabilities.

The new standard also provides practical expedients and certain exemptions for an entity’s ongoing accounting. We have elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases where the initial lease term is one year or less or for which the ROU asset at inception is deemed immaterial, we will not recognize ROU assets or lease liabilities. Those leases are expensed on a straight line basis over the term of the lease

Right to use assets is summarized below:

	March 31, 2020
Right to use assets, net – related party	$	60,486
Right to use assets, net		51,621
Right to use assets, net		332,407
Total	$	444,514

During the three months ended March 31, 2020, the Company recorded $26,550 as lease expense to current period operations.

During the three months ended March 31, 2020, the Company recorded $2,178 as lease expense – related party to current period operations.

Lease liability is summarized below:

	March 31, 2020
Right to use liability, net – related party		53,442
Right to use liability, net		61,789
Right to use liability, net		338,081
Total		453,312
Less: short term portion	$	(113,764	)
Long term position	$	339,548

Lease expense for the three months ended March 31, 2020 was comprised of the following:

Operating lease expense	$	15,582
Operating lease expense	$	9,142
Operating lease expense – related party	$	1,923

NOTE 5 ACCRUED INTEREST – RELATED PARTY

On June 6, 2016, the Company received a $50,000 loan from our principal stockholder. Subsequently on December 1, 2017, the Company received an additional $30,000 loan from the same stockholder. On January 8, 2018 and March 31, 2018 the Company received an additional loan of $100,000 and $15,000, respectively. The Company received additional loan funds from the same stockholder as follows: $20,000 on April 26, 2018; $15,000 on June 21, 2018; $15,000 on June 29, 2018; $20,000 on July 5, 2018; $26,000 on October 1, 2018; $11,000 on October 12, 2018; $20,000 on December 21, 2018; $3,000 on January 4, 2019; $30,000 on January 17, 2019; $30,000 on February 1, 2019; $20,000 on February 15, 2019; $20,000 on March 1, 2019; $17,000 on January 4, 2019, $100,000 on November 20, 2019, $100,000 on December 18, 2019, $100,000 on January 24, 2020, $100,000 on February 19, 2020 and $100,000 on March 9, 2020. Pursuant to the terms of the loan, the advance bears an interest at 3%, is unsecured, and due on demand. Total loan payable to principal stockholder for as of December 31, 2019 is $642,000. Total loan payable to this principal stockholder as of March 31, 2020 is $942,000. During the three months ended March 31, 2020, the Company recorded $9,784 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $5,958. During the three months ended March 31, 2019, the Company recorded $4,947 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $3,445.

NOTE 6 NOTE PAYABLE

On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $265,244 in exchange for outstanding account payable due to the debtor. Pursuant to the terms of the note, the note bears 10% interest per year from the date of default until the date the loan is paid in full. The term of the loan is twenty four months. The loan repayment commenced immediately over a twenty-four month period according to the following table. During the three months ended March 31, 2020, the Company paid $15,000 of the loan balance (See Note 8 (A)):

1. $1,000 per month for the first six months;

2. $2,000 per month for the months seven and eight;

3. $5,000 per month for months nine through twenty three; and,

4. Final payment of all remaining balance, in the amount of $180,224 in month 24.

NOTE 7 STOCKHOLDERS’ DEFICIT

(A) Common Stock Issued for Cash

On March 9, 2019, the Company entered into a purchase agreement with one investor (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 Units at a purchase price of $0.06758 per Unit, for total gross proceeds to the Company of $1,000,000. The Units consist of 14,797,278 shares of the Company’s Class A Common Stock (the “Common Stock”) and two warrants (the “Warrants”): (i) one warrant entitles the investor to purchase up to 14,797,278 shares of Common Stock at an exercise price of $0.06 per share (the “6 Cent Warrants”) and (ii) one warrant entitles the investor to purchase up to 7,398,639 shares of Common Stock at an exercise price of $0.08 per share (the “8 Cent Warrant”). The Warrants shall be exercisable at any time from the issuance date until the following expiration dates:

● ½ of all $0.06 Warrants shall expire on March 8, 2021;

● ½ of all $0.06 Warrants shall expire on March 8, 2022;

● ½ of all $0.08 Warrants shall expire on March 8, 2022; and,

● ½ of all $0.08 Warrants shall expire on March 8, 2023.

(B) Common Stock Issued for Services

Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant.

On March 20, 2019, the Company issued 4,052,652 shares of its class A common stock with a fair value of $281,659 ($0.0695/share) on the date of settlement. The Company settled $243,159 of accounts payable to the University of Notre Dame. The Company recorded an additional amount of $38,500 based on the fair value of the shares on the date of settlement. See Note 8 (A).

(C) Common Stock Warrants and Options

On February 19, 2020 the Company issued a 20-year option to purchase 20,000,000 shares of common stock at an exercise price of $0.0115 per share to a related party for services rendered. The options had a fair value of $2,198,411, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040. During the three months ended March 31, 2020, the Company recorded $2,198,411 as an expense for options issued.

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.56	%
Expected forfeitures	0	%

On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 shares of common stock at an exercise price of $.00115 per share to a related party for services rendered. The options had a fair value of $626,047, based upon the Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030. During the three months ended March 31, 2020, the Company recorded $208,682 as an expense for options issued.

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.50	%
Expected forfeitures	0	%

On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 shares of common stock at an exercise price of $0.0115 per share to employees for services rendered. The options had a fair value of $133,063, based upon the Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. During the three months ended March 31, 2020, the Company recorded $26,613 as an expense for options issued.

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	6 years
Risk free interest rate	1.46	%
Expected forfeitures	0	%

On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants. On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.

On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $267,574 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $66,528 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 3-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $291,842, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $36,331 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to an employee for services rendered. The options had a fair value of $14,859, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $14,859, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $16,723, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $4,158, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $18,240, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $2,271, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $19,525, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the three months ended March 31, 2020, the Company recorded $1,621, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2019, the Company recorded $19,915 as an expense for warrants issued. On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment. In addition the Company also recorded a $19,915 reduction to warrant expense related to the warrant cancellation.

Expected dividends	0	%
Expected volatility	97.56	%
Expected term	4 years
Risk free interest rate	2.65	%
Expected forfeitures	0	%

On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants.

On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)

Balance, December 31, 2019		55,395,917				2.77
Granted		-		-
Exercised		-		-
Cancelled/Forfeited		-		-
Balance, March 31, 2020		55,395,917				2.52
Intrinsic Value	$	9,799,286

For the three months ended March 31, 2020, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.40	$	3,675,000
$	0.056		3,000,000		1.36	$	350,000
$	0.04		2,300,000		1.40	$	402,500
$	0.06		7,398,639		0.94	$	1,294,762
$	0.06		7,398,639		1.94	$	1,294,762
$	0.08		3,699,320		1.94	$	647,381
$	0.08		3,699,320		2.94	$	647,381
$	0.2299		8,500,000		5.14	$	1,487,500

For the year ended December 31, 2019, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.65	$	4,069,800
$	0.056		3,000,000		1.61	$	387,600
$	0.04		2,300,000		1.70	$	445,740
$	0.06		7,398,639		1.19	$	1,433,856
$	0.06		7,398,639		2.19	$	1,433,856
$	0.08		3,699,320		2.19	$	716,928
$	0.08		3,699,320		3.19	$	719,928
$	0.2299		8,500,000		5.39	$	1,647,300

For the three months ended March 31, 2020, the following options were outstanding:

Weighted Average

Exercise

Options

Remaining

Price

Outstanding

Exercisable

Contractual Life

0.115

22,267,800

23.34

(D) Amendment to Articles of Incorporation

On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows:

●	Common stock Class A, unlimited number of shares authorized, no par value
●	Common stock Class B, unlimited number of shares authorized, no par value
●	Preferred stock, unlimited number of shares authorized, no par value

Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized.

(E) Common Stock Issued for Debt

None

NOTE 8 COMMITMENTS AND CONTINGENCIES

On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period at an annual salary of $210,000. There is a 6% annual increase. For the year ending December 31, 2015, the annual salary was $281,027. The employee is also to receive a 20% bonus based on the annual based salary. Any stock, stock options bonuses have to be approved by the board of directors. On January 1, 2016 the agreement was renewed with the same terms for another 5 years with an annual salary of $297,889 for the year ended December 31, 2016. On January 1, 2017 the agreement renewed with the same terms for another 5 years, but with an annual salary of $315,764 for the year ended December 31, 2017. On January 1, 2019 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $354,791 for the year ended December 31, 2019. On January 1, 2020 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $376,078 for the year ended December 31, 2020. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively. (See Note 9).

On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $120,000, which includes salary, health insurance, 401K retirement plan contributions, etc. The Company also agreed to reimburse Mr. Rice for his past educational expenses of approximately $11,000. In addition, Mr. Rice was issued a three-year warrant to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “January 2015 Warrant”) pursuant to the employment agreement. Additionally, on May 28, 2015, the Company issued a three-year warrant to purchase 3,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “May 20165 Warrant”) to Mr. Rice. The 2,000,000 share warrant fully vested on October 28, 2016. For the year ended December 31, 2015, the Company recorded $121,448 for the warrants issued to Mr. Rice. On January 14, 2016, the Company signed a new employment agreement with Mr. Rice. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additionally, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

●The Company maintaining $6,000,000 or more in working capital,

●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

●Upon the fifth year anniversary of the salary increase and the bonus issuance.

As of March 31, 2020 and December 31, 2019 the Company owes $73,582 and $64,352, respectively, to Mr. Rice for payroll payable.

On October 21, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year (effective August 15, 2019). The salary increase is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

●The Company maintaining $6,000,000 or more in working capital,

●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

●Upon the fifth year anniversary of the salary increase and the bonus issuance.

On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively.

(A) License Agreement

On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $10,000. The Company will pay a license maintenance fee of $10,000 on the one year anniversary of this agreement and each year thereafter. The Company will pay an annual research fee of $13,700 with first payment due January 2007, then on each subsequent anniversary of the effective date commencing May 4, 2007. The annual research fees are accrued by the Company for future payment. Pursuant to the terms of the agreement the Company may be required to pay additional fees aggregating up to a maximum of $10,000 a year for patent maintenance and prosecution relating to the licensed intellectual property.

On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 shares of its common stock and to pay a royalty of 2% of net sales. The license agreement has a term of 20 years which can be extended on an annual basis after that. It can be terminated by the University of Notre Dame if the Company defaults on its obligations under the agreement and fails to cure such default within 90 days of a written notice by the university. The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years. On May 5, 2017, the Company signed an addendum to that agreement relating to tangible property and project intellectual property. On March 1, 2019, the Company singed an addendum to that agreement. The Company entered into a separate loan agreement and promissory noted dated March 1, 2019 as a payment for expenses paid by the University prior to January 31, 2019 totaling $265,244 and issued 4,025,652 shares of Class A common stock with a fair value of $281,659 as payment of certain debt. In the event of default the license agreement will be terminated. During the three months ended March 31, 2020, the Company paid $15,000 of the balance (See Notes 6).

(B) Royalty and Research Agreements

On May 1, 2008 the Company entered into a five year consulting agreement for research and development. Pursuant to the terms of the agreement, the Company will be required to pay $1,000 per month, or at the Company’s option, the consulting fee may be paid in the form of Company common stock based upon the greater of $0.05 per share or the average of the closing price of the Company’s shares over the five days preceding such stock issuance. On April 6, 2018, the Company issued 36,000 shares with a fair value of $1,076 ($0.0299/share) to a consultant as consideration for consulting fees owed from October 1, 2014 through December 31, 2019 of $21,000. The issuance of shares resulted in gain on settlement of accounts payable of $19,924. On April 1, 2018, the Company ended the consulting agreement and no additional compensation will be issued. (See Note 7 (B)).

On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007. As of March 31, 2020 and December 31, 2019, the outstanding balance is $65,292. As of December 31, 2019, the Company recorded interest expense and related accrued interest payable of $2,623. In 2020 the Company recorded $490 in interest expensed and related accrued interest payable. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.

On December 30, 2015, the Company entered into a cooperative agreement for the research and pilot production of hybrid silkworms in Vietnam. Under this agreement, the Company will establish a subsidiary in Vietnam where it will develop and produce hybrid silkworms. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd.

(C) Consulting Agreement

On February 20, 2018, the Company signed an agreement with a consultant to provide services. Under this agreement the consultant will receive a warrant for 600,000 shares of common stock and may be awarded additional warrants for up to 3,000,000 shares of common stock if performance metrics are achieved. On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2018, the Company recorded $19,915 as an expense for warrants issued (See Note 7 (C)).’ On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment.

(D) Operating Lease Agreements

On May 9, 2019 the Company signed an 5 year property lease Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on March 31, 2020. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space. On September 5, 2019, the Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ends on September 30, 2021, for its research and development headquarters. The Company pays an annual rent of $42,000 for year one of the lease and $44,800 for year two of the lease.

NOTE 9 RELATED PARTY TRANSACTIONS

On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. Pursuant to the addendum, the Company agreed to issue either 200,000 preferred shares with the following preferences; no dividends and voting rights equal to 100 common shares per share of preferred stock or the payment of $120,000, the officer agreed to terminate the royalty payments due under the agreement and give title to the exclusive license for the non-protective apparel use of the intellectual property to the Company. On the date of the agreement, the Company did not have any preferred stock authorized with the required preferences. In accordance with FASB ASC No. 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007, one year anniversary of the addendum, should be recorded as an accrued expense until such time as the Company has the ability to assert that it has preferred shares authorized. As of March 31, 2020 the outstanding balance is $65,292. Additionally, the accrued expenses are accruing 7% interest per year. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.

On November 10, 2010, the Company entered into an employment agreement, with its CEO, effective January 1, 2011 through the December 31, 2015. Subsequently, on January 1, 2018 the agreement renewed with the same terms for another 5 years with an annual salary of $334,708 for the year ended December 31, 2019. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively.

On January 14, 2016 the Company signed a new employment agreement with Mr. Rice, the Company’s COO. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice. Additionally, on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additional, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

	●	The Company maintaining $6,000,000 or more in working capital,

	●	Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

	●	Upon the fifth year anniversary of the salary increase and the bonus issuance.

As of March 31, 2020 and December 31, 2019, the Company owes $73,582 and $64,351, respectively, to Mr. Rice for payroll payable.

On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to an annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively. ..

On January 23, 2017, the Company signed an 8 year property lease with the Company’s President for land in Texas. The Company pays $960 per month starting on February 1, 2017 and uses this facility to grow mulberry for its U.S. silk operations. Rent expense – related party for three months ended March 31, 2020 and 2019 was $3,135 and $3,273, respectively.

As of March 31, 2020 and December 31, 2019, there was $311,638 and $304,539, respectively, included in accounts payable and accrued expenses - related party, which is owed to the Company’s Chief Executive Officer and Chief Operations Officer.

As of March 31, 2020, there was $1,269,213 of accrued interest- related party and $50,163 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.

As of December 31, 2019, there was $1,196,503 of accrued interest- related party and $43,715 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.

As of March 31, 2020, the Company owes $2,616,686 in accrued salary to principal stockholder, $73,582 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,892 to its office employees.

As of December 31, 2019, the Company owes $2,535,203 in accrued salary to principal stockholder, $64,351 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,477 to its office employees.

The Company owes $65,292 in royalty payable to related party as of March 31, 2020 and December 31, 2019.

NOTE 10 SUBSEQUENT EVENTS

The Company has analyzed its operations subsequent to April 21, 2020 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose.

On April 16, 2020, the Company held a press conference announcing the development of the first Knock In / Knock Out essentially pure spider silk transgenic.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

FORWARD-LOOKING INFORMATION

The following information should be read in conjunction with Kraig Biocraft Laboratories, Inc. and its subsidiaries (“we”, “us”, “our”, or the “Company”) condensed unaudited financial statements and the notes thereto contained elsewhere in this report. Information in this Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and elsewhere in this Form 10-Q that does not consist of historical facts, are “forward-looking statements.” Statements accompanied or qualified by, or containing words such as “may,” “will,” “should,” “believes,” “expects,” “intends,” “plans,” “projects,” “estimates,” “predicts,” “potential,” “outlook,” “forecast,” “anticipates,” “presume,” and “assume” constitute forward-looking statements, and as such, are not a guarantee of future performance.

Forward-looking statements are subject to risks and uncertainties, certain of which are beyond our control. Actual results could differ materially from those anticipated as a result of the factors described in the “Risk Factors” and detailed in our other Securities and Exchange Commission (“SEC”) filings. Risks and uncertainties can include, among others, international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to obtain sufficient financing to continue and expand business operations; the ability to develop technology and products; changes in technology and the development of technology and intellectual property by competitors; the ability to protect technology and develop intellectual property; and other factors referenced in this and previous filings. Consequently, investors should not place undue reliance on forward-looking statements as predictive of future results.

Because of these risks and uncertainties, the forward-looking events and circumstances discussed in this report or incorporated by reference might not transpire. Factors that cause actual results or conditions to differ from those anticipated by these and other forward-looking statements include those more fully described elsewhere in this report and in the “Risk Factors” section of our registration statement on Form S-1.

The Company disclaims any obligation to update the forward-looking statements in this report.

Overview

Kraig Biocraft Laboratories, Inc. is a corporation organized under the laws of Wyoming on April 25, 2006. We were organized to develop high strength fibers using recombinant DNA technology, for commercial applications in both the specialty fiber and technical textile industries. Specialty fibers are engineered for specific uses that require exceptional strength, flexibility, heat resistance and/or chemical resistance. The specialty fiber market is exemplified by two synthetic fiber products: aramid fibers and ultra-high molecular weight polyethylene fiber. The technical textile industry involves products for both industrial and consumer products, such as filtration fabrics, medical textiles (e.g., sutures and artificial ligaments), safety and protective clothing and fabrics used in military and aerospace applications (e.g., high-strength composite materials).

We are using genetic engineering technologies to develop fibers with greater strength, resiliency and flexibility for use in our target markets, namely the textile, specialty fiber and technical textile industries.

The Report of Independent Registered Public Accounting Firm to our financial statements as of December 31, 2019 include an explanatory paragraph stating that our net loss from operations and net capital deficiency at December 31, 2019 raise substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Plan of Operations

During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations:

●	We plan to accelerate both our microbiology and selective breeding programs as well as provide more resources for our material testing protocols. We spent approximately $123,050 over the last 12 months on research and development of high strength polymers. In 2019, we directed our research and development efforts on growing our internal capabilities; we plan to continue to dedicate our efforts in 2020 to grow our internal research and development programs.

●	We will consider buying an established revenue producing company in a compatible business, in order to broaden our financial base and facilitate the commercialization of our products; as of the date hereof, we have not had any formal discussion or entered into any definitive agreements regarding any such purchase.

●	We will also actively consider pursuing collaborative research opportunities with both private and university laboratories in areas of research which overlap the company’s existing research and development. One such potential area for collaborative research which the company is considering is protein expression platforms. If our financing allows, management will give strong consideration to increasing the breadth of our research to include protein expression platform technologies.

●	We plan to actively pursue collaborative research and product testing opportunities with companies in the biotechnology, materials, textile and other industries.

●	We plan to actively pursue collaborative commercialization, marketing and manufacturing opportunities with companies in the textile and material sectors for the fibers we developed and for any new polymers that we create in the remainder of 2020 and going forward.

●	Once safe to restart operation, following the COVID-19 pandemic, we plan resume production operations at our factory in Vietnam and expect to continue to expand our monthly production volumes to address demand for materials.

●	We have initiated and plan to accelerate our efforts for large scale US production. This work will include the research and production of a new transgenic tailored specifically domestic production.

Limited Operating History

We have not previously demonstrated that we will be able to expand our business through an increased investment in our research and development efforts. We cannot guarantee that the research and development efforts described in this filing will be successful. Our business is subject to risks inherent in growing an enterprise, including limited capital resources, risks inherent in the research and development process and possible rejection of our products in development.

If financing is not available on satisfactory terms, we may be unable to continue our research and development and other operations. Equity financing will result in dilution to existing shareholders.

Impact of COVID-19 Outbreak

On January 30, 2020, the World Health Organization declared the coronavirus outbreak a “Public Health Emergency of International Concern” and on March 10, 2020, declared it to be a pandemic. Actions taken around the world to help mitigate the spread of the coronavirus include restrictions on travel, and quarantines in certain areas, and forced closures for certain types of public places and businesses. The coronavirus and actions taken to mitigate it have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. While the closures and limitations on movement, domestically and internationally, are expected to be temporary, if the outbreak continues on its current trajectory the duration of the supply chain disruption could reduce the availability, or result in delays, of materials or supplies to and from the Company, which in turn could materially interrupt the Company’s business operations. Given the speed and frequency of the continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the impact to its consolidated results of operations. The Company’s manufacturing facilities support business that have been deemed essential by their respective state governments and remain operational. We have taken every precaution possible to ensure the safety of our employees.

On March 19, 2020, the Company furloughed non-essential staff consistent with leading health official recommendations in order to help prevent the spread of COVID-19. This decision was made in an abundance of caution and will primarily impact staff at our fully owned subsidiary, Prodigy Textiles, in Vietnam and will result in the temporary closing of silk rearing operations at that facility. The Company is supporting its furloughed staff and will continue to pay their salaries through at least April 30 and is actively considering continuing that financial support through May. During the duration of the furlough, the Company CEO will not receive or accrue any pay.

Additionally, it is reasonably possible that estimates made in the financial statements have been, or will be, materially and adversely impacted in the near term as a result of these conditions, including losses on inventory; impairment losses related to goodwill and other long-lived assets and current obligations.

Three months ended March 31, 2020 compared to the three months ended March 31, 2019

Our revenue, operating expenses, and net loss from operations for the three month period ended March 31, 2020 as compared to the three month period ended March 31, 2019, were as follows – some balances on the prior period’s combined financial statements have been reclassified to conform to the current period presentation:

	Three Months Ended March 31,									% Change Increase
	2020			2019			Change			(Decrease)
NET REVENUES	$	-		$	-			-			0.00	%
OPERATING EXPENSES:
General and Administrative		2,792,781			117,967			2,674,814			2,267.43	%
Professional Fees		19,374			150,311			(130,937	)		-87.11	%
Officer’s Salary		144,562			118,155			26,407			22.35	%
Rent - Related Party		3,135			3,273			(138	)		-4.22	%
Research and Development		4,812			22,304			(17,492	)		-78.43	%
Total operating expenses		2,964,664			412,010			2,552,654			619.56	%
Loss from operations		(2,964,664	)		(412,010	)		(2,552,654	)		619.56	%
Interest expense		(86,675	)		(66,920	)		(19,755	)		29.52	%
Interest income		-			1,184			(1,184	)		100.00	%
Net Loss	$	(3,051,339	)	$	(477,746	)		(2,573,593	)		538.69	%

Net Revenues: During the three months ended March 31, 2020, we realized $0 of revenues from our business. During the three months ended March 31, 2019, we realized $0 of revenues from our business. The change in revenues between the quarter ended March 31, 2020 and 2019 was $0 or 0%.

Cost of Revenues: Costs of revenues for the three months ended March 31, 2020 were $0, as compared to $0 for the three months ended March 31, 2019, a change of $0 or 0%.

Gross Profit: During the three months ended March 31, 2020, we realized a gross profit of $0, as compared to $0 for the three months ended March 31, 2019, a change of $0 or 0%.

Research and development expenses: During the three months ended March 31, 2020, we incurred $4,812 of research and development expenses. During the three months ended March 31, 2019, we incurred $22,304 of research and development expenses, a decrease of $17,492 or 78.43% compared with the same period in 2019. This decrease was due to a reduction in research spend.

Professional Fees: During the three months ended March 31, 2020, we incurred $19,374 of professional expenses, which decresed by $130,937 or 87.11% from $150,311 for the three months ended March 31, 2019. This decrease was primarily due to a decrease in professional fees associated with valuation services for the Company’s stock.

Officers Salary: During the three months ended March 31, 2020, officers’ salary expenses increased to $144,562 or 22.35% from $118,155 for the three months ended March 31, 2019.

General and Administrative Expense: General and administrative expenses increased by $2,674,814 or 2,267.43% to $2,792,781 for the three months ended March 31, 2020 from $117,967 for the three months ended March 31, 2019. Our general and administrative expenses for the three months ended March 31, 2020 consisted of other general and administrative expenses (which includes expenses such as auto, business development, SEC filings, investor relations, general office, warrants issued for services) of $2,711,283, Travel of $14 and office salary of $81,484, for a total of $2,792,781. Our general and administrative expenses for the three months ended March 31, 2019 consisted of consulting fees of $0 and other general and administrative expenses (which includes expenses such as Auto, Business Development, SEC Filing, Investor Relations, General Office) of $73,665, Travel of $30 and office salary of $44,272, for a total of $117,967. The primary reason for this increase March 31, 2020 was primarily due to an increase in the expense associated with the issuance of warrants for services.

Rent – Related Party: During the three months ended March 31, 2020, rent- related party expense decreased to $3,135 or 4.22 % from $3,273 for the three months ended March 31, 2019. The rent-related party expense was attributable to the signing on January 23, 2017 the Company signed an eight year property lease with the Company’s President.

Interest Expense: Interest expense increase by $19,755 to $86,675 for the three month period ended March 31, 2020 from $66,920 for the three month period ended March 31, 2019. The increase was primarily due to interest on certain Company loans.

Interest Income: Interest income decreased by $1,184 to $0 for the three month period ended March 31, 2020 from $1,184 for the three month period ended March 31, 2019. The decrease was primarily due to interest on bank accounts.

Net Loss: Net loss increased by $2,573,593, or 538.69 %, to a net loss of $3,051,339 for the three month period ended March 31, 2020 from a net loss of $477,746 for the three month period ended March 31, 2019. This increase in net loss was primarily attributable to both increases in general and administrative expenses and a decrease in revenues.

Capital Resources and Liquidity

Our financial statements have been presented on the basis that are a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. As presented in the financial statements, we incurred a net loss of $3,051,339 during the three months ended March 31, 2020, and losses are expected to continue in the near term. The accumulated deficit is $32,849,245 at March 31, 2020. Refer to Note 2 for our discussion of stockholder deficit. We have been funding our operations through private loans and the sale of common stock in private placement transactions. Refer to Note 6 and Note 7 in the financial statements for our discussion of notes payable and shares issued, respectively. Our cash resources are insufficient to meet our planned business objectives without additional financing. These and other factors raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of our company to continue as a going concern.

Management anticipates that significant additional expenditures will be necessary to develop and expand our business before significant positive operating cash flows can be achieved. Our ability to continue as a going concern is dependent upon our ability to raise additional capital and to ultimately achieve sustainable revenues and profitable operations. At March 31, 2020, we had $37,411 of cash on hand. These funds are insufficient to complete our business plan and as a consequence, we will need to seek additional funds, primarily through the issuance of debt or equity securities for cash to operate our business. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in the case of equity financing.

Management has undertaken steps as part of a plan to improve operations with the goal of sustaining our operations for the next twelve months and beyond. These steps include (a) raising additional capital and/or obtaining financing; (b) controlling overhead and expenses; and (c) executing material sales or research contracts. There can be no assurance that the Company can successfully accomplish these steps and it is uncertain that the Company will achieve a profitable level of operations and obtain additional financing. There can be no assurance that any additional financing will be available to the Company on satisfactory terms and conditions, if at all. As of the date of this Report, we have not entered into any formal agreements regarding the above.

In the event the Company is unable to continue as a going concern, the Company may elect or be required to seek protection from its creditors by filing a voluntary petition in bankruptcy or may be subject to an involuntary petition in bankruptcy. To date, management has not considered this alternative, nor does management view it as a likely occurrence.

Cash, total current assets, total assets, total current liabilities and total liabilities as of March 31, 2020 as compared to December 31, 2019, were as follows:

	March 31, 2020		December 31, 2019
Cash	$	37,411	$	125,024
Prepaid expenses	$	12,670	$	31,745
Total current assets	$	50,081	$	156,769
Total assets	$	608,055	$	750,850
Total current liabilities	$	5,983,661	$	5,584,383
Total liabilities	$	6,493,453	$	6,138,908

At March 31, 2020, we had a working capital deficit of $5,933,580 compared to a working capital deficit of $5,427,614 at December 31, 2019. Current liabilities increased to $5,983,661 at March 31, 2020 from $5,584,383 at December 31, 2019, primarily as a result of primarily as a result of accounts payable, note payable and accrued compensation.

For the three months ended March 31, 2020, net cash used in operations of $372,613 was the result of a net loss of $3,051,339 offset by offset by depreciation expense of $7,379, options issuance to related parties of $2,544,215, imputed interest on related party loans of $9,784, decrease in prepaid expenses of $19,075 and a decrease in operating lease right of use of $28,728, an increase of accrued expenses and other payables-related party of $174,705, decrease in accounts payable of $78,513 and a decrease in operating lease liabilities of $26,647. For the three months ended March 31, 2019, net cash used in operations of $225,046 was the result of a net loss of $477,746 offset by offset by depreciation expense of $6,665, imputed interest on related party loans of $4,947, decrease in prepaid expenses of $1,713 and increase in operating lease right of use of $162,725, an increase of accrued expenses and other payables-related party of $10,737, an increase in accounts payable of $76,003 and a decrease in operating lease liabilities of $10,090.

Net cash used in our investing activities were $0 and $0 for the three months ended March 31, 2020 and March 31, 2019, respectively. Our investing activities for the three months ended March 31, 2019 are attributable to purchases of fixed assets.

Our financing activities resulted in a cash inflow of $285,000 for the three months ended March 31, 2020, which is represented by $15,000 loan repayment and $300,000 proceeds from a shareholder note payable. Our financing activities resulted in a cash inflow of $1,119,000 for the three months ended March 31, 2019, which is represented by $1,000,000 proceeds from issuance of common stock, $1,000 loan repayment and $120,000 proceeds from shareholder note payable.

Critical Accounting Policies

Please refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the year ended December 31, 2019, for disclosures regarding the Company’s critical accounting policies and estimates, as well as updates further disclosed in our interim financial statements as described in this Form 10-Q.

Recent Accounting Pronouncements

All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, financings, or other relationships with unconsolidated entities or other persons, also known as “special purpose entities” (SPEs).

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of our fiscal quarter ended March 31, 2020, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon those evaluations, management concluded that our disclosure controls and procedures were not effective as of March 31, 2020, to cause the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods prescribed by SEC, and that such information is accumulated and communicated to management, including our chief executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Going forward from this filing, the Company intends to work on re-establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

During the quarter covered by this Report, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. Although we continue to educate our management personnel to increase to increase its ability to comply with the disclosure requirements and financial reporting controls and management oversight of accounting and reporting functions in the future, as we stated in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, we do not expect to remediate the weaknesses in our internal controls over financial reporting until the time when we start to commercialize a recombinant fiber and, therefore may have sufficient cash flow to carry out our remediation plans.

Part II – Other Information

Item 1. Legal Proceedings

From time to time, the Company may become a party to litigation or other legal proceedings that it considers to be a part of the ordinary course of its business. To the best of our knowledge, the Company is not currently involved in any legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations; however, the Company may become involved in material legal proceedings in the future.

Item 1A. Risk Factors

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

(a)	Not applicable.
(b)	None.

ITEM 6. EXHIBITS

EXHIBIT INDEX

Exhibit No.		Description
3.1		Articles of Incorporation (1)
3.2		Articles of Amendment (2)
3.3		Articles of Amendment, filed with the Wyoming Secretary of State on November 15, 2013 (3)
3.4		Articles of Amendment, filed with the Wyoming Secretary of State on December 17, 2013 (4)
3.5		Bylaws(1)
4.1		Form of Warrant issued Mr. Jonathan R. Rice (5)
4.1		Form of Warrant issued pursuant to that certain Purchase Agreement dated as of March 8, 2019 (7)
10.1		Employment Agreement between Mr. Jonathan Rice and the Company (6)
10.2		Form of Purchase Agreement dated March 8, 2019 (7)
31.1		Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
31.2		Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.1		Certification of the Principal Executive Officer pursuant to U.S.C. Section 1350 As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
32.2		Certification of the Principal Financial Officer pursuant to U.S.C. Section 1350 As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
101.INS		XBRL Instance Document (filed herewith)
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

1.	Incorporated by reference to our Registration Statement on Form SB-2 (Reg. No. 333-146316) filed with the SEC on September 26, 2007.
2.	Incorporated by reference to our Registration Statement on Form S-1 (Reg. No. 333-162316) filed with the SEC on October 2, 2009.
3.	Incorporated by reference to our Current Report on Form 8-K filed with the SEC on November 22, 2013.
4.	Incorporated by reference to our Current Report on Form 8-K filed with the SEC on December 19, 2013.
5.	Incorporated by reference to our Annual Report on Form 10-K filed with the SEC on March 22, 2017.
6.	Incorporated by reference to our Current Report on Form 8-K filed with the SEC on January 21, 2015.
7.	Incorporate by reference to our Current Report on Form 8-K filed with the SEC on March 11, 2019.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf of the undersigned thereunto duly authorized

	Kraig Biocraft Laboratories, Inc.
	(Registrant)

Date: April 21, 2020	By:	/s/ Kim Thompson
		Kim Thompson
		President, Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer)

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A) OR RULE 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kim Thompson, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2020, of Kraig Biocraft Laboratories, Inc.;

2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 21, 2020	By:	/s/ Kim Thompson
		Kim Thompson
		Chief Executive Officer
		(Principal Executive Officer)

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULE 13A-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kim Thompson, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the period ended March 31, 2020, of Kraig Biocraft Laboratories, Inc.;

2	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 21, 2020	By:	/s/ Kim Thompson
		Kim Thompson
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kim Thompson, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

	1.	The Quarterly Report on Form 10-Q of Kraig Biocraft Laboratories, Inc. (the “Company”) for the period ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (U.S.C. 78m or 78o(d)); and

	2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 21, 2020

By:

/s/ Kim Thompson

Kim Thompson

Chief Executive Officer

(Principal Executive Officer)

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of a separate disclosure document.

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kim Thompson, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

	1.	The Quarterly Report on Form 10-Q of Kraig Biocraft Laboratories, Inc. (the “Company”) for the period ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (U.S.C. 78m or 78o(d)); and

	2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: April 21, 2020	By:	/s/ Kim Thompson
		Kim Thompson
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-101.INS 6 kblb-20200331.xml XBRL INSTANCE FILE 0001413119 2020-01-01 2020-03-31 0001413119 2019-12-31 0001413119 2020-03-31 0001413119 us-gaap:CommonClassAMember 2019-12-31 0001413119 us-gaap:CommonClassAMember 2020-03-31 0001413119 us-gaap:CommonClassBMember 2019-12-31 0001413119 us-gaap:CommonClassBMember 2020-03-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2018-12-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2019-12-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001413119 us-gaap:RetainedEarningsMember 2018-12-31 0001413119 us-gaap:RetainedEarningsMember 2019-12-31 0001413119 2017-07-24 0001413119 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001413119 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001413119 us-gaap:FairValueInputsLevel3Member 2019-12-31 0001413119 us-gaap:AutomobilesMember 2019-12-31 0001413119 KBLB:LaboratoryEquipmentMember 2019-12-31 0001413119 us-gaap:OfficeEquipmentMember 2019-12-31 0001413119 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001413119 2017-01-23 0001413119 2017-01-22 2017-01-23 0001413119 2017-09-13 0001413119 KBLB:SocialistRepublicOfVietnamMember 2019-05-09 0001413119 2019-01-02 0001413119 2018-04-25 2018-04-26 0001413119 2018-06-20 2018-06-21 0001413119 2018-06-28 2018-06-29 0001413119 2018-07-04 2018-07-05 0001413119 2018-09-27 2018-10-01 0001413119 2018-10-11 2018-10-12 0001413119 2018-12-20 2018-12-21 0001413119 2019-01-03 2019-01-04 0001413119 2019-01-16 2019-01-17 0001413119 2019-01-29 2019-02-01 0001413119 2019-02-14 2019-02-15 0001413119 2019-02-28 2019-03-01 0001413119 2019-11-19 2019-11-20 0001413119 2019-12-17 2019-12-18 0001413119 KBLB:UnsecuredPromissoryNoteMember KBLB:NotreDameMember 2019-03-01 0001413119 KBLB:PurchaseAgreementMember us-gaap:InvestorMember 2019-03-07 2019-03-09 0001413119 KBLB:CommonStockAndWarrantsMember 2019-03-07 2019-03-09 0001413119 KBLB:SixCentWarrantMember 2019-03-08 0001413119 KBLB:EightCentWarrantMember 2019-03-09 0001413119 us-gaap:WarrantMember 2019-03-07 2019-03-09 0001413119 KBLB:WarrantOneMember 2019-03-07 2019-03-09 0001413119 KBLB:WarrantTwoMember 2019-03-07 2019-03-09 0001413119 KBLB:WarrantThreeMember 2019-03-07 2019-03-09 0001413119 us-gaap:WarrantMember 2019-03-09 0001413119 KBLB:WarrantOneMember 2019-03-09 0001413119 KBLB:WarrantTwoMember 2019-03-09 0001413119 KBLB:WarrantThreeMember 2019-03-09 0001413119 2019-03-19 2019-03-20 0001413119 2019-03-20 0001413119 KBLB:UniversityOfNotreDameMember 2019-03-19 2019-03-20 0001413119 2019-09-25 2019-09-26 0001413119 2019-09-26 0001413119 2019-08-12 2019-08-14 0001413119 2019-08-14 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2019-01-01 2019-12-31 0001413119 KBLB:CommonStockWarrantsAndOptionsOneMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsOneMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsTwoMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsTwoMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsThreeMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsThreeMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsThreeMember 2019-01-01 2019-12-31 0001413119 KBLB:CommonStockWarrantsAndOptionsFourMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsFourMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsFourMember 2019-01-01 2019-12-31 0001413119 KBLB:CommonStockWarrantsAndOptionsFiveMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsFiveMember 2019-08-07 2020-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsFiveMember 2019-01-01 2019-12-31 0001413119 KBLB:CommonStockWarrantsAndOptionsSixMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsSixMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsSevenMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsSevenMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsEightMember 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsEightMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2018-03-20 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2018-03-19 2018-03-20 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2018-01-01 2018-12-31 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2019-04-02 2020-04-05 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsFiveMember 2019-08-07 2019-08-08 0001413119 KBLB:CommonStockWarrantsAndOptionsNineMember 2018-03-19 2018-03-20 0001413119 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001413119 us-gaap:WarrantMember 2019-12-31 0001413119 KBLB:WarrantOneMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantOneMember 2019-12-31 0001413119 KBLB:WarrantTwoMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantTwoMember 2019-12-31 0001413119 KBLB:WarrantThreeMember 2019-12-31 0001413119 KBLB:WarrantThreeMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantFourMember 2019-12-31 0001413119 KBLB:WarrantFourMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantFiveMember 2019-12-31 0001413119 KBLB:WarrantFiveMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantSixMember 2019-12-31 0001413119 KBLB:WarrantSixMember 2019-01-01 2019-12-31 0001413119 KBLB:WarrantSevenMember 2019-12-31 0001413119 KBLB:WarrantSevenMember 2019-01-01 2019-12-31 0001413119 KBLB:CommonClassAStockMember 2019-12-31 0001413119 KBLB:CommonClassAStockMember 2018-12-31 0001413119 KBLB:SeriesAPreferredStocksMember 2019-12-31 0001413119 KBLB:SeriesAPreferredStocksMember 2018-12-31 0001413119 KBLB:CommonClassBStockMember 2018-12-31 0001413119 KBLB:CommonClassBStockMember 2019-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2010-11-09 2010-11-10 0001413119 KBLB:EmploymentAgreementMember KBLB:EmployeeMember 2015-01-01 2015-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2015-01-01 2015-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2016-01-01 2016-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2017-01-01 2017-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2019-12-31 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember KBLB:JanuaryTwoThousandAndFifteenWarrantMember 2015-01-20 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember KBLB:MayTwoThousandAndFifteenWarrantMember 2015-05-28 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2015-10-28 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2015-12-31 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2019-04-25 2019-04-26 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2019-08-12 2019-08-15 0001413119 KBLB:MrJonathanRRiceMember 2019-12-31 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2019-08-15 0001413119 KBLB:EmploymentAgreementMember KBLB:MrKennethLeMember 2019-07-03 0001413119 KBLB:EmploymentAgreementMember KBLB:MrKennethLeMember 2019-07-02 2019-07-03 0001413119 KBLB:EmploymentAgreementMember KBLB:MrKennethLeMember 2019-12-31 0001413119 KBLB:LicenseAgreementMember 2006-05-07 2006-05-08 0001413119 KBLB:LicenseAgreementMember 2007-01-01 2007-01-31 0001413119 KBLB:LicenseAgreementMember srt:MaximumMember 2007-01-01 2007-01-31 0001413119 KBLB:LicenseAgreementMember 2011-10-27 2011-10-28 0001413119 KBLB:LicenseAgreementMember us-gaap:CommonClassAMember 2019-01-29 2019-01-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember 2008-04-29 2008-05-01 0001413119 KBLB:RoyaltyAndResearchAgreementsMember srt:MaximumMember 2008-05-01 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:ConsultantMember 2018-04-05 2018-04-06 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:ConsultantMember 2018-04-06 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:MrThompsonMember 2006-12-25 2006-12-26 0001413119 KBLB:RoyaltyAndResearchAgreementsMember 2019-12-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:MrThompsonMember 2019-12-31 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2018-02-19 2018-02-20 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2018-02-20 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2018-03-19 2018-03-20 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2018-03-20 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2019-04-02 2019-04-05 0001413119 KBLB:OperatingLeaseAgreementsMember KBLB:SocialistRepublicOfVietnamMember 2019-05-08 2019-05-09 0001413119 KBLB:OperatingLeaseAgreementsMember srt:PresidentMember 2017-01-22 2017-01-23 0001413119 KBLB:OperatingLeaseAgreementsMember srt:PresidentMember 2017-01-23 0001413119 KBLB:OperatingLeaseAgreementsMember KBLB:SocialistRepublicOfVietnamMember 2019-05-09 0001413119 KBLB:OperatingLeaseAgreementsMember 2017-09-13 0001413119 KBLB:OperatingLeaseAgreementsMember 2017-09-12 2017-09-13 0001413119 KBLB:OperatingLeaseAgreementsMember KBLB:OfficeAndManufacturingSpaceMember 2017-09-12 2017-09-13 0001413119 KBLB:OperatingLeaseAgreementsMember 2019-09-04 2019-09-05 0001413119 KBLB:OperatingLeaseAgreementsMember 2019-09-05 0001413119 KBLB:IntellectualPropertyTransferAgreementMember KBLB:MrThompsonMember 2006-12-25 2006-12-26 0001413119 KBLB:IntellectualPropertyTransferAgreementMember KBLB:MrThompsonMember 2006-12-26 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2019-01-01 2019-12-31 0001413119 KBLB:StockholderMember 2016-06-05 2016-06-06 0001413119 KBLB:StockholderMember 2018-01-06 2018-01-08 0001413119 KBLB:StockholderMember 2018-03-30 2018-03-31 0001413119 KBLB:StockholderMember 2018-04-25 2018-04-26 0001413119 KBLB:StockholderMember 2018-06-20 2018-06-21 0001413119 KBLB:StockholderMember 2018-06-28 2018-06-29 0001413119 KBLB:StockholderMember 2018-07-04 2018-07-05 0001413119 KBLB:StockholderMember 2018-09-29 2018-10-02 0001413119 KBLB:StockholderMember 2018-10-11 2018-10-12 0001413119 KBLB:StockholderMember 2018-12-20 2018-12-21 0001413119 KBLB:StockholderMember 2019-01-03 2019-01-04 0001413119 KBLB:StockholderMember 2019-01-16 2019-01-17 0001413119 KBLB:StockholderMember 2019-01-29 2019-02-01 0001413119 KBLB:StockholderMember 2019-02-14 2019-02-15 0001413119 KBLB:StockholderMember 2019-02-27 2019-03-02 0001413119 KBLB:StockholderMember 2018-12-29 2019-01-05 0001413119 KBLB:StockholderMember 2019-11-19 2019-11-20 0001413119 KBLB:StockholderMember 2019-12-17 2019-12-18 0001413119 KBLB:StockholderMember 2019-12-31 0001413119 KBLB:RelatedPartyMember 2019-12-31 0001413119 srt:ChiefOperatingOfficerMember 2019-12-31 0001413119 srt:BoardOfDirectorsChairmanMember 2019-12-31 0001413119 KBLB:OfficeEmployeeMember 2019-12-31 0001413119 KBLB:RelatedPartyMember 2019-01-01 2019-12-31 0001413119 KBLB:SocialistRepublicOfVietnamMember KBLB:ThreeThroughFiveYearsMember 2019-05-08 2019-05-09 0001413119 2016-06-05 2016-06-06 0001413119 2017-11-30 2017-12-01 0001413119 2018-01-06 2018-01-09 0001413119 2018-03-30 2018-03-31 0001413119 KBLB:LoanOneMember 2019-01-03 2019-01-04 0001413119 KBLB:UnsecuredPromissoryNoteMember KBLB:NotreDameMember 2019-02-27 2019-03-01 0001413119 KBLB:PurchaseAgreementMember us-gaap:InvestorMember 2019-03-09 0001413119 KBLB:UniversityOfNotreDameMember 2019-03-20 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2015-01-19 2015-01-20 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember KBLB:OneTimeBonusMember 2019-04-25 2019-04-26 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember srt:MaximumMember 2018-02-20 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2019-10-20 2019-10-21 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2019-10-21 0001413119 KBLB:StockholderMember us-gaap:SubsequentEventMember 2017-12-02 2020-04-18 0001413119 KBLB:ChiefExecutiveOfficerAndChiefOperationsOfficerMember 2019-12-31 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2016-01-14 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2016-01-13 2016-01-14 0001413119 KBLB:EmploymentAgreementMember KBLB:MrJonathanRRiceMember 2018-01-06 2018-01-09 0001413119 us-gaap:SeriesAPreferredStockMember 2020-03-31 0001413119 us-gaap:SeriesAPreferredStockMember 2019-12-31 0001413119 2019-01-01 2019-03-31 0001413119 KBLB:SeriesAPreferredStocksMember 2020-01-01 2020-03-31 0001413119 KBLB:SeriesAPreferredStocksMember 2019-01-01 2019-03-31 0001413119 KBLB:SeriesAPreferredStocksMember 2020-03-31 0001413119 KBLB:SeriesAPreferredStocksMember 2019-03-31 0001413119 KBLB:CommonClassAStockMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonClassAStockMember 2019-01-01 2019-03-31 0001413119 KBLB:CommonClassAStockMember 2020-03-31 0001413119 KBLB:CommonClassAStockMember 2019-03-31 0001413119 KBLB:CommonClassBStockMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonClassBStockMember 2019-01-01 2019-03-31 0001413119 KBLB:CommonClassBStockMember 2020-03-31 0001413119 KBLB:CommonClassBStockMember 2019-03-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2019-01-01 2019-03-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2020-03-31 0001413119 KBLB:CommonStockClassASharesToBeIssuedMember 2019-03-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001413119 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001413119 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001413119 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001413119 us-gaap:RetainedEarningsMember 2020-03-31 0001413119 us-gaap:RetainedEarningsMember 2019-03-31 0001413119 2018-12-31 0001413119 2019-03-31 0001413119 2018-01-01 2018-01-02 0001413119 2019-01-01 2019-12-31 0001413119 2017-01-01 2017-12-31 0001413119 KBLB:StockWarrantsMember 2020-01-01 2020-03-31 0001413119 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-03-31 0001413119 KBLB:StockWarrantsMember 2019-01-01 2019-03-31 0001413119 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-03-31 0001413119 us-gaap:FairValueInputsLevel1Member 2020-03-31 0001413119 us-gaap:FairValueInputsLevel2Member 2020-03-31 0001413119 us-gaap:FairValueInputsLevel3Member 2020-03-31 0001413119 us-gaap:AutomobilesMember 2020-03-31 0001413119 KBLB:LaboratoryEquipmentMember 2020-03-31 0001413119 us-gaap:OfficeEquipmentMember 2020-03-31 0001413119 us-gaap:LeaseholdImprovementsMember 2020-03-31 0001413119 2015-09-01 2020-03-31 0001413119 KBLB:RelatedPartyMember 2020-01-01 2020-03-31 0001413119 KBLB:RelatedPartyMember 2019-01-01 2019-03-31 0001413119 KBLB:RightToUseAssetsNetRelatedPartyMember 2020-03-31 0001413119 KBLB:RightToUseAssetsNetMember 2020-03-31 0001413119 KBLB:RightToUseAssetsNetOneMember 2020-03-31 0001413119 KBLB:RightToUseLiabilityNetRelatedPartyMember 2020-03-31 0001413119 KBLB:RightToUseLiabilityNetMember 2020-03-31 0001413119 KBLB:RightToUseLiabilityNetOneMember 2020-03-31 0001413119 KBLB:OperatingLeaseExpensesMember 2020-01-01 2020-03-31 0001413119 KBLB:OperatingLeaseExpensesOneMember 2020-01-01 2020-03-31 0001413119 KBLB:OperatingLeaseExpensesRelatedPartyMember 2020-01-01 2020-03-31 0001413119 2020-01-23 2020-01-24 0001413119 2020-02-18 2020-02-19 0001413119 2020-03-08 2020-03-09 0001413119 KBLB:FirstSixMonthsMember 2020-01-01 2020-03-31 0001413119 KBLB:SevenAndEightMonthsMember 2020-01-01 2020-03-31 0001413119 KBLB:NineThroughTwentyThreeMonthsMember 2020-01-01 2020-03-31 0001413119 KBLB:TwentyFourthMonthsMember 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsOneMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2020-02-18 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionsMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionOneMember 2020-02-18 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionOneMember 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionOneMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionTwoMember 2020-02-18 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionTwoMember 2020-02-19 0001413119 KBLB:CommonStockWarrantsAndOptionTwoMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsTwoMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsSixMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsSevenMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionsEightMember 2020-01-01 2020-03-31 0001413119 KBLB:CommonStockWarrantsAndOptionMember 2020-02-18 2020-02-19 0001413119 us-gaap:WarrantMember 2020-03-31 0001413119 us-gaap:WarrantMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantOneMember 2020-03-31 0001413119 KBLB:WarrantOneMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantTwoMember 2020-03-31 0001413119 KBLB:WarrantTwoMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantThreeMember 2020-03-31 0001413119 KBLB:WarrantThreeMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantFourMember 2020-03-31 0001413119 KBLB:WarrantFourMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantFiveMember 2020-03-31 0001413119 KBLB:WarrantFiveMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantSixMember 2020-03-31 0001413119 KBLB:WarrantSixMember 2020-01-01 2020-03-31 0001413119 KBLB:WarrantSevenMember 2020-03-31 0001413119 KBLB:WarrantSevenMember 2020-01-01 2020-03-31 0001413119 srt:ScenarioForecastMember KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2020-01-01 2020-12-31 0001413119 KBLB:EmploymentAgreementMember srt:ChiefExecutiveOfficerMember 2020-03-31 0001413119 KBLB:MrJonathanRRiceMember 2020-03-31 0001413119 KBLB:EmploymentAgreementMember KBLB:MrKennethLeMember 2020-03-31 0001413119 KBLB:LicenseAgreementMember 2020-01-01 2020-03-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:ConsultantMember 2014-10-01 2019-12-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember KBLB:MrThompsonMember 2020-03-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember 2020-03-31 0001413119 KBLB:RoyaltyAndResearchAgreementsMember srt:ScenarioForecastMember 2020-12-31 0001413119 KBLB:OperatingLeaseAgreementsMember 2020-01-01 2020-03-31 0001413119 KBLB:OperatingLeaseAgreementsMember 2019-01-01 2019-03-31 0001413119 KBLB:IntellectualPropertyTransferAgreementMember KBLB:MrThompsonMember 2020-03-31 0001413119 KBLB:EmploymentAgreementMember 2018-01-06 2018-01-09 0001413119 KBLB:StockholderMember 2020-01-23 2020-01-24 0001413119 KBLB:StockholderMember 2020-02-18 2020-02-19 0001413119 KBLB:StockholderMember 2020-03-08 2020-03-09 0001413119 KBLB:StockholderMember 2020-03-31 0001413119 KBLB:StockholderMember 2019-03-31 0001413119 KBLB:OperatingLeaseAgreementsMember srt:PresidentMember 2020-01-01 2020-03-31 0001413119 KBLB:OperatingLeaseAgreementsMember srt:PresidentMember 2019-01-01 2019-03-31 0001413119 KBLB:ChiefExecutiveOfficerAndChiefOperationsOfficerMember 2020-03-31 0001413119 KBLB:RelatedPartyMember 2020-03-31 0001413119 KBLB:PrincipalStockHoldersMember 2020-03-31 0001413119 srt:ChiefOperatingOfficerMember 2020-03-31 0001413119 srt:BoardOfDirectorsChairmanMember 2020-03-31 0001413119 KBLB:OfficeEmployeeMember 2020-03-31 0001413119 KBLB:PrincipalStockHoldersMember 2019-12-31 0001413119 KBLB:RelatedPartyMember 2020-01-01 2020-03-31 0001413119 us-gaap:CommonClassAMember 2020-04-21 0001413119 us-gaap:CommonClassBMember 2020-04-21 0001413119 us-gaap:CommonClassAMember 2020-01-01 2020-03-31 0001413119 us-gaap:CommonClassAMember 2019-01-01 2019-12-31 0001413119 us-gaap:CommonClassBMember 2020-01-01 2020-03-31 0001413119 us-gaap:CommonClassBMember 2019-01-01 2019-12-31 0001413119 KBLB:ConsultingAgreementMember KBLB:ConsultantMember 2018-01-01 2018-12-31 0001413119 KBLB:OperatingLeaseAgreementsMember KBLB:SocialistRepublicOfVietnamMember KBLB:ThreeThroughFiveYearsMember 2019-05-08 2019-05-09 0001413119 KBLB:StockOptionsMember 2020-01-01 2020-03-31 0001413119 KBLB:StockOptionsMember 2019-01-01 2019-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft false 2020-03-31 Q1 2020 --12-31 Kraig Biocraft Laboratories, Inc 0001413119 Yes Non-accelerated Filer true false false 844468378 0 Yes

31745

12670

156769

50081

117321

109942

473242

444514

529135

60486

51621

332407

3518

750850

608055

560948

482435

642000

942000

110678

113764

531462

60000

5584383

5983661

185244

170244

369281

339548

6138908

6493453

5217800

2412969

4966968

-29797906

-32849245

-5388058

-5885398

22000

2043235

2412969

-26888056

-29797906

16757079

15145798

5217800

16757079

16427457

22000

4966968

2048182

-32849245

-27365802

-4459223

-3650363

750850

608055

844468378

22000 22000 1122311 1122311

16757079

2792781

117967

19374

1000

150311

21000

4812

22304

144562

210000

281027

297889

315764

20000

354791

20000

118155

376078

3135 3273

2964664

412010

-2964664

-412010

1184

-86675

-65736

-3051339

-477746

-3051339

-477746

-3051339

-477746

-0.00

0.00

844468378

822016321

7379

6665

-78513

76003

-26647

-10090

-372613

-225046

2544215

1000000

285000

1119000

-87613

893954

125024

37411

13697

907651

265244 281659 167867

1122311

844468378

816883910

844468378

835733840

1122311

4052652 281659 281659

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION   (A) Basis of Presentation   The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations.   It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.   Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries.   (B) Foreign Currency   The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.   (C) Use of Estimates   In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.   (D) Cash   For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of March 31, 2020 or December 31, 2019.   (E) Loss Per Share   Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2020 and March 31, 2019, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.   The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Stock Warrants (Exercise price - $0.001/share)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">55,995,917</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">58,595,917</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock Options (Exercise price - $0.1150/Share)</td> <td> </td> <td> </td> <td style="text-align: right">27,340,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Convertible Preferred Stock</td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td> </td> <td style="text-align: right">83,335,919</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">58,595,919</td> <td> </td></tr> </table>   (F) Research and Development Costs   The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.   (G) Income Taxes   The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allows us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. Since the Tax Act was passed late in the fourth quarter of 2017, and ongoing guidance and accounting interpretation are expected over the next 12 months, we consider the accounting of the transition tax, deferred tax re-measurements, and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final year-end data and tax positions. We expect to complete our analysis within the measurement period in accordance with SAB 118.   Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2019 and December 31, 2017 there were no amounts that had been accrued in respect to uncertain tax positions.   Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.   Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.   (H) Stock-Based Compensation   The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations.   The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.   (I) Recent Accounting Pronouncements   In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements.   In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As a result, the Company has recorded Right-to-use assets and corresponding Lease obligations as more fully discussed in Note 4.   All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.   (J) Equipment   The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.   In accordance with FASB ASC No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.   There were no impairment losses recorded for the three months ended March 31, 2020 and 2019.   (K) Fair Value of Financial Instruments   We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.   The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2020 and December 31, 2019.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Level 1</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">        -</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">          -</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Level 2</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Level 3</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> </table>   (L) Revenue Recognition   During the year ended December 31, 2019, the Company’s revenues were generated primarily from a contract with the U.S. Government. The Company performs work under this cost-plus-fixed-fee contract. Under the base phase of that contract the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017, to that original contract, the Company has worked to develop new recombinant silks.   Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.   For the three months ended March 31, 2020 and 2019, the Company recognized $0 and $0 respectively in revenue from the Government contract. These revenues were generated for work performed in the development and production of the Company’s recombinant silks under the base and option period phases of our ongoing contract with the US Army.   On July 24, 2017, the Company signed a contract option extension with the US Army to research and deliver recombinant spider silk fibers and threads. This contract option increased the total contract award by an additional $921,130 to a total of $1,021,092 and added 12 months to the contract duration. This effort was scheduled to end on September 24, 2018, but the Company requested an extension of this contract option period through April 2019 to complete the work. The Company has been in communication with the contracting office and is working with them as they determine the best path forward; Management believes there is a possibility of securing a follow-up contract to complete the delivery of all materials for the contract. The Company is also continuing to pursue additional contract opportunities with the Department of Defense, Department of Energy and other governmental agencies.   (M) Concentration of Credit Risk   The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2020 and December 31, 2019, the Company had approximately $0 and $0, respectively in excess of FDIC insurance limits.   For the three months ended March 31, 2020 and 2019, the Company booked $0 and $0 for doubtful accounts.

NOTE 2 GOING CONCERN   As reflected in the accompanying financial statements, the Company has a working capital deficiency of $5,933,580 and stockholders’ deficiency of $5,885,398 and used $372,613 of cash in operations for three months ended March 31, 2020. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.   Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

NOTE 3 EQUIPMENT   At March 31, 2020 and December 31, 2019, property and equipment, net, is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of March 31, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Automobile</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">41,805</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">41,805</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Laboratory Equipment</td> <td> </td> <td> </td> <td style="text-align: right">96,536</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">96,536</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Office Equipment</td> <td> </td> <td> </td> <td style="text-align: right">7,260</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,260</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Leasehold Improvements</td> <td> </td> <td> </td> <td style="text-align: right">85,389</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">85,389</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: Accumulated Depreciation</td> <td> </td> <td> </td> <td style="text-align: right">(121,048</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(113,669</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Property and Equipment, net</td> <td> </td> <td>$</td> <td style="text-align: right">109,942</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">117,321</td> <td> </td></tr> </table>   Depreciation expense for the three months ended March 31, 2020 and 2019, was $7,379 and $6,665, respectively.

NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITITY   Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $2,508 for conference facilities, mail, fax, and reception services located at our principal place of business.   On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $960. Rent expense – related party for the three months ended March 31, 2020 and 2019, was $3,135 and $5,760, respectively (See Note 9).   On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on September 30, 2019. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space.   On May 9, 2019 the Company signed a 5 year property lease with the Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.   In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.   The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. The adoption of the new guidance resulted in the recognition of ROU assets of $529,135 and lease liabilities of $531,462.   The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. In calculating the present value of the lease payments, the Company elected to utilize its incremental borrowing rate based on the remaining lease terms as of the January 1, 2019 adoption date. This rate was determined to be 8% and the Company determined the initial present value, at inception, of $559,568.   Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any.   The Company has elected the practical expedient to combine lease and non-lease components as a single component. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as right-of-use assets, current operating lease liabilities and non-current operating lease liabilities.   The new standard also provides practical expedients and certain exemptions for an entity’s ongoing accounting. We have elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases where the initial lease term is one year or less or for which the ROU asset at inception is deemed immaterial, we will not recognize ROU assets or lease liabilities. Those leases are expensed on a straight line basis over the term of the lease   Right to use assets is summarized below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Right to use assets, net – related party</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">60,486</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Right to use assets, net</td> <td> </td> <td> </td> <td style="text-align: right">51,621</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right to use assets, net</td> <td> </td> <td> </td> <td style="text-align: right">332,407</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td>$</td> <td style="text-align: right">444,514</td> <td> </td></tr> </table>   During the three months ended March 31, 2020, the Company recorded $26,550 as lease expense to current period operations.   During the three months ended March 31, 2020, the Company recorded $2,178 as lease expense – related party to current period operations.   Lease liability is summarized below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Right to use liability, net – related party</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">53,442</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Right to use liability, net</td> <td> </td> <td> </td> <td style="text-align: right">61,789</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right to use liability, net</td> <td> </td> <td> </td> <td style="text-align: right">338,081</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td> </td> <td style="text-align: right">453,312</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: short term portion</td> <td> </td> <td>$</td> <td style="text-align: right">(113,764</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Long term position</td> <td> </td> <td>$</td> <td style="text-align: right">339,548</td> <td> </td></tr> </table>   Lease expense for the three months ended March 31, 2020 was comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Operating lease expense</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">15,582</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating lease expense</td> <td> </td> <td>$</td> <td style="text-align: right">9,142</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Operating lease expense – related party</td> <td> </td> <td>$</td> <td style="text-align: right">1,923</td> <td> </td></tr> </table> NOTE 5 ACCRUED INTEREST – RELATED PARTY   On June 6, 2016, the Company received a $50,000 loan from our principal stockholder. Subsequently on December 1, 2017, the Company received an additional $30,000 loan from the same stockholder. On January 8, 2018 and March 31, 2018 the Company received an additional loan of $100,000 and $15,000, respectively. The Company received additional loan funds from the same stockholder as follows: $20,000 on April 26, 2018; $15,000 on June 21, 2018; $15,000 on June 29, 2018; $20,000 on July 5, 2018; $26,000 on October 1, 2018; $11,000 on October 12, 2018; $20,000 on December 21, 2018; $3,000 on January 4, 2019; $30,000 on January 17, 2019; $30,000 on February 1, 2019; $20,000 on February 15, 2019; $20,000 on March 1, 2019; $17,000 on January 4, 2019, $100,000 on November 20, 2019, $100,000 on December 18, 2019, $100,000 on January 24, 2020, $100,000 on February 19, 2020 and $100,000 on March 9, 2020. Pursuant to the terms of the loan, the advance bears an interest at 3%, is unsecured, and due on demand. Total loan payable to principal stockholder for as of December 31, 2019 is $642,000. Total loan payable to this principal stockholder as of March 31, 2020 is $942,000. During the three months ended March 31, 2020, the Company recorded $9,784 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $5,958. During the three months ended March 31, 2019, the Company recorded $4,947 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $3,445.

NOTE 6 NOTE PAYABLE   On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $265,244 in exchange for outstanding account payable due to the debtor. Pursuant to the terms of the note, the note bears 10% interest per year from the date of default until the date the loan is paid in full. The term of the loan is twenty four months. The loan repayment commenced immediately over a twenty-four month period according to the following table. During the three months ended March 31, 2020, the Company paid $15,000 of the loan balance (See Note 8 (A)):   1. $1,000 per month for the first six months; 2. $2,000 per month for the months seven and eight; 3. $5,000 per month for months nine through twenty three; and, 4. Final payment of all remaining balance, in the amount of $180,224 in month 24.

NOTE 7 STOCKHOLDERS’ DEFICIT   (A) Common Stock Issued for Cash   On March 9, 2019, the Company entered into a purchase agreement with one investor (the “Purchase Agreement”). Pursuant to the Purchase Agreement, the Company issued the investor 14,797,278 Units at a purchase price of $0.06758 per Unit, for total gross proceeds to the Company of $1,000,000. The Units consist of 14,797,278 shares of the Company’s Class A Common Stock (the “Common Stock”) and two warrants (the “Warrants”): (i) one warrant entitles the investor to purchase up to 14,797,278 shares of Common Stock at an exercise price of $0.06 per share (the “6 Cent Warrants”) and (ii) one warrant entitles the investor to purchase up to 7,398,639 shares of Common Stock at an exercise price of $0.08 per share (the “8 Cent Warrant”). The Warrants shall be exercisable at any time from the issuance date until the following expiration dates:   ● ½ of all $0.06 Warrants shall expire on March 8, 2021; ● ½ of all $0.06 Warrants shall expire on March 8, 2022; ● ½ of all $0.08 Warrants shall expire on March 8, 2022; and, ● ½ of all $0.08 Warrants shall expire on March 8, 2023.   (B) Common Stock Issued for Services   Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant.   On March 20, 2019, the Company issued 4,052,652 shares of its class A common stock with a fair value of $281,659 ($0.0695/share) on the date of settlement. The Company settled $243,159 of accounts payable to the University of Notre Dame. The Company recorded an additional amount of $38,500 based on the fair value of the shares on the date of settlement. See Note 8 (A).   (C) Common Stock Warrants and Options   On February 19, 2020 the Company issued a 20-year option to purchase 20,000,000 shares of common stock at an exercise price of $0.0115 per share to a related party for services rendered. The options had a fair value of $2,198,411, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040. During the three months ended March 31, 2020, the Company recorded $2,198,411 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.56</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 shares of common stock at an exercise price of $.00115 per share to a related party for services rendered. The options had a fair value of $626,047, based upon the Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030. During the three months ended March 31, 2020, the Company recorded $208,682 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.50</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 shares of common stock at an exercise price of $0.0115 per share to employees for services rendered. The options had a fair value of $133,063, based upon the Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. During the three months ended March 31, 2020, the Company recorded $26,613 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">6 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.46</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants. On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.   On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $267,574 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $66,528 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 3-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $291,842, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $36,331 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to an employee for services rendered. The options had a fair value of $14,859, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $14,859, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $16,723, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $4,158, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $18,240, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $2,271, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $19,525, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the three months ended March 31, 2020, the Company recorded $1,621, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2019, the Company recorded $19,915 as an expense for warrants issued. On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment. In addition the Company also recorded a $19,915 reduction to warrant expense related to the warrant cancellation.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">97.56</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">4 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">2.65</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants.   On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Number of Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life (in Years)</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%">Balance, December 31, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">55,395,917</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">2.77</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">    -</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Cancelled/Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Balance, March 31, 2020</td> <td> </td> <td> </td> <td style="text-align: right">55,395,917</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.52</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Intrinsic Value</td> <td> </td> <td>$</td> <td style="text-align: right">9,799,286</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   For the three months ended March 31, 2020, the following warrants were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Warrants Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Warrants Exercisable</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.001</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">21,000,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">1.40</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">3,675,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.056</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.36</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">350,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,300,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.40</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">402,500</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,294,762</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,294,762</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">647,381</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">647,381</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.2299</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,500,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.14</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,487,500</td> <td> </td></tr> </table>   For the year ended December 31, 2019, the following warrants were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Warrants Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Warrants Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.001</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">21,000,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">1.65</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">4,069,800</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.056</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.61</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">387,600</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,300,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.70</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">445,740</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,433,856</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,433,856</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">716,928</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">719,928</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.2299</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,500,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.39</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,647,300</td> <td> </td></tr> </table>   For the three months ended March 31, 2020, the following options were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Exercise</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Options</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Options</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Remaining</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Contractual Life</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.115</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">22,267,800</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">23.34</td> <td style="width: 1%"> </td></tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table>   (D) Amendment to Articles of Incorporation   On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 14px">●</td> <td style="text-align: justify">Common stock Class A, unlimited number of shares authorized, no par value</td></tr> <tr style="vertical-align: top"> <td>●</td> <td style="text-align: justify">Common stock Class B, unlimited number of shares authorized, no par value</td></tr> <tr style="vertical-align: top"> <td>●</td> <td style="text-align: justify">Preferred stock, unlimited number of shares authorized, no par value</td></tr> </table>   Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized.   (E) Common Stock Issued for Debt   None

NOTE 8 COMMITMENTS AND CONTINGENCIES   On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period at an annual salary of $210,000. There is a 6% annual increase. For the year ending December 31, 2015, the annual salary was $281,027. The employee is also to receive a 20% bonus based on the annual based salary. Any stock, stock options bonuses have to be approved by the board of directors. On January 1, 2016 the agreement was renewed with the same terms for another 5 years with an annual salary of $297,889 for the year ended December 31, 2016. On January 1, 2017 the agreement renewed with the same terms for another 5 years, but with an annual salary of $315,764 for the year ended December 31, 2017. On January 1, 2019 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $354,791 for the year ended December 31, 2019. On January 1, 2020 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $376,078 for the year ended December 31, 2020. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively. (See Note 9).   On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $120,000, which includes salary, health insurance, 401K retirement plan contributions, etc. The Company also agreed to reimburse Mr. Rice for his past educational expenses of approximately $11,000. In addition, Mr. Rice was issued a three-year warrant to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “January 2015 Warrant”) pursuant to the employment agreement. Additionally, on May 28, 2015, the Company issued a three-year warrant to purchase 3,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “May 20165 Warrant”) to Mr. Rice. The 2,000,000 share warrant fully vested on October 28, 2016. For the year ended December 31, 2015, the Company recorded $121,448 for the warrants issued to Mr. Rice. On January 14, 2016, the Company signed a new employment agreement with Mr. Rice. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additionally, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:   ●The Company maintaining $6,000,000 or more in working capital, ●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or ●Upon the fifth year anniversary of the salary increase and the bonus issuance.   As of March 31, 2020 and December 31, 2019 the Company owes $73,582 and $64,352, respectively, to Mr. Rice for payroll payable.   On October 21, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year (effective August 15, 2019). The salary increase is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:   ●The Company maintaining $6,000,000 or more in working capital, ●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or ●Upon the fifth year anniversary of the salary increase and the bonus issuance.   On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively.   (A) License Agreement   On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $10,000. The Company will pay a license maintenance fee of $10,000 on the one year anniversary of this agreement and each year thereafter. The Company will pay an annual research fee of $13,700 with first payment due January 2007, then on each subsequent anniversary of the effective date commencing May 4, 2007. The annual research fees are accrued by the Company for future payment. Pursuant to the terms of the agreement the Company may be required to pay additional fees aggregating up to a maximum of $10,000 a year for patent maintenance and prosecution relating to the licensed intellectual property.   On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 shares of its common stock and to pay a royalty of 2% of net sales. The license agreement has a term of 20 years which can be extended on an annual basis after that. It can be terminated by the University of Notre Dame if the Company defaults on its obligations under the agreement and fails to cure such default within 90 days of a written notice by the university. The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years. On May 5, 2017, the Company signed an addendum to that agreement relating to tangible property and project intellectual property. On March 1, 2019, the Company singed an addendum to that agreement. The Company entered into a separate loan agreement and promissory noted dated March 1, 2019 as a payment for expenses paid by the University prior to January 31, 2019 totaling $265,244 and issued 4,025,652 shares of Class A common stock with a fair value of $281,659 as payment of certain debt. In the event of default the license agreement will be terminated. During the three months ended March 31, 2020, the Company paid $15,000 of the balance (See Notes 6).   (B) Royalty and Research Agreements   On May 1, 2008 the Company entered into a five year consulting agreement for research and development. Pursuant to the terms of the agreement, the Company will be required to pay $1,000 per month, or at the Company’s option, the consulting fee may be paid in the form of Company common stock based upon the greater of $0.05 per share or the average of the closing price of the Company’s shares over the five days preceding such stock issuance. On April 6, 2018, the Company issued 36,000 shares with a fair value of $1,076 ($0.0299/share) to a consultant as consideration for consulting fees owed from October 1, 2014 through December 31, 2019 of $21,000. The issuance of shares resulted in gain on settlement of accounts payable of $19,924. On April 1, 2018, the Company ended the consulting agreement and no additional compensation will be issued. (See Note 7 (B)).   On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007. As of March 31, 2020 and December 31, 2019, the outstanding balance is $65,292. As of December 31, 2019, the Company recorded interest expense and related accrued interest payable of $2,623. In 2020 the Company recorded $490 in interest expensed and related accrued interest payable. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.   On December 30, 2015, the Company entered into a cooperative agreement for the research and pilot production of hybrid silkworms in Vietnam. Under this agreement, the Company will establish a subsidiary in Vietnam where it will develop and produce hybrid silkworms. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd.   (C) Consulting Agreement   On February 20, 2018, the Company signed an agreement with a consultant to provide services. Under this agreement the consultant will receive a warrant for 600,000 shares of common stock and may be awarded additional warrants for up to 3,000,000 shares of common stock if performance metrics are achieved. On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2018, the Company recorded $19,915 as an expense for warrants issued (See Note 7 (C)).’ On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment.   (D) Operating Lease Agreements   Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $2,508 for conference facilities, mail, fax, and reception services located at our principal place of business.   On May 9, 2019 the Company signed an 5 year property lease Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.   On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $960. Rent expense – related party for the three months ended March 31, 2020 and 2019, was $3,135 and $3,273, respectively (See Note 9).   On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on March 31, 2020. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space. On September 5, 2019, the Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ends on September 30, 2021, for its research and development headquarters. The Company pays an annual rent of $42,000 for year one of the lease and $44,800 for year two of the lease.

NOTE 9 RELATED PARTY TRANSACTIONS   On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. Pursuant to the addendum, the Company agreed to issue either 200,000 preferred shares with the following preferences; no dividends and voting rights equal to 100 common shares per share of preferred stock or the payment of $120,000, the officer agreed to terminate the royalty payments due under the agreement and give title to the exclusive license for the non-protective apparel use of the intellectual property to the Company. On the date of the agreement, the Company did not have any preferred stock authorized with the required preferences. In accordance with FASB ASC No. 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007, one year anniversary of the addendum, should be recorded as an accrued expense until such time as the Company has the ability to assert that it has preferred shares authorized. As of March 31, 2020 the outstanding balance is $65,292. Additionally, the accrued expenses are accruing 7% interest per year. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.   On November 10, 2010, the Company entered into an employment agreement, with its CEO, effective January 1, 2011 through the December 31, 2015. Subsequently, on January 1, 2018 the agreement renewed with the same terms for another 5 years with an annual salary of $334,708 for the year ended December 31, 2019. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively.   On January 14, 2016 the Company signed a new employment agreement with Mr. Rice, the Company’s COO. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice. Additionally, on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additional, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">The Company maintaining $6,000,000 or more in working capital,</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Upon the fifth year anniversary of the salary increase and the bonus issuance.</td></tr> </table>   As of March 31, 2020 and December 31, 2019, the Company owes $73,582 and $64,351, respectively, to Mr. Rice for payroll payable.   On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to an annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively. .   On June 6, 2016, the Company received a $50,000 loan from our principal stockholder. Subsequently on December 1, 2017, the Company received an additional $30,000 loan from the same stockholder. On January 8, 2018 and March 31, 2018 the Company received an additional loan of $100,000 and $15,000, respectively. The Company received additional loan funds from the same stockholder as follows: $20,000 on April 26, 2018; $15,000 on June 21, 2018; $15,000 on June 29, 2018; $20,000 on July 5, 2018; $26,000 on October 1, 2018; $11,000 on October 12, 2018; $20,000 on December 21, 2018; $3,000 on January 4, 2019; $30,000 on January 17, 2019; $30,000 on February 1, 2019; $20,000 on February 15, 2019; $20,000 on March 1, 2019; $17,000 on January 4, 2019, $100,000 on November 20, 2019, $100,000 on December 18, 2019, $100,000 on January 24, 2020, $100,000 on February 19, 2020 and $100,000 on March 9, 2020. Pursuant to the terms of the loan, the advance bears an interest at 3%, is unsecured, and due on demand. Total loan payable to principal stockholder for as of December 31, 2019 is $642,000. Total loan payable to this principal stockholder as of March 31, 2020 is $942,000. During the three months ended March 31, 2020, the Company recorded $9,784 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $5,958. During the three months ended March 31, 2019, the Company recorded $4,947 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $3,445.   On January 23, 2017, the Company signed an 8 year property lease with the Company’s President for land in Texas. The Company pays $960 per month starting on February 1, 2017 and uses this facility to grow mulberry for its U.S. silk operations. Rent expense – related party for three months ended March 31, 2020 and 2019 was $3,135 and $3,273, respectively.   As of March 31, 2020 and December 31, 2019, there was $311,638 and $304,539, respectively, included in accounts payable and accrued expenses - related party, which is owed to the Company’s Chief Executive Officer and Chief Operations Officer.   As of March 31, 2020, there was $1,269,213 of accrued interest- related party and $50,163 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.   As of December 31, 2019, there was $1,196,503 of accrued interest- related party and $43,715 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.   As of March 31, 2020, the Company owes $2,616,686 in accrued salary to principal stockholder, $73,582 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,892 to its office employees.   As of December 31, 2019, the Company owes $2,535,203 in accrued salary to principal stockholder, $64,351 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,477 to its office employees.   The Company owes $65,292 in royalty payable to related party as of March 31, 2020 and December 31, 2019.

NOTE 10 SUBSEQUENT EVENTS   The Company has analyzed its operations subsequent to April 21, 2020 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose.   On April 16, 2020, the Company held a press conference announcing the development of the first Knock In / Knock Out essentially pure spider silk transgenic.

125024

37411

83335919

58595919

55995917

58595917

27340000

0.001

0.06

0.08

0.06

0.08

0.001

0.056

0.04

0.06

0.08

0.2299

0.001

0.2299

0.001

0.056

0.04

0.06

0.08

0.2299

41805

96536

7260

85389

41805

96536

7260

85389

960

39200

42000

44800

2508

3135

5760

2508

960

P8Y

P2Y

P5Y

4560.57

15582

9142

1923

453312

53442

61789

338081

65292

9784

4947

20000

15000

20000

26000

11000

20000

3000

30000

20000

100000

50000

30000

100000

15000

17000

100000

0.03

0.10

0.07

0.03

5958

2623

1196503

3445

7033

490

7033

5958

3445

1269213

642000

942000

P1Y

P24M

0.0695

0.2299

0.06758

0.0115

0.00115

0.0115

2021-03-08 2022-03-08 2022-03-08 2023-03-08

14797278

4052652

766667

7967871

2000000

1000000

125000

2000000

2200000

4025652

36000

200000

14797278

20000000

6000000

1340000

281659

38500

281659

1076

120000

1000000

243159

P4Y

P3Y

P4Y

P3Y

19915

267574

118874

14859

66528

2198411

208682

26613

36331

4158

2271

1621

19915 19915

0.00

1.0573

0.9756

1.2519

P2Y

P3Y

P2Y

P3Y

P2Y

P4Y

P3Y

P6Y

P3Y

0.0162

0.0154

0.0162

0.0154

0.0162

0.0265

0.0150

0.0146

0.0156

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

55395917

9799286 4069800 387600 445740 1433856 1433856 716928 719928 1647300 3675000 350000 402500 1294762 1294762 647381 647381 1487500 21000000 3000000 2300000 7398639 7398639 3699320 3699320 8500000 21000000 3000000 2300000 7398639 7398639 3699320 3699320 8500000 P2Y9M7D P1Y7M24D P1Y7M10D P1Y8M12D P1Y2M8D P2Y2M8D P2Y2M8D P3Y2M8D P5Y4M20D P1Y4M24D P1Y4M9D P1Y4M24D P0Y11M8D P1Y11M8D P1Y11M8D P2Y11M8D P5Y1M20D Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024. Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040. Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030. Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. P2Y P3Y P2Y P2Y P2Y P2Y P2Y P2Y P2Y P20Y P10Y P7Y

113668

121048

86675

66920

-9784 -4947

-19075

-1713

-28728 -10737

(B) Foreign Currency   The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.

(C) Use of Estimates   In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.

(D) Cash   For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of March 31, 2020 or December 31, 2019.

(E) Loss Per Share   Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2020 and March 31, 2019, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.   The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Stock Warrants (Exercise price - $0.001/share)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">55,995,917</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">58,595,917</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock Options (Exercise price - $0.1150/Share)</td> <td> </td> <td> </td> <td style="text-align: right">27,340,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Convertible Preferred Stock</td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td> </td> <td style="text-align: right">83,335,919</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">58,595,919</td> <td> </td></tr> </table>

(F) Research and Development Costs   The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.

(G) Income Taxes   The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.   On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allows us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. Since the Tax Act was passed late in the fourth quarter of 2017, and ongoing guidance and accounting interpretation are expected over the next 12 months, we consider the accounting of the transition tax, deferred tax re-measurements, and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final year-end data and tax positions. We expect to complete our analysis within the measurement period in accordance with SAB 118.   Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2019 and December 31, 2017 there were no amounts that had been accrued in respect to uncertain tax positions.   Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.   Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.

(H) Stock-Based Compensation   The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations.   The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.

(I) Recent Accounting Pronouncements   In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements.   In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As a result, the Company has recorded Right-to-use assets and corresponding Lease obligations as more fully discussed in Note 4.   All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

(J) Equipment   The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.   In accordance with FASB ASC No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.   There were no impairment losses recorded for the three months ended March 31, 2020 and 2019.

(K) Fair Value of Financial Instruments   We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.   The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px">●</td> <td style="text-align: justify">Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2020 and December 31, 2019.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.</td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td>●</td> <td style="text-align: justify">Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Level 1</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">        -</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">          -</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Level 2</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Level 3</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> </table>

(M) Concentration of Credit Risk   The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2020 and December 31, 2019, the Company had approximately $0 and $0, respectively in excess of FDIC insurance limits.   For the three months ended March 31, 2020 and 2019, the Company booked $0 and $0 for doubtful accounts.

The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2019</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Stock Warrants (Exercise price - $0.001/share)</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">55,995,917</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">58,595,917</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Stock Options (Exercise price - $0.1150/Share)</td> <td> </td> <td> </td> <td style="text-align: right">27,340,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Convertible Preferred Stock</td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td> </td> <td style="text-align: right">83,335,919</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">58,595,919</td> <td> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Level 1</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">        -</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">          -</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Level 2</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Level 3</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">-</td> <td> </td></tr> </table>

At March 31, 2020 and December 31, 2019, property and equipment, net, is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">As of March 31, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%">Automobile</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">41,805</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 14%; text-align: right">41,805</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Laboratory Equipment</td> <td> </td> <td> </td> <td style="text-align: right">96,536</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">96,536</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Office Equipment</td> <td> </td> <td> </td> <td style="text-align: right">7,260</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,260</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Leasehold Improvements</td> <td> </td> <td> </td> <td style="text-align: right">85,389</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">85,389</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: Accumulated Depreciation</td> <td> </td> <td> </td> <td style="text-align: right">(121,048</td> <td>)</td> <td> </td> <td> </td> <td style="text-align: right">(113,669</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total Property and Equipment, net</td> <td> </td> <td>$</td> <td style="text-align: right">109,942</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">117,321</td> <td> </td></tr> </table>

Lease expense for the three months ended March 31, 2020 was comprised of the following:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Operating lease expense</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">15,582</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Operating lease expense</td> <td> </td> <td>$</td> <td style="text-align: right">9,142</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Operating lease expense – related party</td> <td> </td> <td>$</td> <td style="text-align: right">1,923</td> <td> </td></tr> </table>

On February 19, 2020 the Company issued a 20-year option to purchase 20,000,000 shares of common stock at an exercise price of $0.0115 per share to a related party for services rendered. The options had a fair value of $2,198,411, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040. During the three months ended March 31, 2020, the Company recorded $2,198,411 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.56</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On February 19, 2020 the Company issued a 10-year option to purchase 6,000,000 shares of common stock at an exercise price of $.00115 per share to a related party for services rendered. The options had a fair value of $626,047, based upon the Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030. During the three months ended March 31, 2020, the Company recorded $208,682 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.50</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On February 19, 2020 the Company issued a 7-year option to purchase 1,340,000 shares of common stock at an exercise price of $0.0115 per share to employees for services rendered. The options had a fair value of $133,063, based upon the Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027. During the three months ended March 31, 2020, the Company recorded $26,613 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">125.19</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected term</td> <td> </td> <td> </td> <td style="text-align: right">6 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.46</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants. On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.   On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $267,574 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $66,528 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 3-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $291,842, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $36,331 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to an employee for services rendered. The options had a fair value of $14,859, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023. During the year ended December 31, 2019, the Company recorded $14,859, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year option to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $16,723, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $4,158, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">2 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.62</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $18,240, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2021. Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026. During the three months ended March 31, 2020, the Company recorded $2,271, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $19,525, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the three months ended March 31, 2020, the Company recorded $1,621, as an expense for options issued.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">105.73</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">3 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">1.54</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>   On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2019, the Company recorded $19,915 as an expense for warrants issued. On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment. In addition the Company also recorded a $19,915 reduction to warrant expense related to the warrant cancellation.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify">Expected dividends</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">0</td> <td style="width: 1%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Expected volatility</td> <td> </td> <td> </td> <td style="text-align: right">97.56</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected term</td> <td> </td> <td> </td> <td style="text-align: right">4 years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify">Risk free interest rate</td> <td> </td> <td> </td> <td style="text-align: right">2.65</td> <td>%</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Expected forfeitures</td> <td> </td> <td> </td> <td style="text-align: right">0</td> <td>%</td></tr> </table>

P5Y P5Y P5Y P1Y P1Y P20Y P5Y P5Y P1Y P5Y 0.06 0.20

14797278

7398639

1000000

8000000

600000

2000000 121448 The Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. The Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice.

64352

73582

-5933580 6000000 6000000

0.50

10000 10000 0.02

0.05

0.0299

120000

2007-12-26

Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. 600000

The Company signed a 5 year property lease Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

The Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ends on September 30, 2021, for its research and development headquarters.

P8Y

P5Y

P2Y

3135 3273

Voting rights equal to 100 common shares per share of preferred stock

50000

100000

15000

20000

15000

20000

26000

11000

20000

3000

30000

20000

17000

100000

30000

100000

43715

50163

65292

10-Q

65292

4145465

4320170

174705

162725

300000

120000

15000

265244

120000

1000

2000

5000

15000

9784

4947

9784

4947

(L) Revenue Recognition   During the year ended December 31, 2019, the Company’s revenues were generated primarily from a contract with the U.S. Government. The Company performs work under this cost-plus-fixed-fee contract. Under the base phase of that contract the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017, to that original contract, the Company has worked to develop new recombinant silks.   Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.   For the three months ended March 31, 2020 and 2019, the Company recognized $0 and $0 respectively in revenue from the Government contract. These revenues were generated for work performed in the development and production of the Company’s recombinant silks under the base and option period phases of our ongoing contract with the US Army.   On July 24, 2017, the Company signed a contract option extension with the US Army to research and deliver recombinant spider silk fibers and threads. This contract option increased the total contract award by an additional $921,130 to a total of $1,021,092 and added 12 months to the contract duration. This effort was scheduled to end on September 24, 2018, but the Company requested an extension of this contract option period through April 2019 to complete the work. The Company has been in communication with the contracting office and is working with them as they determine the best path forward; Management believes there is a possibility of securing a follow-up contract to complete the delivery of all materials for the contract. The Company is also continuing to pursue additional contract opportunities with the Department of Defense, Department of Energy and other governmental agencies.

Right to use assets is summarized below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Right to use assets, net – related party</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">60,486</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Right to use assets, net</td> <td> </td> <td> </td> <td style="text-align: right">51,621</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right to use assets, net</td> <td> </td> <td> </td> <td style="text-align: right">332,407</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td>$</td> <td style="text-align: right">444,514</td> <td> </td></tr> </table> Lease liability is summarized below:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%">Right to use liability, net – related party</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: right">53,442</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Right to use liability, net</td> <td> </td> <td> </td> <td style="text-align: right">61,789</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Right to use liability, net</td> <td> </td> <td> </td> <td style="text-align: right">338,081</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Total</td> <td> </td> <td> </td> <td style="text-align: right">453,312</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Less: short term portion</td> <td> </td> <td>$</td> <td style="text-align: right">(113,764</td> <td>)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Long term position</td> <td> </td> <td>$</td> <td style="text-align: right">339,548</td> <td> </td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Number of Warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life (in Years)</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%">Balance, December 31, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">55,395,917</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 14%; text-align: right">2.77</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">    -</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Cancelled/Forfeited</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Balance, March 31, 2020</td> <td> </td> <td> </td> <td style="text-align: right">55,395,917</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.52</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt">Intrinsic Value</td> <td> </td> <td>$</td> <td style="text-align: right">9,799,286</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> </table> For the three months ended March 31, 2020, the following warrants were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Warrants Outstanding</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Warrants Exercisable</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.001</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">21,000,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">1.40</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">3,675,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.056</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.36</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">350,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,300,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.40</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">402,500</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">0.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,294,762</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,294,762</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">647,381</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.94</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">647,381</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.2299</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,500,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.14</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,487,500</td> <td> </td></tr> </table>   For the year ended December 31, 2019, the following warrants were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"> Exercise Price Warrants Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Warrants Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Weighted Average Remaining Contractual Life</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> Aggregate Intrinsic Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.001</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">21,000,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">1.65</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 22%; text-align: right">4,069,800</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.056</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,000,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.61</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">387,600</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.04</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,300,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.70</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">445,740</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,433,856</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.06</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">7,398,639</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,433,856</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">716,928</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>$</td> <td style="text-align: right">0.08</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3,699,320</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">3.19</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">719,928</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>$</td> <td style="text-align: right">0.2299</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">8,500,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">5.39</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">1,647,300</td> <td> </td></tr> </table>

39200

45150

42000

45150

0.05 0.05

26550

2178

9784

4947

265244

180224

6000

600000

267574

291842

118874

14859

16723

18240

19525

267574

2198411

626047

133063

P2Y6M7D 1021092 921130

2535203

1154

64351

1153

4477

2616686

1154

2616686

73582

1153

4892

2535203

60000

6000

120000

140000

11000

2000000

3000000

2000000

600000

3000000

6000000

13700 10000 The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years 19924

2019-03-20

3135

3273

304539

311638

2544245 2544215

0.21

0.115

22267800

P23Y4M2D

(A) Basis of Presentation   The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations.   It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.   Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. For the three months ended March 31, 2020, the following options were outstanding:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Weighted Average</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Exercise</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Options</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Options</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center">Remaining</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Outstanding</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Contractual Life</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: justify"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">0.115</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 25%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">22,267,800</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 22%; text-align: right">23.34</td> <td style="width: 1%"> </td></tr> </table>

Unlimited

0.08

0.1150

559568

EX-101.SCH 7 kblb-20200331.xsd XBRL SCHEMA FILE 00000001 - Document - Document Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies and Organization link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Equipment link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Right to Use Assets and Lease Liability link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accrued Interest - Related Party link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note Payable link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Summary of Significant Accounting Policies and Organization (Policies) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies and Organization (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Right to Use Assets and Lease Liabilitity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Stockholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies and Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Right to Use Assets and Lease Liability - (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Right Use of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Accrued Interest - Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Stockholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Stockholders' Deficit - Schedule of Option Assumption (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stockholders' Deficit - Schedule of Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stockholders' Deficit - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stockholders' Deficit - Schedule of Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 kblb-20200331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 kblb-20200331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 kblb-20200331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock Class A [Member] Common Stock Class B [Member] Equity Components [Axis] Common Stock - Class A Shares to Be Issued [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Fair Value Hierarchy and NAV [Axis] Level 1 [Member] Level 2 [Member] Level 3 [Member] Property, Plant and Equipment, Type [Axis] Automobile [Member] Laboratory Equipment [Member] Office Equipment [Member] Leasehold Improvements [Member] Geographical [Axis] Socialist Republic of Vietnam [Member] Debt Instrument [Axis] Unsecured Promissory Note [Member] Title of Individual [Axis] Notre Dame [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Purchase Agreement [Member] Investor [Member] Common Stock and Warrants [Member] 6 Cent Warrants [Member] 8 Cent Warrants [Member] Warrant [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Legal Entity [Axis] University of Notre Dame [Member] Common Stock Warrants and Options [Member] Common Stock Warrants and Options One [Member] Common Stock Warrants and Options Two [Member] Common Stock Warrants and Options Three [Member] Common Stock Warrants and Options Four [Member] Common Stock Warrants and Options Five [Member] Common Stock Warrants and Options Six [Member] Common Stock Warrants and Options Seven [Member] Common Stock Warrants and Options Eight [Member] Common Stock Warrants and Options Nine [Member] Warrant Four [Member] Warrant Five [Member] Warrant Six [Member] Warrant Seven [Member] Common Stock - Class A [Member] Preferred Stock - Series A [Member] Common Stock - Class B [Member] Employment Agreement [Member] CEO [Member] Employee [Member] Mr. Jonathan R. Rice [Member] January 2015 Warrant [Member] May 2015 Warrant [Member] Mr. Kenneth Le [Member] License Agreement [Member] Statistical Measurement [Axis] Maximum [Member] Royalty and Research Agreements [Member] Consultant [Member] Mr. Thompson [Member] Consulting Agreement [Member] Operating Lease Agreements [Member] President [Member] Office and Manufacturing Space [Member] Intellectual Property Transfer Agreement [Member] Stockholder [Member] Related Party [Axis] Related Party [Member] Chief Operating Officer [Member] Directors [Member] Office Employee [Member] Scenario [Axis] Three through Five Years [Member] Loan One [Member] One-Time Bonus [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Chief Executive Officer and Chief Operations Officer [Member] Series A Preferred Stock [Member] Antidilutive Securities [Axis] Stock Warrants [Member] Convertible Preferred Stock [Member] Right to Use Assets Net - Related Party [Member] Right to Use Assets Net [Member] Right to Use Assets Net One [Member] Right to Use Liability Net - Related Party [Member] Right to Use Liability Net [Member] Right to Use Liability Net One [Member] Operating Lease Expenses [Member] Operating Lease Expenses One [Member] Operating Lease Expenses - Related Party [Member] First Six Months [Member] Seven and Eight Months [Member] Nine Through Twenty Three Months [Member] 24th Month [Member] Common Stock Warrants and Options One [Member] Common Stock Warrants and Options Two [Member] Common Stock Warrants and Options [Member] Forecast [Member] Principal Stockholder [Member] Board of Directors [Member] Stock Options [Member] Statement [Table] Statement [Line Items] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus ASSETS Current Assets Cash Prepaid expenses Total Current Assets Property and Equipment, net Operating lease right-of-use asset, net Security deposit Total Assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued expenses Note payable - related party Royalty agreement payable - related party Accounts payable and accrued expenses - related party Operating lease liability, current Loan payable Total Current Liabilities Long Term Liabilities Loan payable, net of current Operating lease liability, net of current Total Liabilities Commitments and Contingencies Stockholders' Deficit Preferred stock, value Common stock, value Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively Additional paid-in capital Accumulated Deficit Total Stockholders' Deficit Total Liabilities and Stockholders' Deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Common stock issuable Income Statement [Abstract] Revenue Operating Expenses General and Administrative Professional Fees Officer's Salary Rent - Related Party Research and Development Total Operating Expenses Loss from Operations Other Income/(Expenses) Interest expense Interest income Total Other Income/(Expenses) Net (Loss) before Provision for Income Taxes Provision for Income Taxes Net (Loss) Net Income (Loss) Per Share - Basic and Diluted Weighted average number of shares outstanding during the period - Basic and Diluted Beginning Balance Beginning Balance, shares Units issued for cash Units issued for cash, shares Shares issued in exchange for accounts payable Shares issued in exchange for accounts payable, shares Imputed interest - related party Options issued for services Net loss Ending Balance Ending Balance, shares EX-101.PRE 11 kblb-20200331_pre.xml XBRL PRESENTATION FILE XML 12 R34.htm IDEA: XBRL DOCUMENT

Note Payable (Details Narrative) - USD ($)		3 Months Ended
Note Payable (Details Narrative) - USD ($)	Mar. 01, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Debt Instrument, Interest rate		3.00%		3.00%
Repayment of debt		$ 15,000	$ 1,000
First Six Months [Member]
Repayment of debt		1,000
Seven and Eight Months [Member]
Repayment of debt		2,000
Nine Through Twenty Three Months [Member]
Repayment of debt		5,000
24th Month [Member]
Notes payable		$ 180,224
Unsecured Promissory Note [Member] \| Notre Dame [Member]
Notes payable	$ 265,244
Debt Instrument, Interest rate	10.00%
Debt instrument, term	24 months

XML 13 R30.htm IDEA: XBRL DOCUMENT

Right to Use Assets and Lease Liability - Schedule of Right Use of Assets (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Jan. 02, 2019
Operating lease right-of-use asset, net	$ 444,514	$ 473,242	$ 529,135
Right to Use Assets Net - Related Party [Member]
Operating lease right-of-use asset, net	60,486
Right to Use Assets Net [Member]
Operating lease right-of-use asset, net	51,621
Right to Use Assets Net One [Member]
Operating lease right-of-use asset, net	$ 332,407

XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 330 312 1 false 92 0 false 5 false false R1.htm 00000001 - Document - Document Entity Information Sheet http://kraiglabs.com/role/DocumentEntityInformation Document Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://kraiglabs.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://kraiglabs.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://kraiglabs.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) Sheet http://kraiglabs.com/role/StatementOfChangesInStockholdersDeficit Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://kraiglabs.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies and Organization Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization Summary of Significant Accounting Policies and Organization Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://kraiglabs.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Equipment Sheet http://kraiglabs.com/role/Equipment Equipment Notes 9 false false R10.htm 00000010 - Disclosure - Right to Use Assets and Lease Liability Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability Right to Use Assets and Lease Liability Notes 10 false false R11.htm 00000011 - Disclosure - Accrued Interest - Related Party Sheet http://kraiglabs.com/role/AccruedInterest-RelatedParty Accrued Interest - Related Party Notes 11 false false R12.htm 00000012 - Disclosure - Note Payable Sheet http://kraiglabs.com/role/NotePayable Note Payable Notes 12 false false R13.htm 00000013 - Disclosure - Stockholders' Deficit Sheet http://kraiglabs.com/role/StockholdersDeficit Stockholders' Deficit Notes 13 false false R14.htm 00000014 - Disclosure - Commitments and Contingencies Sheet http://kraiglabs.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 00000015 - Disclosure - Related Party Transactions Sheet http://kraiglabs.com/role/RelatedPartyTransactions Related Party Transactions Notes 15 false false R16.htm 00000016 - Disclosure - Subsequent Events Sheet http://kraiglabs.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 00000017 - Disclosure - Summary of Significant Accounting Policies and Organization (Policies) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationPolicies Summary of Significant Accounting Policies and Organization (Policies) Policies http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies and Organization (Tables) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationTables Summary of Significant Accounting Policies and Organization (Tables) Tables http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization 18 false false R19.htm 00000019 - Disclosure - Equipment (Tables) Sheet http://kraiglabs.com/role/EquipmentTables Equipment (Tables) Tables http://kraiglabs.com/role/Equipment 19 false false R20.htm 00000020 - Disclosure - Right to Use Assets and Lease Liabilitity (Tables) Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilitityTables Right to Use Assets and Lease Liabilitity (Tables) Tables http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability 20 false false R21.htm 00000021 - Disclosure - Stockholders' Deficit (Tables) Sheet http://kraiglabs.com/role/StockholdersDeficitTables Stockholders' Deficit (Tables) Tables http://kraiglabs.com/role/StockholdersDeficit 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies and Organization (Details Narrative) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationDetailsNarrative Summary of Significant Accounting Policies and Organization (Details Narrative) Details http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganizationTables 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization-ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetails Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) Details 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) (Parenthetical) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization-ScheduleOfAntidilutiveSecuritiesOfEarningsPerShareDetailsParenthetical Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) (Parenthetical) Details 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies and Organization - Schedule of Fair Value of Financial Instruments (Details) Sheet http://kraiglabs.com/role/SummaryOfSignificantAccountingPoliciesAndOrganization-ScheduleOfFairValueOfFinancialInstrumentsDetails Summary of Significant Accounting Policies and Organization - Schedule of Fair Value of Financial Instruments (Details) Details 25 false false R26.htm 00000026 - Disclosure - Going Concern (Details Narrative) Sheet http://kraiglabs.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://kraiglabs.com/role/GoingConcern 26 false false R27.htm 00000027 - Disclosure - Equipment (Details Narrative) Sheet http://kraiglabs.com/role/EquipmentDetailsNarrative Equipment (Details Narrative) Details http://kraiglabs.com/role/EquipmentTables 27 false false R28.htm 00000028 - Disclosure - Equipment - Schedule of Property and Equipment (Details) Sheet http://kraiglabs.com/role/Equipment-ScheduleOfPropertyAndEquipmentDetails Equipment - Schedule of Property and Equipment (Details) Details 28 false false R29.htm 00000029 - Disclosure - Right to Use Assets and Lease Liability - (Details Narrative) Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability-DetailsNarrative Right to Use Assets and Lease Liability - (Details Narrative) Details http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiabilitityTables 29 false false R30.htm 00000030 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Right Use of Assets (Details) Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability-ScheduleOfRightUseOfAssetsDetails Right to Use Assets and Lease Liability - Schedule of Right Use of Assets (Details) Details 30 false false R31.htm 00000031 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Lease Liability (Details) Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability-ScheduleOfLeaseLiabilityDetails Right to Use Assets and Lease Liability - Schedule of Lease Liability (Details) Details 31 false false R32.htm 00000032 - Disclosure - Right to Use Assets and Lease Liability - Schedule of Lease Cost (Details) Sheet http://kraiglabs.com/role/RightToUseAssetsAndLeaseLiability-ScheduleOfLeaseCostDetails Right to Use Assets and Lease Liability - Schedule of Lease Cost (Details) Details 32 false false R33.htm 00000033 - Disclosure - Accrued Interest - Related Party (Details Narrative) Sheet http://kraiglabs.com/role/AccruedInterest-RelatedPartyDetailsNarrative Accrued Interest - Related Party (Details Narrative) Details http://kraiglabs.com/role/AccruedInterest-RelatedParty 33 false false R34.htm 00000034 - Disclosure - Note Payable (Details Narrative) Sheet http://kraiglabs.com/role/NotePayableDetailsNarrative Note Payable (Details Narrative) Details http://kraiglabs.com/role/NotePayable 34 false false R35.htm 00000035 - Disclosure - Stockholders' Deficit (Details Narrative) Sheet http://kraiglabs.com/role/StockholdersDeficitDetailsNarrative Stockholders' Deficit (Details Narrative) Details http://kraiglabs.com/role/StockholdersDeficitTables 35 false false R36.htm 00000036 - Disclosure - Stockholders' Deficit - Schedule of Option Assumption (Details) Sheet http://kraiglabs.com/role/StockholdersDeficit-ScheduleOfOptionAssumptionDetails Stockholders' Deficit - Schedule of Option Assumption (Details) Details 36 false false R37.htm 00000037 - Disclosure - Stockholders' Deficit - Schedule of Warrants Activity (Details) Sheet http://kraiglabs.com/role/StockholdersDeficit-ScheduleOfWarrantsActivityDetails Stockholders' Deficit - Schedule of Warrants Activity (Details) Details 37 false false R38.htm 00000038 - Disclosure - Stockholders' Deficit - Schedule of Warrants Outstanding (Details) Sheet http://kraiglabs.com/role/StockholdersDeficit-ScheduleOfWarrantsOutstandingDetails Stockholders' Deficit - Schedule of Warrants Outstanding (Details) Details 38 false false R39.htm 00000039 - Disclosure - Stockholders' Deficit - Schedule of Options Outstanding (Details) Sheet http://kraiglabs.com/role/StockholdersDeficit-ScheduleOfOptionsOutstandingDetails Stockholders' Deficit - Schedule of Options Outstanding (Details) Details 39 false false R40.htm 00000040 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://kraiglabs.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://kraiglabs.com/role/CommitmentsAndContingencies 40 false false R41.htm 00000041 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://kraiglabs.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://kraiglabs.com/role/RelatedPartyTransactions 41 false false All Reports Book All Reports kblb-20200331.xml kblb-20200331.xsd kblb-20200331_cal.xml kblb-20200331_def.xml kblb-20200331_lab.xml kblb-20200331_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true XML 15 R38.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit - Schedule of Warrants Outstanding (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Mar. 09, 2019
Exercise Price Warrants Outstanding	$ 0.001		$ 0.001
Weighted Average Remaining Contractual Life	2 years 9 months 7 days
Aggregate Intrinsic Value	$ 9,799,286
Warrant [Member]
Exercise Price Warrants Outstanding	$ 0.001	$ 0.001		$ 0.06
Warrants Exercisable	21,000,000	21,000,000
Weighted Average Remaining Contractual Life	1 year 4 months 24 days	1 year 7 months 24 days
Aggregate Intrinsic Value	$ 3,675,000	$ 4,069,800
Warrant One [Member]
Exercise Price Warrants Outstanding	$ 0.056	$ 0.056		0.06
Warrants Exercisable	3,000,000	3,000,000
Weighted Average Remaining Contractual Life	1 year 4 months 9 days	1 year 7 months 10 days
Aggregate Intrinsic Value	$ 350,000	$ 387,600
Warrant Two [Member]
Exercise Price Warrants Outstanding	$ 0.04	$ 0.04		0.08
Warrants Exercisable	2,300,000	2,300,000
Weighted Average Remaining Contractual Life	1 year 4 months 24 days	1 year 8 months 12 days
Aggregate Intrinsic Value	$ 402,500	$ 445,740
Warrant Three [Member]
Exercise Price Warrants Outstanding	$ 0.06	$ 0.06		$ 0.08
Warrants Exercisable	7,398,639	7,398,639
Weighted Average Remaining Contractual Life	11 months 8 days	1 year 2 months 8 days
Aggregate Intrinsic Value	$ 1,294,762	$ 1,433,856
Warrant Four [Member]
Exercise Price Warrants Outstanding	$ 0.06	$ 0.06
Warrants Exercisable	7,398,639	7,398,639
Weighted Average Remaining Contractual Life	1 year 11 months 8 days	2 years 2 months 8 days
Aggregate Intrinsic Value	$ 1,294,762	$ 1,433,856
Warrant Five [Member]
Exercise Price Warrants Outstanding	$ 0.08	$ 0.08
Warrants Exercisable	3,699,320	3,699,320
Weighted Average Remaining Contractual Life	1 year 11 months 8 days	2 years 2 months 8 days
Aggregate Intrinsic Value	$ 647,381	$ 716,928
Warrant Six [Member]
Exercise Price Warrants Outstanding	$ 0.08	$ 0.08
Warrants Exercisable	3,699,320	3,699,320
Weighted Average Remaining Contractual Life	2 years 11 months 8 days	3 years 2 months 8 days
Aggregate Intrinsic Value	$ 647,381	$ 719,928
Warrant Seven [Member]
Exercise Price Warrants Outstanding	$ 0.2299	$ 0.2299
Warrants Exercisable	8,500,000	8,500,000
Weighted Average Remaining Contractual Life	5 years 1 month 20 days	5 years 4 months 20 days
Aggregate Intrinsic Value	$ 1,487,500	$ 1,647,300

XML 16 R13.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Stockholders' Deficit

NOTE 7 STOCKHOLDERS’ DEFICIT

(A) Common Stock Issued for Cash

● ½ of all $0.06 Warrants shall expire on March 8, 2021;

● ½ of all $0.06 Warrants shall expire on March 8, 2022;

● ½ of all $0.08 Warrants shall expire on March 8, 2022; and,

● ½ of all $0.08 Warrants shall expire on March 8, 2023.

(B) Common Stock Issued for Services

Shares issued for services as mentioned below were valued at the closing price of the stock on the date of grant.

(C) Common Stock Warrants and Options

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.56	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.50	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	6 years
Risk free interest rate	1.46	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $66,528 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $19,525, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the three months ended March 31, 2020, the Company recorded $1,621, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	97.56	%
Expected term	4 years
Risk free interest rate	2.65	%
Expected forfeitures	0	%

On September 26, 2019, the Company issued 766,667 shares in connection with the cashless exercise of the 1,000,000 warrants.

On August 14, 2019, the Company issued 7,967,871 shares in connection with the cashless exercise of the 8,000,000 warrants.

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)

Balance, December 31, 2019		55,395,917				2.77
Granted		-		-
Exercised		-		-
Cancelled/Forfeited		-		-
Balance, March 31, 2020		55,395,917				2.52
Intrinsic Value	$	9,799,286

For the three months ended March 31, 2020, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.40	$	3,675,000
$	0.056		3,000,000		1.36	$	350,000
$	0.04		2,300,000		1.40	$	402,500
$	0.06		7,398,639		0.94	$	1,294,762
$	0.06		7,398,639		1.94	$	1,294,762
$	0.08		3,699,320		1.94	$	647,381
$	0.08		3,699,320		2.94	$	647,381
$	0.2299		8,500,000		5.14	$	1,487,500

For the year ended December 31, 2019, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.65	$	4,069,800
$	0.056		3,000,000		1.61	$	387,600
$	0.04		2,300,000		1.70	$	445,740
$	0.06		7,398,639		1.19	$	1,433,856
$	0.06		7,398,639		2.19	$	1,433,856
$	0.08		3,699,320		2.19	$	716,928
$	0.08		3,699,320		3.19	$	719,928
$	0.2299		8,500,000		5.39	$	1,647,300

For the three months ended March 31, 2020, the following options were outstanding:

Weighted Average

Exercise

Options

Remaining

Price

Outstanding

Exercisable

Contractual Life

0.115

22,267,800

23.34

(D) Amendment to Articles of Incorporation

On February 16, 2009, the Company amended its articles of incorporation to amend the number and class of shares the Company is authorized to issue as follows:

●	Common stock Class A, unlimited number of shares authorized, no par value
●	Common stock Class B, unlimited number of shares authorized, no par value
●	Preferred stock, unlimited number of shares authorized, no par value

Effective December 17, 2013, the Company amended its articles of incorporation to designate a Series A no par value preferred stock. Two shares of Series A Preferred stock have been authorized.

(E) Common Stock Issued for Debt

None

XML 17 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Organization (Policies)

3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

(A) Basis of Presentation

Foreign Currency

(B) Foreign Currency

Use of Estimates

(C) Use of Estimates

Cash

(D) Cash

Loss Per Share

(E) Loss Per Share

	March 31, 2020		March 31, 2019
Stock Warrants (Exercise price - $0.001/share)		55,995,917		58,595,917
Stock Options (Exercise price - $0.1150/Share)		27,340,000		-
Convertible Preferred Stock		2		2
Total		83,335,919		58,595,919

Research and Development Costs

(F) Research and Development Costs

Income Taxes

(G) Income Taxes

Stock-Based Compensation

(H) Stock-Based Compensation

Recent Accounting Pronouncements

(I) Recent Accounting Pronouncements

All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

Equipment

(J) Equipment

The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.

There were no impairment losses recorded for the three months ended March 31, 2020 and 2019.

Fair Value of Financial Instruments

(K) Fair Value of Financial Instruments

The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

	●	Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2020 and December 31, 2019.

	●	Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

	●	Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

	March 31, 2020		December 31, 2019
Level 1	$	-	$	-
Level 2	$	-	$	-
Level 3	$	-	$	-
Total	$	-	$	-

Revenue Recognition

(L) Revenue Recognition

Concentration of Credit Risk

(M) Concentration of Credit Risk

For the three months ended March 31, 2020 and 2019, the Company booked $0 and $0 for doubtful accounts.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Going Concern

3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

NOTE 2 GOING CONCERN

Management believes that actions presently being taken to obtain additional funding and implement its strategic plans provide the opportunity for the Company to continue as a going concern.

XML 19 R40.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)																									1 Months Ended	3 Months Ended		12 Months Ended						55 Months Ended	63 Months Ended
Commitments and Contingencies (Details Narrative)	Oct. 21, 2019 USD ($)	Sep. 26, 2019 shares	Sep. 05, 2019 USD ($)	Aug. 15, 2019 USD ($)	Aug. 14, 2019 shares	Jul. 03, 2019 USD ($) $ / shares shares	May 09, 2019 USD ($) ft²	Apr. 26, 2019 USD ($)	Apr. 05, 2019 shares	Mar. 20, 2019 USD ($) shares	Jan. 31, 2019 USD ($) shares	Apr. 06, 2018 USD ($) $ / shares shares	Mar. 20, 2018 USD ($) $ / shares shares	Feb. 20, 2018 USD ($) shares	Jan. 09, 2018	Sep. 13, 2017 USD ($)	Jan. 23, 2017 USD ($)	Jan. 14, 2016 USD ($) $ / shares shares	Jan. 20, 2015 USD ($) $ / shares shares	Oct. 28, 2011 shares	Nov. 10, 2010 USD ($)	May 01, 2008 USD ($) $ / shares	Dec. 26, 2006 USD ($)	May 08, 2006 USD ($)	Jan. 31, 2007 USD ($)	Mar. 31, 2020 USD ($) $ / shares	Mar. 31, 2019 USD ($) $ / shares	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Mar. 31, 2020 USD ($) $ / shares	Dec. 31, 2019 USD ($)	Oct. 28, 2015 shares	May 28, 2015 $ / shares shares
Annual salary																										$ 144,562	$ 118,155
Warrant exercise price \| $ / shares																										$ 0.001	$ 0.001							$ 0.001
Working capital																										$ (5,933,580)								$ (5,933,580)
Number of shares issued \| shares		766,667			7,967,871					4,052,652
Payment for debt																										15,000	$ 1,000
Stock issued during period, value										$ 281,659																	1,000,000
Consulting fee																										19,374	150,311
Interest expensed and related accrued interest payable																										5,958	3,445							5,958
Payments for rent																	$ 960																	2,508
Annual rent, year one																$ 39,200
Annual rent, year two																42,000
Socialist Republic of Vietnam [Member]
Annual rent, year one							$ 45,150
Annual rent, year two							$ 45,150
Area of Land \| ft²							4,560.57
Three through Five Years [Member] \| Socialist Republic of Vietnam [Member]
Rent increase percentage							5.00%
Mr. Jonathan R. Rice [Member]
Payroll payable																										73,582			$ 64,352					73,582	$ 64,352
Employment Agreement [Member]
Extended expiration date description															The Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice.
Employment Agreement [Member] \| CEO [Member]
Agreement term																					5 years								5 years		5 years	5 years
Annual salary																					$ 210,000								$ 354,791		$ 315,764	$ 297,889	$ 281,027
Annual salary rate, increase																					6.00%
Accrued salary balance																										2,616,686			2,535,203					2,616,686	2,535,203
Employment Agreement [Member] \| CEO [Member] \| Forecast [Member]
Agreement term																												5 years
Annual salary																												$ 376,078
Employment Agreement [Member] \| Employee [Member]
Employee bonus rate																																	20.00%
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member]
Agreement term																			1 year
Annual salary	$ 20,000			$ 20,000				$ 20,000
Annual cash compensation																		$ 140,000	$ 120,000
Educational expenses																			$ 11,000
Warrant term																		3 years
Warrant to purchase shares \| shares																		6,000,000
Warrant exercise price \| $ / shares																		$ 0.001
Warrant shares fully vested \| shares																																				2,000,000
Warrants issued value																																	$ 121,448
Extended expiration date description															The Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019.
Working capital	$ 6,000,000			$ 6,000,000
Ownership percentage	50.00%			50.00%
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member] \| January 2015 Warrant [Member]
Warrant term																			3 years
Warrant to purchase shares \| shares																			2,000,000
Warrant exercise price \| $ / shares																			$ 0.001
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member] \| May 2015 Warrant [Member]
Warrant term																																					3 years
Warrant to purchase shares \| shares																																					3,000,000
Warrant exercise price \| $ / shares																																					$ 0.001
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member] \| One-Time Bonus [Member]
Annual salary								$ 20,000
Employment Agreement [Member] \| Mr. Kenneth Le [Member]
Agreement term						1 year
Accrued salary balance																										1,154			1,154					1,154	1,154
Annual cash compensation						$ 60,000
Warrant term						3 years
Warrant to purchase shares \| shares						2,000,000
Warrant exercise price \| $ / shares						$ 0.2299
License Agreement [Member]
Agreement term																				20 years				1 year
License fee																								$ 10,000
License maintenance fee																								$ 10,000
Annual research fee																									$ 13,700
Number of shares issued \| shares																				2,200,000
Royalty percentage																				2.00%
Termination agreement description																				The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years
Payment for debt																										15,000
License Agreement [Member] \| Maximum [Member]
Annual research fee																									$ 10,000
License Agreement [Member] \| Common Stock Class A [Member]
Number of shares issued \| shares											4,025,652
Payment for debt											$ 265,244
Stock issued during period, value											$ 281,659
Royalty and Research Agreements [Member]
Agreement term																						5 years
Consulting fee																						$ 1,000
Interest expensed and related accrued interest payable																										7,033			2,623					7,033	2,623
Royalty and Research Agreements [Member] \| Maximum [Member]
Shares issued, price per share \| $ / shares																						$ 0.05
Royalty and Research Agreements [Member] \| Forecast [Member]
Interest expensed and related accrued interest payable																												$ 490
Royalty and Research Agreements [Member] \| Consultant [Member]
Number of shares issued \| shares												36,000
Stock issued during period, value												$ 1,076
Consulting fee																																			21,000
Shares issued, price per share \| $ / shares												$ 0.0299
Gain on settlement of accounts payable																																			19,924
Royalty and Research Agreements [Member] \| Mr. Thompson [Member]
Payment for debt																							$ 120,000
Maturity date																							Dec. 26, 2007
Outstanding balance																										65,292			$ 65,292					$ 65,292	$ 65,292
Consulting Agreement [Member] \| Consultant [Member]
Annual cash compensation														$ 6,000
Warrant term													4 years
Warrant to purchase shares \| shares													600,000	600,000
Warrant exercise price \| $ / shares													$ 0.001
Fair value of warrants													$ 19,915
Warrants exercisable date													Mar. 20, 2019
Warrants exercisable description													Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022.
Warrants expenses																														$ 19,915
Cancelled warrant issued \| shares									600,000
Consulting Agreement [Member] \| Consultant [Member] \| Maximum [Member]
Warrant to purchase shares \| shares														3,000,000
Operating Lease Agreements [Member]
Payments for rent			$ 44,800													$ 39,200										2,508
Operating lease, term			2 years													2 years
Operating lease, description			The Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ends on September 30, 2021, for its research and development headquarters.
Operating leases, rent expense																										3,135	$ 3,273
Operating Lease Agreements [Member] \| Office and Manufacturing Space [Member]
Payments for rent																$ 42,000
Operating Lease Agreements [Member] \| Socialist Republic of Vietnam [Member]
Operating lease, term							5 years
Operating lease, description							The Company signed a 5 year property lease Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.
Annual rent, year one							$ 45,150
Annual rent, year two							$ 45,150
Area of Land \| ft²							4,560.57
Operating Lease Agreements [Member] \| Three through Five Years [Member] \| Socialist Republic of Vietnam [Member]
Rent increase percentage							5.00%
Operating Lease Agreements [Member] \| President [Member]
Payments for rent																	$ 960									$ 960
Operating lease, term																	8 years

XML 20 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue
Operating Expenses
General and Administrative	2,792,781	117,967
Professional Fees	19,374	150,311
Officer's Salary	144,562	118,155
Rent - Related Party	3,135	3,273
Research and Development	4,812	22,304
Total Operating Expenses	2,964,664	412,010
Loss from Operations	(2,964,664)	(412,010)
Other Income/(Expenses)
Interest expense	(86,675)	(66,920)
Interest income		1,184
Total Other Income/(Expenses)	(86,675)	(65,736)
Net (Loss) before Provision for Income Taxes	(3,051,339)	(477,746)
Provision for Income Taxes
Net (Loss)	$ (3,051,339)	$ (477,746)
Net Income (Loss) Per Share - Basic and Diluted	$ (0.00)	$ 0.00
Weighted average number of shares outstanding during the period - Basic and Diluted	844,468,378	822,016,321

XML 21 R29.htm IDEA: XBRL DOCUMENT

Right to Use Assets and Lease Liability - (Details Narrative)			3 Months Ended		55 Months Ended
	May 09, 2019 USD ($) ft²	Jan. 23, 2017 USD ($)	Mar. 31, 2020 USD ($)	Mar. 31, 2019 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Jan. 02, 2019 USD ($)	Sep. 13, 2017 USD ($)
Rent payments		$ 960			$ 2,508
Lease term		8 years						2 years
Annual rent, year one								$ 39,200
Annual rent, year two								$ 42,000
Right of Use Assets			$ 444,514		444,514	$ 473,242	$ 529,135
Lease liabilities			$ 113,764		$ 113,764	$ 110,678	$ 531,462
Lease percentage			8.00%		8.00%
Lease present value			$ 559,568		$ 559,568
Lease expenses			26,550
Socialist Republic of Vietnam [Member]
Lease term	5 years
Annual rent, year one	$ 45,150
Annual rent, year two	$ 45,150
Area of Land \| ft²	4,560.57
Socialist Republic of Vietnam [Member] \| Three through Five Years [Member]
Rent increase percentage	5.00%
Related Party [Member]
Rent payments			3,135	$ 5,760
Lease expenses			$ 2,178

XML 22 R21.htm IDEA: XBRL DOCUMENT

Stockholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Schedule of Option Assumption

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.56	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	3 years
Risk free interest rate	1.50	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	125.19	%
Expected term	6 years
Risk free interest rate	1.46	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 2,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $267,574, based upon the Black-Scholes option-pricing model on the date of grant and is fully vested on August 8, 2020. Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025. During the three months ended March 31, 2020, the Company recorded $66,528 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year option to purchase 1,000,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $118,874, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on the date granted. Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024. During the year ended December 31, 2019, the Company recorded $118,874 as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	2 years
Risk free interest rate	1.62	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

On August 8, 2019, the Company issued a 2-year options to purchase 125,000 shares of common stock at an exercise price of $0.2299 per share to a related party for services rendered. The options had a fair value of $19,525, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on August 8, 2022. Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027. During the three months ended March 31, 2020, the Company recorded $1,621, as an expense for options issued.

Expected dividends	0	%
Expected volatility	105.73	%
Expected term	3 years
Risk free interest rate	1.54	%
Expected forfeitures	0	%

Expected dividends	0	%
Expected volatility	97.56	%
Expected term	4 years
Risk free interest rate	2.65	%
Expected forfeitures	0	%

Schedule of Warrants Activity

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)

Balance, December 31, 2019		55,395,917				2.77
Granted		-		-
Exercised		-		-
Cancelled/Forfeited		-		-
Balance, March 31, 2020		55,395,917				2.52
Intrinsic Value	$	9,799,286

Schedule of Warrants Outstanding

For the three months ended March 31, 2020, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.40	$	3,675,000
$	0.056		3,000,000		1.36	$	350,000
$	0.04		2,300,000		1.40	$	402,500
$	0.06		7,398,639		0.94	$	1,294,762
$	0.06		7,398,639		1.94	$	1,294,762
$	0.08		3,699,320		1.94	$	647,381
$	0.08		3,699,320		2.94	$	647,381
$	0.2299		8,500,000		5.14	$	1,487,500

For the year ended December 31, 2019, the following warrants were outstanding:

Exercise Price Warrants Outstanding		Warrants Exercisable		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
$	0.001		21,000,000		1.65	$	4,069,800
$	0.056		3,000,000		1.61	$	387,600
$	0.04		2,300,000		1.70	$	445,740
$	0.06		7,398,639		1.19	$	1,433,856
$	0.06		7,398,639		2.19	$	1,433,856
$	0.08		3,699,320		2.19	$	716,928
$	0.08		3,699,320		3.19	$	719,928
$	0.2299		8,500,000		5.39	$	1,647,300

Schedule of Options Outstanding

For the three months ended March 31, 2020, the following options were outstanding:

Weighted Average

Exercise

Options

Remaining

Price

Outstanding

Exercisable

Contractual Life

0.115

22,267,800

23.34

XML 23 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Organization - Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Fair value of assets and liabilities
Level 1 [Member]
Fair value of assets and liabilities
Level 2 [Member]
Fair value of assets and liabilities
Level 3 [Member]
Fair value of assets and liabilities

XML 24 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Changes in Stockholders Deficit (Unaudited) - USD ($)	Preferred Stock - Series A [Member]	Common Stock - Class A [Member]	Common Stock - Class A Shares to Be Issued [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Beginning Balance at Dec. 31, 2018	$ 5,217,800	$ 15,145,798	$ 22,000	$ 2,043,235	$ (26,888,056)	$ (4,459,223)
Beginning Balance, shares at Dec. 31, 2018	2	816,883,910	1,122,311
Units issued for cash		$ 1,000,000				1,000,000
Units issued for cash, shares		14,797,278
Shares issued in exchange for accounts payable		$ 281,659				281,659
Shares issued in exchange for accounts payable, shares		4,052,652
Imputed interest - related party				4,947		4,947
Net loss					(477,746)	(477,746)
Ending Balance at Mar. 31, 2019	$ 5,217,800	$ 16,427,457	$ 22,000	2,048,182	(27,365,802)	(3,650,363)
Ending Balance, shares at Mar. 31, 2019	2	835,733,840	1,122,311
Beginning Balance at Dec. 31, 2019	$ 5,217,800	$ 16,757,079	$ 22,000	2,412,969	(29,797,906)	(5,388,058)
Beginning Balance, shares at Dec. 31, 2019	2	844,468,378	1,122,311
Imputed interest - related party				9,784		9,784
Options issued for services				2,544,215		2,544,245
Net loss					(3,051,339)	(3,051,339)
Ending Balance at Mar. 31, 2020	$ 5,217,800	$ 16,757,079	$ 22,000	$ 4,966,968	$ (32,849,245)	$ (5,885,398)
Ending Balance, shares at Mar. 31, 2020	2	844,468,378	1,122,311

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 25 R1.htm IDEA: XBRL DOCUMENT

Document Entity Information - shares	3 Months Ended
Document Entity Information - shares	Mar. 31, 2020	Apr. 21, 2020
Entity Registrant Name	Kraig Biocraft Laboratories, Inc
Entity Central Index Key	0001413119
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Common Stock Class A [Member]
Entity Common Stock, Shares Outstanding		844,468,378
Common Stock Class B [Member]
Entity Common Stock, Shares Outstanding		0

XML 26 R9.htm IDEA: XBRL DOCUMENT

Equipment

3 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Equipment

NOTE 3 EQUIPMENT

At March 31, 2020 and December 31, 2019, property and equipment, net, is as follows:

	As of March 31, 2020			December 31, 2019
Automobile	$	41,805		$	41,805
Laboratory Equipment		96,536			96,536
Office Equipment		7,260			7,260
Leasehold Improvements		85,389			85,389
Less: Accumulated Depreciation		(121,048	)		(113,669	)
Total Property and Equipment, net	$	109,942		$	117,321

Depreciation expense for the three months ended March 31, 2020 and 2019, was $7,379 and $6,665, respectively.

XML 27 R41.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details Narrative) - USD ($)																																					3 Months Ended		12 Months Ended				29 Months Ended	55 Months Ended
	Mar. 09, 2020	Feb. 19, 2020	Jan. 24, 2020	Dec. 18, 2019	Nov. 20, 2019	Oct. 21, 2019	Sep. 26, 2019	Sep. 05, 2019	Aug. 15, 2019	Aug. 14, 2019	Jul. 03, 2019	Apr. 26, 2019	Mar. 20, 2019	Mar. 02, 2019	Feb. 15, 2019	Feb. 01, 2019	Jan. 17, 2019	Jan. 05, 2019	Jan. 04, 2019	Dec. 21, 2018	Oct. 12, 2018	Oct. 02, 2018	Jul. 05, 2018	Jun. 29, 2018	Jun. 21, 2018	Apr. 26, 2018	Mar. 31, 2018	Jan. 09, 2018	Jan. 08, 2018	Sep. 13, 2017	Jan. 23, 2017	Jun. 06, 2016	Jan. 14, 2016	Jan. 20, 2015	Nov. 10, 2010	Dec. 26, 2006	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Apr. 18, 2020	Mar. 31, 2020
Number of shares issued							766,667			7,967,871			4,052,652
Number of shares issued, value													$ 281,659																									$ 1,000,000
Accrued interest percentage																																					3.00%		3.00%					3.00%
Interest expense and related accrued interest payable																																					$ 5,958	3,445						$ 5,958
Annual salary																																					$ 144,562	$ 118,155
Warrant exercise price																																					$ 0.001	$ 0.001						$ 0.001
Working capital																																					$ (5,933,580)							$ (5,933,580)
Payments for rent																															$ 960													2,508
Related Party [Member]
Interest expense and related accrued interest payable																																					1,269,213		$ 1,196,503					1,269,213
Loan interest - related party																																					50,163		43,715					50,163
Royalty payable to related party																																					65,292		65,292
Mr. Jonathan R. Rice [Member]
Payroll payable																																					73,582		64,352					73,582
Stockholder [Member]
Outstanding balance																																					$ 9,784	$ 4,947						$ 9,784
Accrued interest percentage																																					3.00%							3.00%
Interest expense and related accrued interest payable																																					$ 5,958	3,445						$ 5,958
Loan received	$ 100,000	$ 100,000	$ 100,000	$ 100,000	$ 100,000									$ 20,000	$ 20,000	$ 30,000	$ 30,000	$ 17,000	$ 3,000	$ 20,000	$ 11,000	$ 26,000	$ 20,000	$ 15,000	$ 15,000	$ 20,000	$ 15,000		$ 100,000			$ 50,000
Loans payable																																					942,000		642,000					942,000
Stockholder [Member] \| Subsequent Event [Member]
Loan received																																											$ 30,000
Chief Executive Officer and Chief Operations Officer [Member]
Accounts payable and accrued expenses																																					311,638		304,539					311,638
Principal Stockholder [Member]
Accrued salary balance																																					2,616,686		2,535,203					2,616,686
Chief Operating Officer [Member]
Accrued salary balance																																					73,582		64,351					73,582
Board of Directors [Member]
Accrued salary balance																																					1,153		1,153					1,153
Office Employee [Member]
Accrued salary balance																																					4,892		$ 4,477					4,892
Intellectual Property Transfer Agreement [Member] \| Mr. Thompson [Member]
Number of shares issued																																				200,000
Dividends, preferred stock
Preferred stock voting rights																																				Voting rights equal to 100 common shares per share of preferred stock
Number of shares issued, value																																				$ 120,000
Fair value of the payment																																				$ 120,000
Maturity date																																				Dec. 26, 2007
Debt instrument, term																																				1 year
Outstanding balance																																					$ 65,292							$ 65,292
Accrued interest percentage																																					7.00%							7.00%
Interest expense and related accrued interest payable																																					$ 7,033							$ 7,033
Employment Agreement [Member]
Extended expiration date description																												The Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice.
Employment Agreement [Member] \| CEO [Member]
Agreement term																																			5 years				5 years	5 years	5 years
Annual salary																																			$ 210,000				$ 354,791	$ 315,764	$ 297,889	$ 281,027
Accrued salary balance																																					2,616,686		2,535,203					2,616,686
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member]
Agreement term																																		1 year
Annual salary						$ 20,000			$ 20,000			$ 20,000
Annual cash compensation																																	$ 140,000	$ 120,000
Warrant term																																	3 years
Warrant to purchase shares																																	6,000,000
Warrant exercise price																																	$ 0.001
Extended expiration date description																												The Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019.
Working capital						$ 6,000,000			$ 6,000,000
Ownership percentage						50.00%			50.00%
Employment Agreement [Member] \| Mr. Jonathan R. Rice [Member] \| One-Time Bonus [Member]
Annual salary												$ 20,000
Employment Agreement [Member] \| Mr. Kenneth Le [Member]
Agreement term											1 year
Accrued salary balance																																					1,154		$ 1,154					$ 1,154
Annual cash compensation											$ 60,000
Warrant term											3 years
Warrant to purchase shares											2,000,000
Warrant exercise price											$ 0.2299
Operating Lease Agreements [Member]
Operating lease, term								2 years																						2 years
Payments for rent								$ 44,800																						$ 39,200							2,508
Operating Lease Agreements [Member] \| President [Member]
Operating lease, term																															8 years
Payments for rent																															$ 960						960
Operating leases, rent expense																																					$ 3,135	$ 3,273

XML 28 R20.htm IDEA: XBRL DOCUMENT

Right to Use Assets and Lease Liabilitity (Tables)

3 Months Ended

Mar. 31, 2020

Right To Use Assets And Lease Liability

Schedule of Right Use of Assets

Right to use assets is summarized below:

	March 31, 2020
Right to use assets, net – related party	$	60,486
Right to use assets, net		51,621
Right to use assets, net		332,407
Total	$	444,514

Schedule of Lease Liability

Lease liability is summarized below:

	March 31, 2020
Right to use liability, net – related party		53,442
Right to use liability, net		61,789
Right to use liability, net		338,081
Total		453,312
Less: short term portion	$	(113,764	)
Long term position	$	339,548

Schedule of Lease Cost

Lease expense for the three months ended March 31, 2020 was comprised of the following:

Operating lease expense	$	15,582
Operating lease expense	$	9,142
Operating lease expense – related party	$	1,923

XML 29 R24.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) (Parenthetical) - $ / shares	Mar. 31, 2020	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Warrants exercise price	$ 0.001	$ 0.001
Option exercise price	$ 0.1150	$ 0.1150

XML 30 R28.htm IDEA: XBRL DOCUMENT

Equipment - Schedule of Property and Equipment (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Less: Accumulated Depreciation	$ (121,048)	$ (113,668)
Total Property and Equipment, net	109,942	117,321
Automobile [Member]
Property and Equipment, gross	41,805	41,805
Laboratory Equipment [Member]
Property and Equipment, gross	96,536	96,536
Office Equipment [Member]
Property and Equipment, gross	7,260	7,260
Leasehold Improvements [Member]
Property and Equipment, gross	$ 85,389	$ 85,389

EXCEL 31 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 32 R39.htm IDEA: XBRL DOCUMENT v3.20.1

Stockholders' Deficit - Schedule of Options Outstanding (Details)
3 Months Ended

Mar. 31, 2020

$ / shares

shares

Equity [Abstract]

Exercise Price | $ / shares $ 0.115

Options Outstanding

Options Exercisable 22,267,800

Weighted Average Remaining Contractual Life 23 years 4 months 2 days

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Change in the weighted average exercise price of options outstanding.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 33 R35.htm IDEA: XBRL DOCUMENT v3.20.1

Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended

Feb. 19, 2020

Sep. 26, 2019

Aug. 14, 2019

Aug. 08, 2019

Mar. 20, 2019

Mar. 09, 2019

Mar. 20, 2018

Mar. 31, 2020

Mar. 31, 2019

Aug. 08, 2020

Apr. 05, 2020

Dec. 31, 2019

Dec. 31, 2018

Mar. 08, 2019

Number of shares issued 766,667 7,967,871 4,052,652

Share price $ 0.0695

Proceeds from issuance of common stock $ 1,000,000

Warrants to purchase up share 1,000,000 8,000,000

Warrants exercise price $ 0.001 $ 0.001

Number of shares issued, value $ 281,659 $ 1,000,000

Number of warrants cancelled

University of Notre Dame [Member]

Number of shares issued, value 38,500

Accounts payable $ 243,159

Common Stock and Warrants [Member]

Number of shares issued 14,797,278

6 Cent Warrants [Member]

Warrants to purchase up share 14,797,278

Warrants exercise price $ 0.06

8 Cent Warrants [Member]

Warrants to purchase up share 7,398,639

Warrants exercise price $ 0.08

Warrant [Member]

Warrants exercise price $ 0.06 $ 0.001 $ 0.001

Warrant expiration date Mar. 08, 2021

Warrant One [Member]

Warrants exercise price $ 0.06 0.056 0.056

Warrant expiration date Mar. 08, 2022

Warrant Two [Member]

Warrants exercise price $ 0.08 0.04 0.04

Warrant expiration date Mar. 08, 2022

Warrant Three [Member]

Warrants exercise price $ 0.08 $ 0.06 $ 0.06

Warrant expiration date Mar. 08, 2023

Common Stock Warrants and Options [Member]

Number of shares issued 20,000,000 2,000,000

Share price $ 0.0115 $ 0.2299

Warrants to purchase up share 600,000

Warrants exercise price $ 0.001

Warrants term 4 years

Fair value of adjustments of warrants $ 19,915

Warrants cancelled amount $ 6,000

Option term 20 years 2 years

Fair value of options $ 2,198,411 $ 267,574

Common stock warrants and options, description Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040. Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022.

Share based compensation $ 2,198,411 $ 267,574

Warrants expenses $ 19,915

Number of warrants cancelled 600,000

Common Stock Warrants and Options One [Member]

Number of shares issued 6,000,000

Share price $ 0.00115

Option term 10 years

Fair value of options $ 626,047

Common stock warrants and options, description Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030.

Share based compensation 208,682

Common Stock Warrants and Options Two [Member]

Number of shares issued 1,340,000

Share price $ 0.0115

Option term 7 years

Fair value of options $ 133,063

Common stock warrants and options, description Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027.

Share based compensation 26,613

Common Stock Warrants and Options One [Member]

Number of shares issued 2,000,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 267,574

Common stock warrants and options, description Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025.

Share based compensation 66,528

Common Stock Warrants and Options Two [Member]

Number of shares issued 2,000,000

Share price $ 0.2299

Option term 3 years

Fair value of options $ 291,842

Common stock warrants and options, description Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026.

Share based compensation 36,331

Common Stock Warrants and Options Three [Member]

Number of shares issued 1,000,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 118,874

Common stock warrants and options, description Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023.

Share based compensation 118,874

Common Stock Warrants and Options Four [Member]

Number of shares issued 1,000,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 118,874

Common stock warrants and options, description Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024.

Share based compensation 118,874

Common Stock Warrants and Options Five [Member]

Number of shares issued 125,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 14,859

Common stock warrants and options, description Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023.

Share based compensation $ 14,859

Common Stock Warrants and Options Six [Member]

Number of shares issued 125,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 16,723

Common stock warrants and options, description Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025.

Share based compensation 4,158

Common Stock Warrants and Options Seven [Member]

Number of shares issued 125,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 18,240

Common stock warrants and options, description Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026.

Share based compensation 2,271

Common Stock Warrants and Options Eight [Member]

Number of shares issued 125,000

Share price $ 0.2299

Option term 2 years

Fair value of options $ 19,525

Common stock warrants and options, description Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027.

Share based compensation $ 1,621

Purchase Agreement [Member] | Investor [Member]

Number of shares issued 14,797,278

Share price $ 0.06758

Proceeds from issuance of common stock $ 1,000,000

X

- Definition
Common stock warrants and options, description.
+ References
No definition available.
+ Details

Name: KBLB_CommonStockWarrantsAndOptionsDescription

Namespace Prefix: KBLB_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Option term
+ References
No definition available.
+ Details

Name: KBLB_OptionTerm

Namespace Prefix: KBLB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrant expiration date.
+ References
No definition available.
+ Details

Name: KBLB_WarrantExpirationDate

Namespace Prefix: KBLB_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Warrants cancelled amount.
+ References
No definition available.
+ Details

Name: KBLB_WarrantsCancelledAmount

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Warrants expenses.
+ References
No definition available.
+ Details

Name: KBLB_WarrantsExpenses

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878
+ Details

Name: us-gaap_AccountsPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section 25
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875
+ Details

Name: us-gaap_FairValueAdjustmentOfWarrants

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of noncash expense for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks of a company.
+ References
No definition available.
+ Details

Name: us-gaap_SharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=KBLB_UniversityOfNotreDameMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockAndWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_SixCentWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_EightCentWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_WarrantOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_WarrantTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_WarrantThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsFourMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsFiveMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsSixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsSevenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsEightMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_PurchaseAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_TitleOfIndividualAxis=us-gaap_InvestorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R31.htm IDEA: XBRL DOCUMENT v3.20.1

Right to Use Assets and Lease Liability - Schedule of Lease Liability (Details) - USD ($)

Mar. 31, 2020

Dec. 31, 2019

Jan. 02, 2019

Total $ 453,312

Less: short term portion (113,764) $ (110,678) $ (531,462)

Long term position 339,548 $ 369,281

Right to Use Liability Net - Related Party [Member]

Total 53,442

Right to Use Liability Net [Member]

Total 61,789

Right to Use Liability Net One [Member]

Total $ 338,081

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_RightToUseLiabilityNetRelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_RightToUseLiabilityNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_RightToUseLiabilityNetOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R12.htm IDEA: XBRL DOCUMENT v3.20.1

Note Payable
3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Note Payable

NOTE 6 NOTE PAYABLE

On March 1, 2019, the Company entered into an unsecured promissory note with Notre Dame - an unrelated party in the amount of $265,244 in exchange for outstanding account payable due to the debtor. Pursuant to the terms of the note, the note bears 10% interest per year from the date of default until the date the loan is paid in full. The term of the loan is twenty four months. The loan repayment commenced immediately over a twenty-four month period according to the following table. During the three months ended March 31, 2020, the Company paid $15,000 of the loan balance (See Note 8 (A)):

1. $1,000 per month for the first six months;

2. $2,000 per month for the months seven and eight;

3. $5,000 per month for months nine through twenty three; and,

4. Final payment of all remaining balance, in the amount of $180,224 in month 24.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R16.htm IDEA: XBRL DOCUMENT v3.20.1

Subsequent Events
3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

NOTE 10 SUBSEQUENT EVENTS

The Company has analyzed its operations subsequent to April 21, 2020 through the date these financial statements were issued, and has determined that, other than disclosed below, it does not have any material subsequent events to disclose.

On April 16, 2020, the Company held a press conference announcing the development of the first Knock In / Knock Out essentially pure spider silk transgenic.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R7.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies and Organization
3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summary of Significant Accounting Policies and Organization

NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

(A) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the Securities and Exchange Commission for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations.

It is management’s opinion, however that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.

Kraig Biocraft Laboratories, Inc. (the “Company”) was incorporated under the laws of the State of Wyoming on April 25, 2006. The Company was organized to develop high strength, protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries.

(B) Foreign Currency

The assets and liabilities of Prodigy Textiles, Co., Ltd. (the Company’s Vietnamese subsidiary) whose functional currency is the Vietnamese Dong, are translated into US dollars at period-end exchange rates prior to consolidation. Income and expense items are translated at the average rates of exchange prevailing during the period. The adjustments resulting from translating the Company’s financial statements are reflected as a component of other comprehensive (loss) income. Foreign currency transaction gains and losses are recognized in net earnings based on differences between foreign exchange rates on the transaction date and settlement date.

(C) Use of Estimates

In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.

(D) Cash

For the purposes of the cash flow statements, the Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. There were no cash equivalents as of March 31, 2020 or December 31, 2019.

(E) Loss Per Share

Basic and diluted net loss per common share is computed based upon the weighted average common shares outstanding as defined by the Financial Accounting Standards Board (“FASB” Accounting Standards Codification (“ASC”) No. 260, “Earnings per Share.” For March 31, 2020 and March 31, 2019, warrants were not included in the computation of income/ (loss) per share because their inclusion is anti-dilutive.

The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

March 31, 2020 March 31, 2019

Stock Warrants (Exercise price - $0.001/share) 55,995,917 58,595,917

Stock Options (Exercise price - $0.1150/Share) 27,340,000 -

Convertible Preferred Stock 2 2

Total 83,335,919 58,595,919

(F) Research and Development Costs

The Company expenses all research and development costs as incurred for which there is no alternative future use. These costs also include the expensing of employee compensation and employee stock based compensation.

(G) Income Taxes

The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10-25”). Under ASC No. 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC No. 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law and the new legislation contains several key tax provisions that affected us, including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act* (SAB 118), which allows us to record provisional amounts during a measurement period not to extend beyond one year of the enactment date. Since the Tax Act was passed late in the fourth quarter of 2017, and ongoing guidance and accounting interpretation are expected over the next 12 months, we consider the accounting of the transition tax, deferred tax re-measurements, and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final year-end data and tax positions. We expect to complete our analysis within the measurement period in accordance with SAB 118.

Effective January 1, 2009, the Company adopted guidance regarding accounting for uncertainty in income taxes. This guidance clarifies the accounting for income taxes by prescribing the minimum recognition threshold an income tax position is required to meet before being recognized in the financial statements and applies to all federal or state income tax positions. Each income tax position is assessed using a two-step process. A determination is first made as to whether it is more likely than not that the income tax position will be sustained, based upon technical merits, upon examination by the taxing authorities. If the income tax position is expected to meet the more likely than not criteria, the benefit recorded in the financial statements equals the largest amount that is greater than 50% likely to be realized upon its ultimate settlement. As of December 31, 2019 and December 31, 2017 there were no amounts that had been accrued in respect to uncertain tax positions.

Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model. In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.

Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.

(H) Stock-Based Compensation

The Company accounts for stock-based compensation for employees and directors in accordance with ASC 718, Compensation (“ASC 718”). ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operations based on their fair values. Under the provisions of ASC 718, stock-based compensation costs are measured at the grant date, based on the fair value of the award, and are recognized as expense over the employee’s requisite service period (generally the vesting period of the equity grant). The fair value of the Company’s common stock options are estimated using the Black Scholes option-pricing model with the following assumptions: expected volatility, dividend rate, risk free interest rate and the expected life. The Company expenses stock-based compensation by using the straight-line method. In accordance with ASC 718 and, excess tax benefits realized from the exercise of stock-based awards are classified as cash flows from operating activities. All excess tax benefits and tax deficiencies (including tax benefits of dividends on share-based payment awards) are recognized as income tax expense or benefit in the condensed consolidated statements of operations.

The Company accounts for stock-based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the measurement date guidelines enumerated in ASU 2018-07.

(I) Recent Accounting Pronouncements

In June 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. Currently, the accounting requirements for nonemployee and employee share-based payment transactions are significantly different. ASU 2018-07 expands the scope of Topic 718, Compensation — Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, Equity — Equity-Based Payments to Nonemployees. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s adoption date of Topic 606, Revenue from Contracts with Customers. The Company early adopted ASU 2018-07 effective April 1, 2018. The adoption of this ASU did not have a material impact on the Company’s condensed consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. As a result, the Company has recorded Right-to-use assets and corresponding Lease obligations as more fully discussed in Note 4.

All other newly issued accounting pronouncements but not yet effective have been deemed either immaterial or not applicable.

(J) Equipment

The Company values property and equipment at cost and depreciates these assets using the straight-line method over their expected useful life. The Company uses a five year life for automobiles.

In accordance with FASB ASC No. 360, Property, Plant and Equipment, the Company carries long-lived assets at the lower of the carrying amount or fair value. Impairment is evaluated by estimating future undiscounted cash flows expected to result from the use of the asset and its eventual disposition. If the sum of the expected undiscounted future cash flow is less than the carrying amount of the assets, an impairment loss is recognized. Fair value, for purposes of calculating impairment, is measured based on estimated future cash flows, discounted at a market rate of interest.

There were no impairment losses recorded for the three months ended March 31, 2020 and 2019.

(K) Fair Value of Financial Instruments

We hold certain financial assets, which are required to be measured at fair value on a recurring basis in accordance with the Statement of Financial Accounting Standard No. 157, “Fair Value Measurements” (“ASC Topic 820-10”). ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. Level 1 instruments include cash, account receivable, prepaid expenses, inventory and account payable and accrued liabilities. The carrying values are assumed to approximate the fair value due to the short term nature of the instrument.

The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:

● Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. We believe our carrying value of level 1 instruments approximate their fair value at March 31, 2020 and December 31, 2019.

● Level 2 - Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

● Level 3 - Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. We consider depleting assets, asset retirement obligations and net profit interest liability to be Level 3. We determine the fair value of Level 3 assets and liabilities utilizing various inputs, including NYMEX price quotations and contract terms.

March 31,
2020
December 31,

2019

Level 1 $ - $ -

Level 2 $ - $ -

Level 3 $ - $ -

Total $ - $ -

(L) Revenue Recognition

During the year ended December 31, 2019, the Company’s revenues were generated primarily from a contract with the U.S. Government. The Company performs work under this cost-plus-fixed-fee contract. Under the base phase of that contract the Company produced recombinant spider silk woven into ballistic shootpack panels. Those shootpack panels were delivered to the U.S. Government customer. Under an option period award starting in July 2017, to that original contract, the Company has worked to develop new recombinant silks.

Effective January 1, 2018, the Company adopted ASC No. 606 — Revenue from Contracts with Customers. Under ASC No. 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

For the three months ended March 31, 2020 and 2019, the Company recognized $0 and $0 respectively in revenue from the Government contract. These revenues were generated for work performed in the development and production of the Company’s recombinant silks under the base and option period phases of our ongoing contract with the US Army.

On July 24, 2017, the Company signed a contract option extension with the US Army to research and deliver recombinant spider silk fibers and threads. This contract option increased the total contract award by an additional $921,130 to a total of $1,021,092 and added 12 months to the contract duration. This effort was scheduled to end on September 24, 2018, but the Company requested an extension of this contract option period through April 2019 to complete the work. The Company has been in communication with the contracting office and is working with them as they determine the best path forward; Management believes there is a possibility of securing a follow-up contract to complete the delivery of all materials for the contract. The Company is also continuing to pursue additional contract opportunities with the Department of Defense, Department of Energy and other governmental agencies.

(M) Concentration of Credit Risk

The Company at times has cash in banks in excess of FDIC insurance limits. At March 31, 2020 and December 31, 2019, the Company had approximately $0 and $0, respectively in excess of FDIC insurance limits.

For the three months ended March 31, 2020 and 2019, the Company booked $0 and $0 for doubtful accounts.

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R3.htm IDEA: XBRL DOCUMENT v3.20.1

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
3 Months Ended 12 Months Ended

Mar. 31, 2020

Dec. 31, 2019

Preferred stock, par value

Preferred stock, shares authorized Unlimited Unlimited

Preferred stock, shares issued

Preferred stock, shares outstanding

Common stock issuable 1,122,311 1,122,311

Series A Preferred Stock [Member]

Preferred stock, par value

Preferred stock, shares issued 2 2

Preferred stock, shares outstanding 2 2

Common Stock Class A [Member]

Common stock, par value

Common stock, shares authorized Unlimited Unlimited

Common stock, shares issued 844,468,378 844,468,378

Common stock, shares outstanding 844,468,378 844,468,378

Common Stock Class B [Member]

Common stock, par value

Common stock, shares authorized Unlimited Unlimited

Common stock, shares issued

Common stock, shares outstanding

X

- Definition
Common stock issuable.
+ References
No definition available.
+ Details

Name: KBLB_CommonStockIssuableShares

Namespace Prefix: KBLB_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is "Unlimited".
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorizedUnlimited

Namespace Prefix: us-gaap_

Data Type: us-types:authorizedUnlimitedItemType

Balance Type: na

Period Type: duration

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicates that the number of nonredeemable preferred shares, or preferred stock redeemable solely at the option of the issuer, permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is "Unlimited".
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorizedUnlimited

Namespace Prefix: us-gaap_

Data Type: us-types:authorizedUnlimitedItemType

Balance Type: na

Period Type: duration

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R22.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies and Organization (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended

Jan. 02, 2018

Mar. 31, 2020

Mar. 31, 2019

Dec. 31, 2019

Dec. 31, 2017

Jul. 24, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Cash equivalents

Income tax rate, percentage 21.00%

Income tax, uncertain tax positions

Impairment losses on equipment

Revenue

Additional contract award $ 921,130

Contract award $ 1,021,092

Cash excess of FDIC insurance limits 0 $ 0

Doubtful accounts $ 0 $ 0

X

- Definition
Additional contract award.
+ References
No definition available.
+ Details

Name: KBLB_AdditionalContractAward

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Contract award.
+ References
No definition available.
+ Details

Name: KBLB_ContractAward

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of allowance for credit loss on accounts receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 50
-Paragraph 13
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.
+ References
No definition available.
+ Details

Name: us-gaap_CashUninsuredAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.Fact.4)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856
+ Details

Name: us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.20.1

Going Concern (Details Narrative) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Dec. 31, 2019

Dec. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Working capital $ (5,933,580)

Stockholders' deficiency (5,885,398) $ (3,650,363) $ (5,388,058) $ (4,459,223)

Cash used in operating activities $ (372,613) $ (225,046)

X

- Definition
Working capital.
+ References
No definition available.
+ Details

Name: KBLB_WorkingCapital

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 41 R18.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies and Organization (Tables)
3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Antidilutive Securities of Earnings Per Share

The computation of basic and diluted loss per share for March 31, 2020 and March 31, 2019 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:

March 31, 2020 March 31, 2019

Stock Warrants (Exercise price - $0.001/share) 55,995,917 58,595,917

Stock Options (Exercise price - $0.1150/Share) 27,340,000 -

Convertible Preferred Stock 2 2

Total 83,335,919 58,595,919

Schedule of Fair Value of Financial Instruments

March 31,
2020
December 31,

2019

Level 1 $ - $ -

Level 2 $ - $ -

Level 3 $ - $ -

Total $ - $ -

X

- Definition
Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R10.htm IDEA: XBRL DOCUMENT v3.20.1

Right to Use Assets and Lease Liability
3 Months Ended

Mar. 31, 2020

Right To Use Assets And Lease Liability

Right to Use Assets and Lease Liability

NOTE 4 - RIGHT TO USE ASSETS AND LEASE LIABILITITY

Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $2,508 for conference facilities, mail, fax, and reception services located at our principal place of business.

On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $960. Rent expense – related party for the three months ended March 31, 2020 and 2019, was $3,135 and $5,760, respectively (See Note 9).

On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on September 30, 2019. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space.

On May 9, 2019 the Company signed a 5 year property lease with the Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

In February 2016, the FASB issued ASU 2016-02, “Leases” Topic 842, which amends the guidance in former ASC Topic 840, Leases. The new standard increases transparency and comparability most significantly by requiring the recognition by lessees of right-of-use (“ROU”) assets and lease liabilities on the balance sheet for all leases longer than 12 months. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. For lessees, leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.

The Company adopted the new lease guidance effective January 1, 2019 using the modified retrospective transition approach, applying the new standard to all of its leases existing at the date of initial application which is the effective date of adoption. Consequently, financial information will not be updated and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019. We elected the package of practical expedients which permits us to not reassess (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) any initial direct costs for any existing leases as of the effective date. We did not elect the hindsight practical expedient which permits entities to use hindsight in determining the lease term and assessing impairment. The adoption of the lease standard did not change our previously reported consolidated statements of operations and did not result in a cumulative catch-up adjustment to opening equity. The adoption of the new guidance resulted in the recognition of ROU assets of $529,135 and lease liabilities of $531,462.

The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes its incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. In calculating the present value of the lease payments, the Company elected to utilize its incremental borrowing rate based on the remaining lease terms as of the January 1, 2019 adoption date. This rate was determined to be 8% and the Company determined the initial present value, at inception, of $559,568.

Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any.

The Company has elected the practical expedient to combine lease and non-lease components as a single component. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as right-of-use assets, current operating lease liabilities and non-current operating lease liabilities.

The new standard also provides practical expedients and certain exemptions for an entity’s ongoing accounting. We have elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases where the initial lease term is one year or less or for which the ROU asset at inception is deemed immaterial, we will not recognize ROU assets or lease liabilities. Those leases are expensed on a straight line basis over the term of the lease

Right to use assets is summarized below:

March 31, 2020

Right to use assets, net – related party $ 60,486

Right to use assets, net 51,621

Right to use assets, net 332,407

Total $ 444,514

During the three months ended March 31, 2020, the Company recorded $26,550 as lease expense to current period operations.

During the three months ended March 31, 2020, the Company recorded $2,178 as lease expense – related party to current period operations.

Lease liability is summarized below:

March 31, 2020

Right to use liability, net – related party 53,442

Right to use liability, net 61,789

Right to use liability, net 338,081

Total 453,312

Less: short term portion $ (113,764 )

Long term position $ 339,548

Lease expense for the three months ended March 31, 2020 was comprised of the following:

Operating lease expense $ 15,582

Operating lease expense $ 9,142

Operating lease expense – related party $ 1,923

X

- References
No definition available.
+ Details

Name: KBLB_RightToUseAssetsAndLeaseLiabilitityAbstract

Namespace Prefix: KBLB_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Right To Use Assets and Lease Liabilitity [Text block]
+ References
No definition available.
+ Details

Name: KBLB_RightToUseAssetsAndLeaseLiabilitityTextBlock

Namespace Prefix: KBLB_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R14.htm IDEA: XBRL DOCUMENT v3.20.1

Commitments and Contingencies
3 Months Ended

Mar. 31, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

NOTE 8 COMMITMENTS AND CONTINGENCIES

On November 10, 2010, the Company entered into an employment agreement with its CEO, effective January 1, 2011 through the December 31, 2015. The term of the agreement is a five year period at an annual salary of $210,000. There is a 6% annual increase. For the year ending December 31, 2015, the annual salary was $281,027. The employee is also to receive a 20% bonus based on the annual based salary. Any stock, stock options bonuses have to be approved by the board of directors. On January 1, 2016 the agreement was renewed with the same terms for another 5 years with an annual salary of $297,889 for the year ended December 31, 2016. On January 1, 2017 the agreement renewed with the same terms for another 5 years, but with an annual salary of $315,764 for the year ended December 31, 2017. On January 1, 2019 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $354,791 for the year ended December 31, 2019. On January 1, 2020 the agreement renewed again with the same terms for another 5 years, but with an annual salary of $376,078 for the year ended December 31, 2020. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively. (See Note 9).

On January 20, 2015, the board of directors appointed Mr. Jonathan R. Rice as our Chief Operating Officer. Mr. Rice’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to an annual cash compensation of $120,000, which includes salary, health insurance, 401K retirement plan contributions, etc. The Company also agreed to reimburse Mr. Rice for his past educational expenses of approximately $11,000. In addition, Mr. Rice was issued a three-year warrant to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “January 2015 Warrant”) pursuant to the employment agreement. Additionally, on May 28, 2015, the Company issued a three-year warrant to purchase 3,000,000 shares of common stock of the Company at an exercise price of $0.001 per share (the “May 20165 Warrant”) to Mr. Rice. The 2,000,000 share warrant fully vested on October 28, 2016. For the year ended December 31, 2015, the Company recorded $121,448 for the warrants issued to Mr. Rice. On January 14, 2016, the Company signed a new employment agreement with Mr. Rice. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of the January 2015 warrant from January 19, 2018 to January 31, 2020, and on January 10, 2020 the Company extended the expiration date of the warrant to January 23, 2015 and on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 31, 2019. On March 25, 2019, the Company signed an extension of its at-will employment agreement with its COO, extending the term to January 1, 2020. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additionally, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

●The Company maintaining $6,000,000 or more in working capital,

●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

●Upon the fifth year anniversary of the salary increase and the bonus issuance.

As of March 31, 2020 and December 31, 2019 the Company owes $73,582 and $64,352, respectively, to Mr. Rice for payroll payable.

On October 21, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year (effective August 15, 2019). The salary increase is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

●The Company maintaining $6,000,000 or more in working capital,

●Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

●Upon the fifth year anniversary of the salary increase and the bonus issuance.

On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively.

(A) License Agreement

On May 8, 2006, the Company entered into a license agreement. Pursuant to the terms of the agreement, the Company paid a non- refundable license fee of $10,000. The Company will pay a license maintenance fee of $10,000 on the one year anniversary of this agreement and each year thereafter. The Company will pay an annual research fee of $13,700 with first payment due January 2007, then on each subsequent anniversary of the effective date commencing May 4, 2007. The annual research fees are accrued by the Company for future payment. Pursuant to the terms of the agreement the Company may be required to pay additional fees aggregating up to a maximum of $10,000 a year for patent maintenance and prosecution relating to the licensed intellectual property.

On October 28, 2011, the Company entered into a license agreement with the University of Notre Dame. Under the agreement, the Company received exclusive and non-exclusive rights to certain spider silk technologies including commercial rights with the right to sublicense such intellectual property. In consideration of the licenses granted under the agreement, the Company agreed to issue to the University of Notre Dame 2,200,000 shares of its common stock and to pay a royalty of 2% of net sales. The license agreement has a term of 20 years which can be extended on an annual basis after that. It can be terminated by the University of Notre Dame if the Company defaults on its obligations under the agreement and fails to cure such default within 90 days of a written notice by the university. The Company can terminate the agreement upon a 90 day written notice subject to payment of a termination fee of $5,000 if the termination takes place within 2 years after its effectiveness, $10,000 if the termination takes place within 4 years after its effectiveness and $20,000 if the Agreement is terminated after 4 years. On May 5, 2017, the Company signed an addendum to that agreement relating to tangible property and project intellectual property. On March 1, 2019, the Company singed an addendum to that agreement. The Company entered into a separate loan agreement and promissory noted dated March 1, 2019 as a payment for expenses paid by the University prior to January 31, 2019 totaling $265,244 and issued 4,025,652 shares of Class A common stock with a fair value of $281,659 as payment of certain debt. In the event of default the license agreement will be terminated. During the three months ended March 31, 2020, the Company paid $15,000 of the balance (See Notes 6).

(B) Royalty and Research Agreements

On May 1, 2008 the Company entered into a five year consulting agreement for research and development. Pursuant to the terms of the agreement, the Company will be required to pay $1,000 per month, or at the Company’s option, the consulting fee may be paid in the form of Company common stock based upon the greater of $0.05 per share or the average of the closing price of the Company’s shares over the five days preceding such stock issuance. On April 6, 2018, the Company issued 36,000 shares with a fair value of $1,076 ($0.0299/share) to a consultant as consideration for consulting fees owed from October 1, 2014 through December 31, 2019 of $21,000. The issuance of shares resulted in gain on settlement of accounts payable of $19,924. On April 1, 2018, the Company ended the consulting agreement and no additional compensation will be issued. (See Note 7 (B)).

On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. In accordance with FASB ASC No 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007. As of March 31, 2020 and December 31, 2019, the outstanding balance is $65,292. As of December 31, 2019, the Company recorded interest expense and related accrued interest payable of $2,623. In 2020 the Company recorded $490 in interest expensed and related accrued interest payable. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.

On December 30, 2015, the Company entered into a cooperative agreement for the research and pilot production of hybrid silkworms in Vietnam. Under this agreement, the Company will establish a subsidiary in Vietnam where it will develop and produce hybrid silkworms. On April 24, 2018, the Company announced that it had received its investment registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd. On May 1, 2018, the Company announced that it had received its enterprise registration certificate for its new Vietnamese subsidiary Prodigy Textiles Co., Ltd.

(C) Consulting Agreement

On February 20, 2018, the Company signed an agreement with a consultant to provide services. Under this agreement the consultant will receive a warrant for 600,000 shares of common stock and may be awarded additional warrants for up to 3,000,000 shares of common stock if performance metrics are achieved. On March 20, 2018, the Company issued a 4-year warrant to purchase 600,000 shares of common stock at an exercise price of $0.001 per share to a consultant for services rendered. The warrants had a fair value of $19,915, based upon the Black-Scholes option-pricing model on the date of grant and are fully vested on March 20, 2018. Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022. During the year ended December 31, 2018, the Company recorded $19,915 as an expense for warrants issued (See Note 7 (C)).’ On April 5, 2019, the Company cancelled 600,000 warrant issued to a consultant on February 20, 2018 in exchange for $6,000 cash payment.

(D) Operating Lease Agreements

Since September of 2015, we rent office space at 2723 South State Street, Suite 150, Ann Arbor, Michigan 48104, which is our principal place of business. We pay an annual rent of $2,508 for conference facilities, mail, fax, and reception services located at our principal place of business.

On May 9, 2019 the Company signed an 5 year property lease Socialist Republic of Vietnam which consists of 4,560.57 square meters of space, which it leases at a current rent of approximately $45,150 per year one and two and with the 5% increase per year for years three through five.

On January 23, 2017 the Company signed an 8 year property lease with the Company’s President for land in Texas where the Company grows its mulberry. The Company pays a monthly rent of $960. Rent expense – related party for the three months ended March 31, 2020 and 2019, was $3,135 and $3,273, respectively (See Note 9).

On September 13, 2017, the Company signed a new two year lease commencing on October 1, 2017 and ending on March 31, 2020. The Company pays an annual rent of $39,200 for the year one of lease and $42,000 for the year two of lease for office and manufacturing space. On September 5, 2019, the Company signed a new two-year lease for this 5,000 square foot property in Lansing, MI that commenced on October 1, 2019 and ends on September 30, 2021, for its research and development headquarters. The Company pays an annual rent of $42,000 for year one of the lease and $44,800 for year two of the lease.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R37.htm IDEA: XBRL DOCUMENT v3.20.1

Stockholders' Deficit - Schedule of Warrants Activity (Details)
3 Months Ended

Mar. 31, 2020

USD ($)

$ / shares

shares

Equity [Abstract]

Number of Warrants, Beginning balance | shares 55,395,917

Number of Warrants, Granted | shares

Number of Warrants, Exercised | shares

Number of Warrants, Cancelled/Forfeited | shares

Number of Warrants, Ending balance | shares 55,395,917

Number of Warrants, Intrinsic Value | $ $ 9,799,286

Weighted Average Exercise Price, Beginning balance

Weighted Average Exercise Price, Granted

Weighted Average Exercise Price, Exercised

Weighted Average Exercise Price, Cancelled/Forfeited

Weighted Average Exercise Price, Ending balance

Weighted Average Exercise Price, Intrinsic Value

Weighted Average Remaining Contractual Life (In Years), Beginning balance 2 years 9 months 7 days

Weighted Average Remaining Contractual Life (In Years), Ending balance 2 years 6 months 7 days

X

- Definition
Weighted Average Exercise Price, Cancelled/Forfeited.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: KBLB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of Warrants, Intrinsic Value.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted Average Exercise Price, Beginning balance.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: KBLB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted Average Exercise Price, Intrinsic Value.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceIntrinsicValue

Namespace Prefix: KBLB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted Average Exercise Price, Exercised.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: KBLB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted Average Exercise Price, Granted.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: KBLB_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted Average Remaining Contractual Life (In Years), Ending balance.
+ References
No definition available.
+ Details

Name: KBLB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: KBLB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted Average Remaining Contractual Life (In Years), Beginning balance.
+ References
No definition available.
+ Details

Name: KBLB_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: KBLB_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of non-option equity instruments exercised by participants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Net number of non-option equity instruments granted to participants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.1

Accrued Interest - Related Party (Details Narrative) - USD ($)
3 Months Ended

Mar. 09, 2020

Feb. 19, 2020

Jan. 24, 2020

Dec. 18, 2019

Nov. 20, 2019

Mar. 01, 2019

Feb. 15, 2019

Feb. 01, 2019

Jan. 17, 2019

Jan. 04, 2019

Dec. 21, 2018

Oct. 12, 2018

Oct. 01, 2018

Jul. 05, 2018

Jun. 29, 2018

Jun. 21, 2018

Apr. 26, 2018

Mar. 31, 2018

Jan. 09, 2018

Dec. 01, 2017

Jun. 06, 2016

Mar. 31, 2020

Mar. 31, 2019

Dec. 31, 2019

Proceeds from debt $ 100,000 $ 100,000 $ 100,000 $ 100,000 $ 100,000 $ 20,000 $ 20,000 $ 30,000 $ 30,000 $ 3,000 $ 20,000 $ 11,000 $ 26,000 $ 20,000 $ 15,000 $ 15,000 $ 20,000 $ 15,000 $ 100,000 $ 30,000 $ 50,000

Debt Instrument, Interest rate 3.00% 3.00%

Loans payable amount $ 942,000 $ 642,000

In-kind contribution of interest 9,784 $ 4,947

Accrued interest $ 5,958 $ 3,445

Loan One [Member]

Proceeds from debt $ 17,000

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of interest payable on debt, including, but not limited to, trade payables.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910
+ Details

Name: us-gaap_InterestPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a)(5))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_PaidInKindInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=KBLB_LoanOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 R11.htm IDEA: XBRL DOCUMENT v3.20.1

Accrued Interest - Related Party
3 Months Ended

Mar. 31, 2020

Accrued Interest - Related Party

Accrued Interest - Related Party

NOTE 5 ACCRUED INTEREST – RELATED PARTY

On June 6, 2016, the Company received a $50,000 loan from our principal stockholder. Subsequently on December 1, 2017, the Company received an additional $30,000 loan from the same stockholder. On January 8, 2018 and March 31, 2018 the Company received an additional loan of $100,000 and $15,000, respectively. The Company received additional loan funds from the same stockholder as follows: $20,000 on April 26, 2018; $15,000 on June 21, 2018; $15,000 on June 29, 2018; $20,000 on July 5, 2018; $26,000 on October 1, 2018; $11,000 on October 12, 2018; $20,000 on December 21, 2018; $3,000 on January 4, 2019; $30,000 on January 17, 2019; $30,000 on February 1, 2019; $20,000 on February 15, 2019; $20,000 on March 1, 2019; $17,000 on January 4, 2019, $100,000 on November 20, 2019, $100,000 on December 18, 2019, $100,000 on January 24, 2020, $100,000 on February 19, 2020 and $100,000 on March 9, 2020. Pursuant to the terms of the loan, the advance bears an interest at 3%, is unsecured, and due on demand. Total loan payable to principal stockholder for as of December 31, 2019 is $642,000. Total loan payable to this principal stockholder as of March 31, 2020 is $942,000. During the three months ended March 31, 2020, the Company recorded $9,784 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $5,958. During the three months ended March 31, 2019, the Company recorded $4,947 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $3,445.

X

- References
No definition available.
+ Details

Name: KBLB_AccruedInterestRelatedPartyAbstract

Namespace Prefix: KBLB_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Accrued Interest - Related Party [Text block]
+ References
No definition available.
+ Details

Name: KBLB_AccruedInterestRelatedPartyTextBlock

Namespace Prefix: KBLB_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R15.htm IDEA: XBRL DOCUMENT v3.20.1

Related Party Transactions
3 Months Ended

Mar. 31, 2020

Related Party Transactions [Abstract]

Related Party Transactions

NOTE 9 RELATED PARTY TRANSACTIONS

On December 26, 2006, the Company entered into an addendum to the intellectual property transfer agreement with Mr. Thompson, its CEO. Pursuant to the addendum, the Company agreed to issue either 200,000 preferred shares with the following preferences; no dividends and voting rights equal to 100 common shares per share of preferred stock or the payment of $120,000, the officer agreed to terminate the royalty payments due under the agreement and give title to the exclusive license for the non-protective apparel use of the intellectual property to the Company. On the date of the agreement, the Company did not have any preferred stock authorized with the required preferences. In accordance with FASB ASC No. 480, Distinguishing Liabilities from Equity, the Company determined that the present value of the payment of $120,000 that was due on December 26, 2007, one year anniversary of the addendum, should be recorded as an accrued expense until such time as the Company has the ability to assert that it has preferred shares authorized. As of March 31, 2020 the outstanding balance is $65,292. Additionally, the accrued expenses are accruing 7% interest per year. As of March 31, 2020, the Company recorded interest expense and related accrued interest payable of $7,033.

On November 10, 2010, the Company entered into an employment agreement, with its CEO, effective January 1, 2011 through the December 31, 2015. Subsequently, on January 1, 2018 the agreement renewed with the same terms for another 5 years with an annual salary of $334,708 for the year ended December 31, 2019. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $2,616,686 and $2,535,203, respectively.

On January 14, 2016 the Company signed a new employment agreement with Mr. Rice, the Company’s COO. The employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Rice is entitled to annual cash compensation of $140,000, which includes salary, health insurance, 401K retirement plan contributions, etc. In addition, Mr. Rice was issued a three-year warrant to purchase 6,000,000 shares of common stock of the Company at an exercise price of $0.001 per share pursuant to the employment agreement. On January 9, 2018, the Company extended the expiration date of a warrant for 2,000,000 shares of common stock from January 19, 2018 to January 31, 2020 and on January 10, 2020, the Company extended the expiration date of the warrant to January 23, 2015 for Mr. Rice. Additionally, on March 15, 2018, the Company signed an extension of its at-will employment agreement with its COO. On April 26, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by $20,000 per year and issue a one-time $20,000 bonus. Additional, on August 15, 2019, the Company signed an agreement to increase Mr. Rice’s base salary by an additional $20,000 per year. The salary increase and the bonus is accrued and to be paid in full earlier by the direction of the Board or upon the earlier of:

● The Company maintaining $6,000,000 or more in working capital,

● Upon the transfer of ownership of more than 50% of the Corporation’s voting share or an assignment for the benefit of creditors or bankruptcy, or

● Upon the fifth year anniversary of the salary increase and the bonus issuance.

As of March 31, 2020 and December 31, 2019, the Company owes $73,582 and $64,351, respectively, to Mr. Rice for payroll payable.

On July 3, 2019, the board of directors appointed Mr. Kenneth Le as the Company’s Director of Government relations and President of Prodigy Textiles. Mr. Le’s employment agreement has a term of one year and can be terminated by either the Company or Mr. Rice at any time. Under the employment agreement, Mr. Le is entitled to an annual cash compensation of $60,000. In addition, Mr. Le was issued two three-year warrants to purchase 2,000,000 shares of common stock of the Company at an exercise price of $0.2299 per share. As of March 31, 2020 and December 31, 2019, the accrued salary balance is $1,154 and $1,154, respectively. .

On June 6, 2016, the Company received a $50,000 loan from our principal stockholder. Subsequently on December 1, 2017, the Company received an additional $30,000 loan from the same stockholder. On January 8, 2018 and March 31, 2018 the Company received an additional loan of $100,000 and $15,000, respectively. The Company received additional loan funds from the same stockholder as follows: $20,000 on April 26, 2018; $15,000 on June 21, 2018; $15,000 on June 29, 2018; $20,000 on July 5, 2018; $26,000 on October 1, 2018; $11,000 on October 12, 2018; $20,000 on December 21, 2018; $3,000 on January 4, 2019; $30,000 on January 17, 2019; $30,000 on February 1, 2019; $20,000 on February 15, 2019; $20,000 on March 1, 2019; $17,000 on January 4, 2019, $100,000 on November 20, 2019, $100,000 on December 18, 2019, $100,000 on January 24, 2020, $100,000 on February 19, 2020 and $100,000 on March 9, 2020. Pursuant to the terms of the loan, the advance bears an interest at 3%, is unsecured, and due on demand. Total loan payable to principal stockholder for as of December 31, 2019 is $642,000. Total loan payable to this principal stockholder as of March 31, 2020 is $942,000. During the three months ended March 31, 2020, the Company recorded $9,784 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $5,958. During the three months ended March 31, 2019, the Company recorded $4,947 as an in-kind contribution of interest related to the loan and recorded accrued interest payable of $3,445.

On January 23, 2017, the Company signed an 8 year property lease with the Company’s President for land in Texas. The Company pays $960 per month starting on February 1, 2017 and uses this facility to grow mulberry for its U.S. silk operations. Rent expense – related party for three months ended March 31, 2020 and 2019 was $3,135 and $3,273, respectively.

As of March 31, 2020 and December 31, 2019, there was $311,638 and $304,539, respectively, included in accounts payable and accrued expenses - related party, which is owed to the Company’s Chief Executive Officer and Chief Operations Officer.

As of March 31, 2020, there was $1,269,213 of accrued interest- related party and $50,163 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.

As of December 31, 2019, there was $1,196,503 of accrued interest- related party and $43,715 in shareholder loan interest – related party included in accounts payable and accrued expenses – related party, which is owed to the Company’s Chief Executive officer.

As of March 31, 2020, the Company owes $2,616,686 in accrued salary to principal stockholder, $73,582 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,892 to its office employees.

As of December 31, 2019, the Company owes $2,535,203 in accrued salary to principal stockholder, $64,351 to the Company’s COO, $1,153 to Director of Prodigy Textiles and $4,477 to its office employees.

The Company owes $65,292 in royalty payable to related party as of March 31, 2020 and December 31, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_RelatedPartyTransactionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R19.htm IDEA: XBRL DOCUMENT v3.20.1

Equipment (Tables)
3 Months Ended

Mar. 31, 2020

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

At March 31, 2020 and December 31, 2019, property and equipment, net, is as follows:

As of March 31, 2020 December 31, 2019

Automobile $ 41,805 $ 41,805

Laboratory Equipment 96,536 96,536

Office Equipment 7,260 7,260

Leasehold Improvements 85,389 85,389

Less: Accumulated Depreciation (121,048 ) (113,669 )

Total Property and Equipment, net $ 109,942 $ 117,321

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R36.htm IDEA: XBRL DOCUMENT v3.20.1

Stockholders' Deficit - Schedule of Option Assumption (Details)

Feb. 19, 2020

Aug. 08, 2019

Mar. 20, 2018

Common Stock Warrants and Options [Member]

Expected dividends 0.00%

Expected volatility 125.19%

Expected term 3 years

Risk free interest rate 1.56%

Expected forfeitures 0.00%

Common Stock Warrants and Options One [Member]

Expected dividends 0.00%

Expected volatility 125.19%

Expected term 3 years

Risk free interest rate 1.50%

Expected forfeitures 0.00%

Common Stock Warrants and Options Two [Member]

Expected dividends 0.00%

Expected volatility 125.19%

Expected term 6 years

Risk free interest rate 1.46%

Expected forfeitures 0.00%

Common Stock Warrants and Options [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options One [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options Two [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 3 years

Risk free interest rate 1.54%

Expected forfeitures 0.00%

Common Stock Warrants and Options Three [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options Four [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options Five [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options Six [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 2 years

Risk free interest rate 1.62%

Expected forfeitures 0.00%

Common Stock Warrants and Options Seven [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 3 years

Risk free interest rate 1.54%

Expected forfeitures 0.00%

Common Stock Warrants and Options Eight [Member]

Expected dividends 0.00%

Expected volatility 105.73%

Expected term 3 years

Risk free interest rate 1.54%

Expected forfeitures 0.00%

Common Stock Warrants and Options Nine [Member]

Expected dividends 0.00%

Expected volatility 97.56%

Expected term 4 years

Risk free interest rate 2.65%

Expected forfeitures 0.00%

X

- Definition
Expected forfeitures.
+ References
No definition available.
+ Details

Name: KBLB_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresdRate

Namespace Prefix: KBLB_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsThreeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsFourMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsFiveMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsSixMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsSevenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsEightMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=KBLB_CommonStockWarrantsAndOptionsNineMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 50 R32.htm IDEA: XBRL DOCUMENT v3.20.1

Right to Use Assets and Lease Liability - Schedule of Lease Cost (Details)
3 Months Ended

Mar. 31, 2020

USD ($)

Operating Lease Expenses [Member]

Lease expenses $ 15,582

Operating Lease Expenses One [Member]

Lease expenses 9,142

Operating Lease Expenses - Related Party [Member]

Lease expenses $ 1,923

X

- Definition
Amount of lease cost recognized by lessee for lease contract.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971
+ Details

Name: us-gaap_LeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_OperatingLeaseExpensesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_OperatingLeaseExpensesOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TypeOfArrangementAxis=KBLB_OperatingLeaseExpensesRelatedPartyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

ZIP 51 0001493152-20-006856-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-006856-xbrl.zip M4$L#!!0 ( #J(E5"3?FJ/IM %AX"@ 1 :V)L8BTR,#(P,#,S,2YX M;6SLO7USVSBR+_S_J3K?@4]NYE92)3LB]9[9F5NVX\QZ)[%];&?W[OUGBQ8A MBR<4J>6+$YU/_Z ; E2E$1HMZ(/6=F9(D$&HT?&MV-[L9?_L_/B:.]$C^P M/?>W-_IY\XU&W%GV>[+;V^^/9Y=/%[=W+S1_L_O__D?&OW?7_Z_LS/MLTT< MZZ/VR1N>W;@C[U?MUIR0C]H?Q"6^&7K^K]K?32>";[S/MD-\[Y ])W-:?EU\NM5^,3YK1-)K-5DO7].9_:?^E:Y\^WY[_'-&Q?#)#^AS\ M3!]KMNF_#/W):'YL]C\:O?]7L-/0#,@[K3YL\G_QU[_R\]GW[$_PK\U.A]N M\/%G8/_V1AKGC]:YY[]\H"3J'_[OUR^/PS&9F&>V&X2F.R1OQ%N.[7[/>T\? M# 8?\%?QZ-R3T+GHH_4!?GXV@Z1E('#)\W.4T%^M,'Y!?KCS@?V8>M3.?;3+ M'K7%HQ;)/!>0X?F+]_J!_D"?UP=G3?VLI8O'?3):2'+W _U5/&@'7MO0>\O& MQYX0+T2AO_#AP0?Z:_Q@ZM?2K] :8"O\ZG#7WH&WJ1&_JS M_+GC/^:\%OCA?#?TRYQ'81G'SW[W3?O%,9]!$P^B(7]1JQ3P/;' %?0 QEI MN"P^CA$LWY^=YS/QPOG/P'K#?X:1_?8FL$&.O=$^B;8NAUZ;DA^AIIM_?;F ML^]-!'E-/?38Y]99TG_\&G%#.YS%W\;?VQ;\,KIX$0J26J&!-NN;OY\\SN5 M('I;;^GZX"\?LB\GW7W([8_W-J6SZUGS5-#U[(<@^WY/AB-:2GZ;>XT:^DE M&'?2O95Z17R?(D!\R5FZF,\7P=T(5[QN'!]OF;0,?T\&$'?!?]DFDXX4@ F3 MLDBJ@DEB(O[%!?._J,XR\=PKQPR"BZ]D\DS\O?$O69/D94D@<<_6928GU/' M'MHAHU6S;/HD4^KXB#Z"$D+@?1S4W>@Q](;?+W[:P9O?Q2/S@_[+A]SV9=H^ MY!-W3$M#S?JAS/J^U_IE'6?]F3X,F[)#=!$!'KQ)!P_>^(T@T.&,^E?P8,#6 N?2S(BCUA7[U4B'>"Q0^ MC@\?.]@U8ODA=HT+R[)#RDO3N3=MZ\:],J=V:#JU@(5X;"D/:B(O%!X.'P_[ MD \/)#1MEUC7IN_:[DM0R#D#[YF$D$AX) 0L L9T#MK]LZ,]M$Z6,4 =KI, M/INVC^>A-^XT"H,OY)4X^FFLE7AHE[/XXU]I/Z8_',]PH.E%LX05)[YRBH#" M4#(L$!PFDI4&1843-07$2A-_&>;8>'LWJ&\NW MT+.FT-[E M[&DV)1F+SOZFLP^]])],9\]##6;Q5RJ$0C0.[>0!35!@I #=Z.1/21UA(%X M.)<#-4/!%V(&9.PYULUDZGNO:C6<5]8PH<31T0/0M2,UE';X#" :IC$PA)Y M'P:$)1XIP^2P1#&<&+=%PAS?XD+)'V03%_;+Q-@Q$&4+$,;W9H-TG>_2& MMNG80?A IM$SE5!WH[_;)'3-R7'+\< /$^?I'\1[\?ND3$L);OY<,K);C[N:F1WPN?N MF=$4?:?CRUR.LMG&$YI/L.X=\#GOL3GP?'SN;\.GP=5\YGNYFW!9_JY<^1\ MAN&4YC.,NVH^#\Z,'N>S#BDS1\YG&$Y9/N.X^8S[4/7$S[KQZ8X9/B,PUF# MS[I1-9^-9!^$ST>.9QQ.:3X;5>^#3'=L(9_9YV,+)$CQF0^G')_YNOGL]Y- M^SWCI[/>G<-/NN]ZOEL# 2?C2/?!_EP2O/9J'H?Q#[T=L)G_:CU.CZ<-?BL M5ZO781_<3AE PLK1X]DH;:?P<5?,9YW)B$WZ&>C>=Q\QN&4Y3..NVH^TS73 M$WRFG_M'SF=#VM(\QG&7>D9 %\SPKW]S:7LB7QBW=-IL(/ \V>W7DB8(U<\ M1+_QR2=S0H[;Y2U.(S^1Y_#(_@D8D?_=29JQV=A>A =SN3W;HD+O1C6O9 MK[85I5SN&5;OU\,N"]=G,>LCYZTB<7G+O>1/QR; ;EX\0E) @CBH_4;]Y70 M!_W3@"0?&K\"T>(ONQR?0]L\K.DS.N?H )V_<>]\/^]7LAZF9 MCT7'M?TR#FLY]_DCW_OL5Q1OL&03$>I.G1 @'MOKW!_X5K%:[^#HW8PK!> T9UU6 >.C)L%8\D78%1 MB.D[MO%!&YQN#0#8MVY3V,2UZE(GV]_CSG#BPRG-YT%E&4Z)V#M"WJ;%GLRDJL0> M1'\+,-+/QQZ6W9%K%AOX9"O[)C[%3NB)[$OG1(I9!R/$B95PO7.,R2 ;9W\5,K!W@Q3BCQHY!RF$@Y0?%3 MK].8HKQ0(DBAY7#1Y M1_NG0E6:$_79XQ12C@LI!V['K2-^R"MQ%:RRO% B2'E<-%R>F(("^ H8&5Y MH<200LOAHN4XQ% _G2VG(K(/-2);$C[]'614]J6,2H61(\%(2N3TUTFA[.\@ MA;(ON1C[B'D.%5WK78K]UFA,[;.F(0Y(Z.>.@M9108O/8.F#D7;55Z>M MJXTK:!T0M Y,!]\T>$F=N1W>F=MA0FQ==?[65LEP=2D(51E4"8GE0D(!Y3 -QR"FA5CO2^R\D>LYA0 M0#E!,;%\QNN55GI@=8DD AX2"1L N9L'A/NSOGG!9VSU!S?\!S?\NC,GFF4Z-%1;"CY_U.(3_ M>C)UO!D,Z>+%)\@^-O9_!7[XKZNQ34;7/\DP"NU73[,I'= % M&)4O.&P))0N9LAHG14B@G/WX9(<.[?_&M>Q7VXI,AW4//RUA^EY-7HZB"\A3BLY M?1SP[DKP[BIXWBO!>_N.O#N[@#>/0G>/05O!>^UX-U;!]Z]W1\L4@K2._? MP<&QB2J/4<"IP1_XZO_-<\UP;+H/#Y1)Z1__9KJ1Z<^>?GA/8R\3->Z<W/ M]B@DQ#VI-./#1#)VGSM!V^EZSEV(WL"[$;H#)1(PV"/:XOCONJUU3DS^MM9 M6U]-M:YJOJX06"_:PKP7O&:TIL;KRFU3 YMF52(2<1+U9@LY3E7FP])G<1 M!=L^,SJBO!W]W%7X5/@L4Q#4B&M[%BZI!S"KU%.(9?MT(ZG:J'<4K!6LRU2 MU,O5N14PVZ6'\20>A0PV7D5%26ZE.@J@\F4#H*D[VS9JL$)O\DKDO"\1>% MQ^KQF.'U?K$(.G:>NGQP44+A4NBZMWO;+7&&3AO-\#8 7A^D%XMQ'MS2XX MZ=F]!_QS[$S_0E4=-R"9:3AE[.6/>)]"3,Q/2$F)K)UTM3"M)BGQ.!IH!S M ,!9)_Q)3.1A 0?CH+Z:/^U)-%%0VG3S>X ^DU"G%%\58/.L#QW/#-G50'KZ MO%E)NOT#1\Q/.3U?3Q\$5W<;BS$09FL!22PAK^ RAX2G](>1#52R/$ M<(/("6L1@;M+7"YSV65YOM==NY^^!K?PU8 MTJ=S@K2"M+KE=5)8;,B)[1N M\.A$_GD-G'[UG\;>9!IX)U++\QAPFN7YGEWEB**RKG$VR[/^Y21=%A&TGZO MS%("3@FX_6,SL8$,Z8IR(W5%.:HDMONR($JA3GKB0F;40SW,6CS&.I>A&Y5= MAIY8/ K "L"K[1NCLLSO1RV)+':4JA4J"P@5EOKB-76#L2J K "\&JQVJI: MK&&81(6#GY7A4J%RJ5BE6.F]FZ[-2OE@$8C8%F.GG@<#J'6W8A.G[0DPI M3"+C'GCTAK;IV$'X0;1,V7LW>CO-@E=LP9'I,LYM#V8QU$D?Q#OQ3>G8WN8 M@OJJ.=@W].6HX,+0[TBUJJNK]V@8O-XC?&X5A#[$ =S[)$#49A7+,WAIPRW M]PIHCIMR@.8 JU1%5B!6("ZF)F?06%4FK](F#A&AQZ9-I+-^9;6@$MS2M3$X MTPM487'_4@OF%C7S61ZP<D0<'BR2MF@=%&=#)"JLC+6 U+\%-:!OG"M MKZ8;CI68<++O8$P4=][Y'>PMG]PZ5)I3?< W9%'J[G &),E6K MID0MA06^)G!I"5_30'<IEZ@#5SU=IS\V@,J=E8EHH\!P>>-**NHR"78?O MWM"''8=0P6PZ0JP_408&(^(OK'92GS"W$NRI1[S;403TI KD&]'/&?16M4Q M>7R=EKI[Z) K4!W8W4/SZ>AEK]/Q"Q7=1EB5^1MLL^Q8,8D_['G6,<.VU42 M;6Z@>X4GY%R4.%35RE4^HCAKHC#U5B9PHJ^XIRU59+QSEJ%=AG)57V#I6N%=<&"HP=3N 2E^"RD!!Y0"@4C)^DD]=U5#IB>,<]KFCH+)O MJ/1']CPJ:L:@-1DK /)1";AH+OJ$R%WFCT]=Q5"A?>AZ A5=067?4,$9 M60,J>N50,1U%CXKM7;O4#'64&MQZJH./=&I39[4Q&VV%50.P+'?@<5/G75 M0T7O)E#1>PHJ^X>7M);RZ>N>J@DE;8-J9JL@LI15:\VBLVG$#%.-/;"51T M92SO'2HP(VM I:IK6&6H\(L?!G"0H(SE0X!V:L>^-3MP 2KGI0+KB#L(#6 MN3ZA\D(/$KFGJWB5O4/%D(R9 M$E%P>D7QOE5914\3JU"ZX+JP<2A4++N0QGQSW1(C)7'A%&B9O#D#X07,[D M7^12P7,LJ D$XA#M./GH)$TB\1'YX^X1O-^Z9F^=3?Z9/MD&'I^<#4V;7]B M'GDVR8JI7S[HFLQ^AF=I2J0(\\_7[7'YXWU5&=[='9,#P194S]F/O/AE.,S'W?%QPK9A+7!,?-Y M@VRORB.HL]E>1\[GPTR56A+]]<4SW3OWR"T9H=%^(L_A#;4+_"B36YX:Y;[W M\(,-^\JFSS>7SFCD4\V?/FH'@>?/;KV0I#56^HU//IF34X?24F9L3S]= M9IAG6+UO/\;&E#I[>:\C]CPNH_\X5BN$<71R^?[7S?NZ$/'KD3MTB=C06< MJ!RZ@K8TI_?J4$$5.P^3-W:\\VEYJ0?4'KO1B;J WX9C=7Z> M]ZV[EJ]7,:BR7L66KE#%L^JOYD][$M7@WHBCNV>M:\/,-CD'#XUH7O4H'9Q M=>L TF=Y:BO[7!XHM@CFE#J52P(WIGPPWTO#3:))%)05E$L8JRE,5G33 M"QRHX04=1A.4FR71[K&[[#%Z#LB_(SJPZU=R[->G51#L7&8]9'B9W+6QX($# M$+ <,Z4$K !7U0)6#MKK>I[X5IR-"M5WTX]@)?IJ6OP8K^BK_+@SBYZ6MIJ M.U;;<2%,)R/B^\1"T^$T !L[]J\<,Z"CQZ%E#)7%H]_?KBWFJ.)S M?F9W!P<+ [VD$!T]!&M:Z;85![1"FM:\#F6P<)IE0>^$SE6CM<>W,T:SJZ\ MR=1SZ9^![U:,OY];N)BSDH[C784'IU:M I,APVF Y1,&8U0 >C@ +1SG5 A MX>"1D)4)56B%R[05RJJ)YZ(J?7&1L(20"P8NM)12NHH"D'!&CT4P4;/8- MF_WJ(VK^#V?^#T@+N:PO%BX/9 LY=BU$06CO$#I&+43!IMY:B)I_I850AB K MN&XV-GT2/'F7Y"8((F+5#1LK6:&TE+6T% 6QXX#8D6DQ"E:'"ZM#T'(4/HX! M'WO3@D3LV(5EV9"83KWIFW=N%?FU Y-IQ80$8\MY8'2>HIJ/0I21P"IP]=R M%(P.%$9[TFH4'@X>#WO78AY(:-HNL:Y-W[7=EWH$.B57^0-7NDM9?46!:# M M'Q:"H.'L'SIYU$X6 T) M=I(7#4/\[N.+-\J55AM%_>9'6-2VF[U6IXY MK$O)ZL:1,2PG>[KDKLW'O4/5[QA7[S:TH^HO).M)?.X=/Y][Z_"Y5SV?EV:E MPH''/TPH]Q">B"YR0=NU; ?+23W"G1AV:)/@^N?0B2QB 4M /8E"K"MU-QZ MR#WQ\H#.H@$=12<.3EH8'",H%'LK/INW_W70B M;8>'LWJ&\NW M.."80GN7L_FZ'.CK\GLBTM[S6?/-T//G\5< MJA$(V(V^BUA0$R0(.<#M=<1!N+A7 [4# 5?B!D0N'B9C+UO5<\(:[COK"$ M#Z>B.3T4'& WS,1SQ\. ?GU%QVQ/- '-J==4])G1WWVEM5('Q^I,H#7M(# MKL"B'(1+=?P'^V4&!.UQ(&:>V3# MG5N#NU"6C;NN"/ABF\^V0PFO\::PG <&?7:&N;'K1!0NPTB=^BGBH/5_@A^ MIZ?[@EZQZY]3RM53.2U:!HAEXU9^BJV J!:"9<70%92V J5ZZ:]%>:# M1!< M1DN BWYN'_$AAQA.:3[#NOFLW&F]P6?Z>?!D?/9D"Z>+\QG&'?5?&Z=-?N) ML&P>.Y]A.&O(C:IN:5V]7VV_2!\M']^I6^-CUPYAI.8.$'\<4A$EG%!B MI:!]5PA@"ET2&_8-K0,S:9,=2\'I&."4WM-D7!S4GJ8P%D MWS@YFIUM+7> PM<<)Q3 M@DP"(]0 $MQ0@%LJP"#< H%L2PO%,BV"3(6JZ- MEN&% MD6O0P7@D7]@VL@_4OII4<>;5 CCBL=28:QBWI.9>[3T%1 3?;SC' M:G4^DAUS#86$FGUU$+:&FB5,S [YMJ+"37[2DP4$Q.8:U([J"2C5J)"(4") MBZ+B M-:H>59-"U%Q9J_I6H"HJ[-?Z;2O)H)6H4/.O1$4Q45&KN)+LF&LO M-3LS%13$S4SIH?M15"@$'&Q"CBZ < )_/!?HFK9\\G0S/@S!8NIY, M'6\&3+IX\0G.!7\ WKT:VV1T_9,,\;9G=H_:D9N^2RKX$^YW%J-N#H7U;^ M<^%\;(>$)5?QP$]+YOL8%QTN@EWNT;5;30K2!ZA)Y&/SJ_\WSS7#L>D^/% > M'#?N5ETIECO8>LWW8ED4 ^)/XKHD''\Y,SP^E2QN-J^4+7HQN0 MS#2<,O;R1WR,"E7U%VVS_1FS'3"V85K/9" F/YP'',T2$NV M\\-(B<\F6CBI9?;K.3;B1]^C38>S)\KK8$3\ MA5ZY^BCZ)=BC-/[M[Y]Z'Y=1%\4>^SQ8Z3T^93QNX"2N4-CQ62HG[/AT5A]Q MD+YL,;X#"TIAC#W'.O8#SE428VZ@^U>PCN2^2 65?4/EP&K"++[R4D%EWU Y ML%L[\[5M!8]3TU/9/&=-&0"S!B].6V^;BR@@ M#@6D=4_!/#MN+ B1)H\('=?F$"?Y^1'::ODPI(AUV3NX]R7>)<_]0TA3CS)'W&-YOW2,WWK;O3)]LDP]/S@:FS: M_L0\\L/-%5._?- UF7UAYR#PV5)?M&^\Q([@-@=VI<.6807!RW!)FK=H&# MNANAP$A?"# _Z/WN'S C56L+BV;]LHZS?GG:LU[@'A"U[M4FL0@XF0,5IGHJ MX!P,<-8]N@P\;7)_RDO!<>=M]69 $4J<" M!@N94?FI_^'5+>BO ^;^#L!,5UF'!^7RSX."@2PB9L\;VJ9C!^$#F4;/E+%W MH[_;)'3-2?HYO)"_LN+7L901_J?Q#QV!^(AQ;_$\OT/XKWXYG1L#],1ARNF MJ0)TKG,2,42$.Q[K^F4#806RV7GVJT<+,LO.CZ-=71!V[5L!\-L'LDP\NW0 M)L'USZ$36<0"CD =V2C$>)N[T;7INW1A!??$?QR;/KF0C;M-\4SIQB7# M&Q7LCAUV!Q$&+DVP]RWQT]S$)K0W3+RR>]VX+4-O?>1/B,:$S^ENX#6%K2/ MLQ0L[((S 1]:NP]W_V"?E US>$MO'L;34 ]\'+VV1(\R-8UZK4Z2?B>A/; M7=7M:KYD^\UK6/R>XD(!AM[3;E9,V91^7!\4_QZ%"]N/0O]C0!\HWKI%[(\7 M=)U:L%8_.^:+QC'_0$;+-O,WOX],)Z##F&M ;OF3-XS@^WM<7-=LZ17N0=XS M%K:6U]UG.Z!)'OL,_TN-SE?V6ZFFMI<7>@$I;K##[G=1>W)'=V%?E^ZHFR MW#P31MFRUN0>KU%0/Y 7JGQ#O?M;1*N**6^Z5!CF?S\D\PTR#OQ0M;R^F.\8;:&YX/!A#8!25F M]9\@=5:U-M_K9]LA_A6=@A?/+S[$6\\],X=#XH#<)):&K$2!!M(9W^';LF:1H4T9'/SVYN;V M\YO?^^UVN]MO]?HIE"TAI%R+XN2W5R?7"CXD-0RRNA,LKDVK=!9G?FNA5 MZ-;W/IF:MG7];20P M5 :??/-[RV]U^[\YHI-?7,P:!OKT9/V 3[8+^/P;O0M(,C4=1G4 MIOR1"5K:R:84%6(1%:@=O;TCBK@1:RP'L3'06YT=\RB.E(0WGCSQ1D"!D9,G MM8S\;K/=[QX.]04H[NA=>='NF^([EQ0@ND474K.W)M7;GVQS6?;0<_=AIMUI]LM-J=_%69XXD9$3IN"_U5?S>=J,R"^!G8 M'UW;^>T-.$W?:!_6:WW1H+;;>NS@>R3@J+](OUW$C#+T7K^9]C1E^]^,O7LA M\<R;#@#-YU[T[9NW"MS:H>FLR[6C;9N#%)>L?SVUR>CF (]Z'8'W7YI,AY( M:-HNL40\ 56SHTF$2N$G,H8@'49O3_FI+O8'5G6R&O$,/.6D:_/3!D M5VYY\J0>@&[8WIM;G5:?6HYRJ;P7-MK]5Z,&9U^O],:;+_W^=#D^R '92P M$X,G[Y+B-MSFR+TL'14-K/2,\%2[T(@=]S@=<'-S'9$-U#(W"N MNN1!2:W!-HAK&STJMW;)N5VLN;WUG3_N@]0)<[ETB)3.N2?65PWG;-YM,W,K M"G9?[QO5 JZ@6MIK[U6M]-O;I]W0H-8WGV[W1D81JLRWJR8FFZG MV>J6ZEUR>EZXUO8\$]E3\U7];(&NM4[:R]55DSN3?_.QZ1!"[V&(J^F,-=$ MXD5)+VZ)?O.YLKM^RWMKJZ=M?4_RFK2QM]@>6@P;E?23@X5^RG)WP5AP\8B M1[U,Q5;X?V#T+@_)WC)H5L=_;Q$YQ3K;R73DA)UO/B?[IEQ2Y#<1BTMS$\I( MP_7H5*%;9?T%"FU50MOT9+8>JM?LO M4BKFJUB0G2M7>OP2=X1U-;G6WDB>/FDF ^2;Q:]R=M:C9-;HM99NV"WC M4CFE,8-$73>,EJXOIH&]MS8E2S3S2C)@6'AB)5"L9OWZVTS6(JWU[(H MTJI/3&Q#BO6[/4/XA+?=" UP)K8+B:=0QXH3X0LFE&Z=.WV!D9/#O-?F M).;5O%F5H3CH]M:F\-[W1B0(T+?]F9#"6>-+21JT>FW9X$EWL08)S3[F+ ^ M!/C3$"5?>S'3"&1WP PF(Z0_'V?)FS(JT^&#&]-:?@8[392)VZ2A?:8W MLU5%"_-K897(I4NE'"/COEWK$WDECH=9JUM+X14\!5#&@OV,UJTLVG:[D\HMR>EG35HH%'5"ZY>]EEO"HRQRVRP6F&F M5&E\JU?VSL.B8&Q6,YB.--F=]-J:#!]O6GTJAE,5QI,=R>#&?3Z_4$U@^E) M@^GM8C MO9/.$=OB8 :XXW6$3&?NZL'PQ_XZO^-RMUP;+H/#[2S0L?4E:T7 M2CRT(N/33X9FD&%G1>NCUVVFTH:7 MC)-?E06ENY+B%]O0FUI8VB.W^;)]EY[HEM%KK>@[YHW( N1JY58,/6/0;7=S MDZ1%+^N049H-;1WTRG6HN'&'WH1\\8I72UL1;[^('TE'Z]%2FB=G"YFRF!2L MI46"D#UQ%XZ)OR9;5KENBO6TCN"3F)_3R7SQ!==+\V6+%NA9O]OM26)X86>; M4%4>&-U.K]5=@ZH$-ZP6L4O?B.#FX?CJ^4LRHM?/?=D_H3BQ:%O>KYETZUA M=A.220!9Q_1-WW,<[(_-T%:XW6IV]%9K(,]_903OES=K"(->K]?N[I$UM D. MJTOBDI&][I2O%BQ%>RO"Q%6]W9)PRSO('(A3793M?W.@;-3]TFL#2B2';#H- M2^O([Y".9?PHF.Y1)2MV1$)!+FR2V[$E+E1)PFHNE,[=J)XK.R=IZ;5ZI9(R MF'.7BA9RI.ULD JWW,V(J_4EC1WX89V$,X5X%[,3(Q4D7WZ/L%P0QGS7/9 MX[.BZ\TI7;V;+Z)T(T+_0:#T)+$N7JEN^$)N(YBRNQ&^H4#;1@&KGUDCV7UJR[W6ZG6,]4N/E0J>L38?^]<3.U,)]\T]J.@Z+7 MIY(_9146Z'EK]);F8:_;;%9 ;E(@;4$ELK7=@=UNN[>,WKR>MT9O>>-/;S8' MS4WII=OSE1F,[WT/;MJQ+F?? F))KUY K?[M\;C5,[HRAHMWOU7"RS/;,#K- MC%I3DG#T^W\V;1]C[NY&_&8OIH]_]GQJVK[:PRUY^COMMJ&+@XX"G6Z!R"UY M:/X>N.^DF K:R4@&UP@/8\),1"1Q]&V;I#.@V2/5?1P-?IEXVQV4O&FUP# M>Q_YP[%\=RD_0!2F!>.H5^3<$(.#,L%JRVG=UN#G69L3.8"\'VV7?KJUF6Q MT>^DRTP7[GVK=]Q:J0/MD0XO ;_0,+YJ^F =OQ 4>G;0ZJHPP\LZE+Z0GJ2 MW4LVO^O"!9!XF$GQ3W7L!S,DUZ,1&6[GV3?2^V?NQW!P?&O-'CZ RBW>Q+\ MB_OY9 =3+S"=/WPOFJA&0S9$1&QDA.B==-P=KX&-OB6$F:#XQ?Q0),>FTY M.KS&["I4MT5O=0<]Q:ZBA68&S5ZW=;7NYU!,9ZE.D]1?6%Y4W:[.=Y5\ @.;]-?[]1F!8. M=U7>GNCV^I"1MZR?NJ.96P[["I6QV%4K2$PX;8WT'O:X:&[6IF MU@L8VQ%UY9+2PU>FU6OWVMJ56^1"T+:^\/?:^>>#9KK?H?9/+ M]%NIZM-[QRGST_H^SF%$S96D!JH>(YE1Z]DIN-SM@8@ECH12->QG>FBMQ M5S2NLP"V0O/V#<>"'5=)[38#PZNDKV"T]G$P>\.@Z^I)VUKD"J&T>> MQD0SZ1J93$UW!@IZY)H1E32S4!)X0D@Z#>.; ML7Z5-O)\VE](&YXDXZ/?T.\GV-BY=H'CH&0[LP8T.],L3W.]D#X%)V,#CH" M[%)Z4W/)D 2!Z<^P%U,#]OID3)EI4WY-);@!P4GO4R] 2<^'!66Z<$A>?+AV M7@]4WE >!_1!UWQ!I#$Z^H;>^Y4R9&J[E!<-;>S](_$I^PWPW@NZ!30;B@S M30M:9#A]1[%,%SM"D/+3A9ER(?AKF3X3GKVO03J"80X_QC;0XIAG\Q-Z\BT M?6GVDG6!Q,C3?(ZX%C,;S/(,/A-,4"$=4'1);JQZ=PJ9TZQ$I_ MJBD="C M-&KDYY3 D6WT-?7,4:E_,9X^N$@\4_(9VXP[/M7? M$8$=H_GK%1-S\3?ZK^^1QA]F &O:\Z?0 N5F1"4?XZ=C_DBD"DPP_/&/F3=! M+G:!95HCF9T&IK1;';9//-N-&C68TH-;9-.F,7JP&EC^V5,6>(3]R4<-SA: MO)!0^?=L,H%+]:>&%@70"X6I-WD&F(7:I]L+RH_AV/4<[X5)9AV^BN5CPA! M^]) @1CZ MIAM@ 1P0EY[V[1')L#S',7U=\BEYQFA(R!BG_=1 D.&TH?9#NDC0-=)DO2-B MTAN>&E&#(^Y,O);'SKP-!BGURH8M%."_@X:%( MNPP7OL=ZL[@Z I\7JJ',E'@E;L0[))&ER2N!-VQW+H8AA%JR$S9I%QS++ZF MN>1":1YSIG8+\]-[#<(DZ[88/W,S8QI173D@L6H\I+S01H[W0X(?4QBD;0WW M81NN[M/ 4@,MF"Y.QZ;+#783R/1A"QJ7+U7D34F6G3"F,?>?$T"1W4&+1K MC2[@>$%0,."F/L(KJ"V:[$"21)4"MNS72]_2!H=HXRU=%#O MC2;T]XE:9^#=Y%_J@]I!__J]AE4B[BD3T-/@#T(%"20'ZB M/49UF !9 Y38 6IA^"13D(I5WI^\.( L9(IOTP1)V<4T!:9 1N=NUYAB_' M;G M\7)K(A8QT"X]"'U\)]F_GR\>+R7C%XG+??6JOXC;DBF6KAXO)M9^W6 M.]>,;K,A6]GB% "9@0 YE]X!G3.[K("5\5=(%2RL!C6@?:H4@D @W#?"/6^6 M,&X97V-7&M-K/P@U%PA 3E(5=&A&(!#&Q/99^@%M&%/#.TSG$BJ(-=D,3_- ML^YY#M0"T,SIBVP'Y),^?QQ^HH#R3]&Q^K(K!2C8$8W@:D(^:^/0FH0=(\44_5,B$=%D[ M A//7AAZD^1I.(_#-RSQAHR@(0&'9=[X0VM)$WR\9ZPS2OMY1YR=%6F%CHER MT/WMC1&SBX];-/CLF!1;VR&=GX:^#+9M$G@M7Y'[7_=75U??WY\[(%PA=D MM_M+8>:P7/)_B,WMW?5/<-\&<#)D#XEVIKV%TD[Z!Y2Y[TMR2@B(7TI#;/,W MV[^D0>.#D<+=+ZK4:K!1O8X.0A%^_5FP\U!WL? MT-),?;4#\[9J)^/G]YJX0 ]=#-(5>MJ5%X2U.P:3 TOB(QQPH_LRFZR$34C/ M$%BEL?"6"/!V .YOTZ'6G"_B$+#0YWA MS$]E QZ3B4P)@2DL#@LI ==UVBW]Y$WMH=9K-_$2L$[639W$CNLS[5O&-H% M#X#O.GZH O'/OA0%(0+O^J!E^&8B_P[8L$/9ACZ]G/$W($0 M Y83&+'@ %<;FKZ/0;G243+YR>(8>=#'LG-EVP?A &"LR!,EAWP3D5IH6& MJDV("8?2%@]$(ZZ)L8;P%H9N( UQ""(=',2?S> #?00'S&>3>^LA.!&/ZX4 M@C-D.E8(N_-G=9 ]W++SRSTAI7$%_B\\ 0ZQQ)6#BG**78\3Q$E108-AS6 M:SP\!:@60V6! 7+L2SRT^)B3QW%B4 "7D\P'CHRK6Q#+G9NF^P[F>',3J$68)"-Y.#A&Q$=K2U'U%0>"XYPP/F"9R2A9[/ MHZ58Q#8TYV'H>S2)6/A8'.XDSL,P>H2BR(J&XM2%G9#PN%-)]B'H&+ \S=!_ MX2B&=?PWTXU@M3"7:K\!P@&V8-C.Z=K^!^%Q6DD02XS;U'I@G4-?P#L&^3AH ME$/9&[$E+O#;T(((- TXBJ0* ]Q$SB-(TJQHT#Z9\$#M(/U;^>/Y\5$+)SV M4;7&A/4&SP2!D'9L;D/XWK'_A[TRPT@WVD&!MB'R3$DC,?'ZRL0NJ,17>20 M&@4'H?0/Z63T,G(<$OE#C)&!\;#VK$!ZLE&+K]T,Y&"<3F[9=1K,>)Q86)+ M[QXO+J'Q]PT1=PZG8W0C#,1$^E8"6YZ0(78''M!C"KF-$H?/)!R>TA;H6H5 MR6P_%=BGQFF[PV _(!(' ME,1$2&T@&> F<)3\XD7@6<6(R;9!&A;.?!=3FE"""4Q[B+LY-+.MXABP07 M XL57H"D&+5))VK&(5 M1'_U83\)9Y(:@/HJV$MT9N(VAHY)2;6Y%I!I)Z7H/L\P+6A(5459VH& G403 M(<$9BL?TP;'GT 4D]YXD#V5#& D5F<]X\1O]CT@H2/28E=&#F%1 <"V O3DB M%FZBH(2%F5U+0O"U2:77 O86(_U2E,+?WAG04BF(-H@^>5 M("@R,^I$8NZ9WX)'ML4EL\E!%Y0\YUGM/@O< ,AVS6XMDI!2W?5D"53N5JG M^4M, =>]8V,F0J+%I ML30LNG#\B V0VS- 5;P.V6I)H:\>X@T\&NO4(%?EBU\[5.98H\B?Y@L'W32 M/!,+L$7L/WW#U4,0[]B,%$:'=#/-I@>9($PB^)B+.3SPL\AR"#(#>4!+& MK;!=5-Z3V%9L,TM^E%"-:7122#8/D4]+:M@4BGD>U.Z BCOBLPS DQDOB1Z8"Y0G7 MG/BV)Q,V-Y(TDU%BBKJO( HT E/!)"&7WWS&@S2ZT&R(<2@^W"&F6EQV'9 M6KP,>;QK)TE2@+?5KC+R<=&::4;A=)AA,0#5%'TY&QM:UR:M9-++=@G+L M$Q+'N^:+!:,R,64B ]EJ6+HG\:VA&Q2A1H3 S4 W.)Z_FO[]DI]=DE:CI7 MLL->N:&9&QK/<[FSRFXJ>O')QH!CYFEZR7TF'C_M MJ>9?)ALZ:-\8$\;H0EFYHP)5S#N!4FRX^J%!9G))S3L#(8M!?ILXEU-&P6) M'SJ]YN,=O0B)?XUJ.(@V+"(M^<2?8\<]4=1X%>B4:J?Q0@2$(L M1%!9H)+!8GI()FG1#.I8FQ=VBC,]4R#2?)N83X>E6<_)-6Z7J,""FXZW-))'M8V) MO'K@-07/&MV5;+@J!1+(D/&^'7Q'&9 &"Q4Y?J_BNV2MIEZ O9/S'W-DI96O\57/:7V? W+)X(SQ[HO&A7>(JZV\ MRDN2)4TLV7:L8P&2]?8%#AWN10ZA6(Q[EFP4^#Z_&:T!DR18API.+P)+E9\NI0 G^?M)[-X\?@-3RW.FKV:("E1 MNVX@I 7BZ.5#@GO?F4?H2% M!;NF:PDKSHJ&++(&MP;FX_\)"@/N%)YF3T!]DNWDQ+R#)4QE2Z+1S>\- 2.! MU38)>06K'#\1$Q/9!M,Q.SD[CU2M@>V505)SSTF.\L-Y1M#MR(0M#<78D.XL M(--B3F>4Y%4SQ [)AF0=)_$HDG\[+V0LOP>F:(<+BIB\9,'X',0T8R> M0V1LI]DYZ]!MY1I54K:H)"^1Q>RH\+Z$,I)B,_9A%K&X4/\,7=6(D2G"?Y\RU;'9^BX7) MS3"&940)HML66Q)Y"IW>4<$-=F.Z8[SF3S[>!@(5[7G[#ILOKIG3:.16BE4 MVN-M+X&\%S"D]-M&?& _(4ZQ>> -M:^F? 8)?%4XH@X W'<0 ,$1#($H@[ M;(3W+F"R%ZHM0LTJ<4J'V/9%4,0$]I6T28:9N(D9D4_DD-%^B,44B L @K# MF\^\T1FDVLJ[W<-=>I>5XRR -J0F%4[%L/EL.LB(8 R'7.CVI\+,8<-Q/J5 M\C4:'^_+;@3!@H94"68BW(1YV=L^3S_-U]HX/@ [15K6P90>R)5\S+U&!7AD^8"') MT^8EHPG-M-BRY,Y;\2"/?&1A2G&I3.$V%VF1:0?%.$[W "4)YQ;?]Q,C+F0 M%F1"A"5!5> QCF&]"9I(-L)&++)]U^?A+Z7!"0FD1EXN&,.QPT602A>3N&? M'S]#EC^=+,Y$0V9+8ECPS#3!?'8^A0'R4DD%) B7A,B.+N+YQ8(9?,(@IG. M931EHG6^I(]T&A^7%40J4J.3VYKRVIQH5AQX2&Q(_S_ S/6E,9+%]4P09 1$B\DI[I[^/C]AYY+G-(S!CU@_C M31&6)!8DQ'@[/D<-[9WQGIT\(WS2&(TUHD6MBT: ^]:[_E!!IM=YG7E;L.D MD=2;O)#+_'PCP_C6RI:)(\HX487#"D &YG%.2S,-3LU"'AX!XC)YUYX_Q&0< M@.]$2E^]@A;N>U/8H59U@<$^>SE&#%"^!6/<0&02TZVXL"9Y94="KDU>$^ M;(M//ISTQ!%$&H]H!+[1.1N.SZ)IYL2'-H1#9!Y/# $P>3/IL\.Q&20'2P^X MRX0>[C+23D)_AF-^#X^!D(PO[-2"O&7Y-P)W12CB%6+"(81!I10@N'R/JU= M$W4&O(TL7HU$S!]F Z3JG.69:"[(?FHM+M''Y< ZMA%I\<%/%"3GA$ I2G9OLL M-4LPO)O[&B3C4TB)^$H"+AD2)\AS.G1"/CAT42<7-QX\X^4G.<$JF! C1WXL MK3((.PEWXO:DW42N.9A,\%8(Q MTP2@8]M:N70]3;CQ)AD-A<"K>_X>'B]KN-&(.H"22D85^_QNTG"@0'B:D M/[5C/8VE'K07"'/C)N3+& (D>%>ZQXOG7WGV!A&]-E\]C(1Z >R%@[YTCPGN&PPHL&L!L/!P\;ZF5 M;BF'T:P(99"/PQXN(^-Z44PW$]/HHX@DH![3K O"Z7[[JP;YDV8P5DU( W M",H+F_$ ,;^"/H^%RIQT<71.LLWID)93?L8MUFL^80:_8%;J@%RZRP5V MOX8PGCCI[. ;U#;2?'D!M:K=3$+4,IE@K,BH#[4G6 ;@6C<&+ M$(Q#8FZ@0^PG"Z[/1 !(&4C!F-KXS)W@LC!@+QOO6Y,]Y2G>:!V8XZ2ZY"(Y M$,4IPREPPU1825 &H0NHDB2FW#P"I+AMZT0-4\HSW]N6X!M>3= B586/N# M;F_P:\$:+'EE7[):SI>A;PYPPTP&SZY#?G/TI9=YH5D_C4T)[C\!$DR9 E5 M_P#GCF.35^8J3,L@6"Y.CG#,B"';ST2=YRBR"^ICYS$\IYA-:4 5!4]9D!5< MGOL:R8%#WB@$>0R$L">V8_KY\&[DO+!J1=ANO(#8XN"5H]GB:N#Q&O-KHNBZ63 S)PUXG@4CC8EE/F?894M3#J MMS!:"Q9&%HQ!-.7G-W R;T-V)?.^"X67AQSS:+'XM>3$/\Y2GXL=S02UP#6J'RZM^+RX)O6FI;0W:_D RFOC5[[V(29O^T7+3XC[:>2)MK:WEC/S MB5,@:\8+?9J[(R>G'OMT=^ HI1CLND [M]MKIFM%1,O0.';-6G;K.BX-:M M?"I:#7KK'%9S M7:/W<.O8G]A\4XFZJB9+^_CI+2'),#J:E1E,RGY/9B+&'(JOF3I^2 M>GEY^7'QQ<@8T\4>_#S!DH"Y+]CU"9^ SC&!DL:/L'1BZ\XDS4^)#F@AM MU_._QVD?/)(/PF+/IDX4G(WLG\0Z&V'1?-:^G/8$SF%MBO?8HN?6#"77I=R9 M[T$NL87A9Y-G"->AZV^CMS =KY3(N@H69GD9]-Q(#UBB)0$8\\+(4]$HPT1 M!\,3H"1W]GO&'DCO9_6WN6LYPP)MR-,AQ2 @=(-E,/#25@? 9(0_#@9UH8, M<&KQHLL"<"%^C90>X77P M,AX6N,B"#']^QA_QF M"?/%)SQC1?;=8\745Y84M<&"HD&'S%UB1T6CF:BTHFTALT8KFQN($DI]3A? MPRPG3SKL2.JF8&N_8E92^C1##E3"(PCZ4/L]UG(>BHB>N6=$Z ]6\LB'NA_ MDFL6L/S /.1E1F+^B=,A5BT!XD88MQ"^!PFQ;FDBUY8T05ZGAZ1($$GC_. M8PQA&8#AE3S'=F>0JTF51OK[VX&A-_16$X.)^#L4"6_U1I/^T!P8+-@1R\K& MZ=M"18@;MR6:LB(0Q+(""JH8TGY8#@F5N2P_9Q@P7@Z$72K8I7ZVV(O@\RU M]&$ %V6=RLQ511/R+(@OJ"#&K O+!68U6' I&6YTCIT @LOK=:!WH$9Y]I%L5C'K)EBR1&4=N(-8;&G,I0A(QZ3%UA+0WI$,E3:=8_>][W ME(:&I12\Z#F$Y%%1T4]BZ%\^4'O\Q32G'^_\%Y/J=[B(KN+D>?K'A6O=P];L MLF"BNU&<&1/GRP2?XK(/].G')!HK29VYI^V!@'JBH[^D]L#WW__S/\#G]1?1 M_V,23O@)"+YX]J+P#]"X<'W[;OPFRE3ZQP,9_?;F,U4U@2EG39W^?^BQSZVS MEO[F]]1K9,-1-@CVFY4@RA#O/5CZ,.C9%8&7P.EJ)&B1S27I=FW\5]!B+3(%2=VE) M+8D:I)V1(NDYG/VH]8&.Q;9P6,!V>Z0##QU3$YJ;ATBB]5@$27IF-]&E-O@ M,:(3K##R#"5R8-LP?9;58J>';(-])RX>7#+XFFPL^2JTR8)I ;A3)MX=QDQ6 M!S\TO\,-C9[F/6,VIC35HXA5JI^?:JAF$)(7>XAS'8B/C@YB?X[BU7K'(PN M@GC>EE5\R\AN-B+M'Q/^Z985I_LG&]D);34!R,!X9P6:T#= ML$L@DCI8QPA!<"'V!R>/P2T-\W!DX!<2!!^AZA:/=R$=OKE+>KBBFMP+!8?^KU MYJ Q:%>2]7:<_-![C991-/.WE! _^0P%>7.(+QT;IGTAHC@9+>W1B$Q MY]_TT13[>1QP@ND=7A^JT+U]4N_&?/;VA?[>'8?C%=K=W7FVU1TM4.^#T. ME )[2O>FJ6,.,?U#'!YC[9RIR8(T73?":^'<4,0-O34:G68?5QW%%[!-H3J M.L.XHM;$M)T&_>8GNU(#BERRX,CX2DD6I([U8U<14P\\0 OSZHP6BS6-S?4 MU]7Z2 GF(\6E\=FU'7& :%Y, 8058>X!3IS#KD'3J+B!/!>,\92[HTK0CP"/ MF:E:3O'ISS+)1^:,B5B3R5N\#83%3KX==)OGV@/$01T3(C^WV,J?D0;CG+ M%=W+"UASL=UJZT.$]N=1J_;9#7E4P%O[QYIDWA3Q^!]?5"4B!2]M2QF'"F! M=;PA\>RV_C5.9 XX^+-]73!W@U##]OBD,3#6A:1D J?;C7%#4%9E&2$""D M-6@8S6:J@CE2X+F\2J1($WC;-AI-]F22A0<$QT_!+U(,-&5;1"51R 347C6 M9^J_4I$]X+=CY:8)=))+Q:)CD!H]._80>/UWFX2N.>$[")9P M"]C]/NU&AR[W3D\+_AVQ2]5#?O\9,C_>=,+XJJ00TZ+\>$<1J,A$L;8[#;J? M03A]@@U,0"S#_^->[\$J<=)$\#+-BUD$RR\'!\O+FC)H!0MQ"J6PC5+82+ M;R&LAQ1(Y2@LO6J1,;#$=8O:UJ]:Y'-8\KI%;+^>&==@YPM%7$U&(4:[Y8F\;)CQ5?6(5O$>19/K3:@V2=Q7V_?< MY!I3JN?]Y&Q2V(PQCY=DCK=>IHAL9#U!&]6L":NJATO!OJ@R:1"(A%D297= M3^,%Q0073U2A+8-[(\[4%1P3MUP0UV:3\E"(VKT<(@<@J!#)B>5Z[EGL6YMZ+BLT M$Z!PQ98;Y&@$H9";ARN740++Y 'VJAP)=P <1G"T+ 2'(/] -7.'^9^P"O:Z7_,-4#WHM%G3@& MBS)O' MSW7T1K>:\+D]Q4"?W RU6D:CW>P=RA2IZN&%>FJWVXV.WJYBUDX_+C6I%+TR MED1^^OD>I\^//C6Z#8ZG288WVDO #@6N.'-"PPFGOZ:F,];8W%#[_7G.;PX M1DWQG@5MR'>F_M.V7?OMNM?1_J.U M#;IZHW=2&:RG.$FM5K_1[!^,C7VX!MQ.9J--!5U+WSR!\G#6#,OZQO,G=FP" MT4T5Y7L?E(V-:="];BDCNT"SAY\&_<4#VXU-=6#78JY;K4&C4ZX$@/GI S. M90F^LMV/Q,298A! !2$5OHUGMZ/TU3W3CTP&R<;G<4G?5]63 4B9#O6CMYI M=/JG;.UL!H3CW2<T+U3$.1[E;,(\;.RR.=X;UQL#8_-[D GI _H:VN"C$ M7SZ4KDN1FAQ,1SZ$;%N>.3Z YO5>YC4$RIDT=$NKJX>OEU_TFYNGZX?KA^? M4EA^N/YR\73]"4FZOWBH7RT+O3,)5JW(26:2@Z M+(EYF>])3^FZQ%O:J)3VU,G Q(1 J4.I M"D.?W0>&L:RR:YI^5:!3[ QO,&NRWC&;G6[A]'.VP@R0\I3;98]N L@2.[[ MRY(OETS7WAJL7\HU?OT8FYW^KX(,^ FGS=#9<=F"7P?Q>TF3>"==)_FAWY( MUPO YO2YWXR<%L74,DJ2UUMQEWQ>V#UM@U_C>95^ T3,_1@G0>OQCT;.CYW, MKTB(Y_Y3]ZE?>13U$@FF_YX"Q45\6Y9M[/"9+[>3_SIADSVOQ,,_5$0OA M*I A/\$('XB;4.[AMC23)7B):-4X.07@Q1:3:;UB$/@S)L^;++\ESDPR0ZWU M2X/=^8'7OT%6 "::0?:#JUF$2A#K7&-%SQ"T4W,F;@?)7>4LCCE@E[%EBH%# M1V^[K 8$7R>Y#>-%?/FMFSDUW;'9 6]6V]:Y\J#1Z[EG2[W3F?4T**Z!+9JT4^D>?3O$6DJ^%_[B_^>7'YY5JKH4:1DKN9 M;#V$"++0T(H_&)Y! D5$SL(H+2W"\5_L[ K1?Z1/L$.^:9AH^G8SS$Q5@L MQ&+7'4[#:/=YM?FL:1<+#83A9C (258( T"X2 )^;JP#H]?X7H!1H;\23BQ:++$]<^X+D$RFC:FY8XBQV$I1JE4 M!?Y4^(.X6)&)ZF.B,L63^-TG/)TLSE'#E MBV:Q<"\OR9"1@.V=)._'-[$.0 M#OSRSI1/3@M9LFHI49R"! Z1JRYLYY8&)Q;DH)0?>W=Q?OWE;@"#V\QZ>=X MD6Z3%=-A4R(\JB/;Q_(I/SFK=TR:<0[Q6/FD\;D/X.KJ^YL I;JCHELG4.- ML7DB.8$NNU WN>Z7+R1$,-Z>WM@MO>US#6Z-=$0&J+AM-\E0Y@NBP96[K.C3 M^\V&8:#H8Z,UVKEU,!?LOG.734KW %YC20%8@R>Y;?>TQZ>[JS__>O?ET_7# MHWSIX:?KSS=7-[6[$BQF#Y6W(PG4#4.\#=L!I4L)"NS&!<-\;J%!.OH-&I"I6]^E"_&27-1J7C.9?SY% M%Y,7;.)81B?O5V\W>H->P^CUM6\NWJ<)5=YBDJEIQHIZOFV>-[N]3A\E3S) M$T;1JGOQO0"O,1P28L6WNPN6\.O@F7V;.$U8=[PB'3PDD1,39_$BE9>48\OSXVTJUT!KO)(9@5[[#7) M[L']KHUN:\#\;D4H3X.FOX3J?HKJ-, !(F(X\#HK1\;[0-\YKJX0ZR:$=!$G M2C;@'-5&U=1Q%1S4>'AB2[6[Z#;&_SIT'OTX]H(6C7)ODB4J,O%2M0C+ZU=-T7J MD6TF=L)N,BX"54I7)#/(DD%:?D!!2FP8(\5%]ZAE@A(]'C/8<4X@<6\.(IP MN;P -&N"NUA'3H0P>=#Y@2^^S_ ](&+)+L-.EIMGW_.IXH]UJZ+0M$"O,11>D MCPM0;WRE]BB_PSUQ#Z9;31S:J=,]R59N]1N=9C-5% II2(^.55MAG%D\GK1[ MJB8@2X3;54:XQ?L J)YWK.I-W:3;7=Y)7\XB-.DO9W%Q;UY93M;#V:$F>K&2 M)9I:ELO4;UWO2 HXE&[-J>,OY"Z2X(//EIJPHGH9JUDT-JV,PTLDZ32%3Z- MCP!'%IQL6+).L@[:>VP$T\\MHP30JG=V>$%QU%7807RD8C,^^VR1XX+#NUB MKO&#.SE65K";@:,20:(B7M>/>+T6M=LL&TI_N5;1:Q>//V6OZ/V9ZP?G_KP MARU%2&X%3>0].4&4G=M^^B\6G\C%0WCE<:)8I-A%TXB8U)X)HN$0;D9X)PP98_TA=/<7:B!887:XG$C/1C;6X>S1MI[ 0_;:B5/A];8)5U5QME M1D\894C(9L=CW497;RF;3-EDRB93-IFRR91-5KI0J;+)#GI^]/.V.AM3-IFR MR9;99(]D&O(Z)-TE,;R]+E67NSVF__. :A>RJEPH4X-WHX?L,KZA&8SQFK[8 M N/AKXU^3^\3"46;9S]6\6&[?(I_U8MYO(N3J9O,M#WI4=7$L[.$]E6AL: MIV C-SOGO5E,0]A>@O(@:U,\%';S\:1V,_;F+'3LZV[I2H2UVE1KM;V=W* M3-NVF68'J1-/QI2LT57.1C/6M-$ZVSN%['8;':.O[#1EIRD[3=EIRDX[4950 MV6E'LB25G5:?1:GL-&6G;<=.:QVKG3;0&_VVL7,[32]GI[76M-.ZV[/36MU& MJ[6G2BK3E-VFK+3E)VF[#1EIRT;Q;'D""H[+3=_<-M7?I_,HE1VFK+3=G&> MIA^LG:;K_4;_I,,>6UL)>^1\4F::,M.4F:;,-&6FG:A&>-1FFCI..V8S31VG M3--F6G3#MN,VU!"98=9:!ZXWNH8RTY29ILPT9:8I,^UD-4)EIAW) MDE1F6GT6I3+3E)FVTDQC:CPH\-1,ZR\PT]J)F<9O^4Z9:=VUXF/XNY1_(P4.]%0!.PRL20A6^ _A0FT!)#,N$U9:,J&U79J,I&/5QE:= [[W25 M-GR")FI;F:A'.W?&>;>C%J4R496)NJ:)^DBF(;-FC.Z2T\1>M]OH=GM(#[=$ MJ2U!S0V7,+7_AQV.\46P):CU%R0V36XX(>D"8P?PY.Z:_ZO%9O+V-Q8]#M M-?H]?1,F]P^?R4=D62T3T9S8,_8D[?B\PV5,&3 MGP\^6P7;TX&M]D FINU"C,]N^[^B M#?CF,(Q,1_MBCW8-Y'=46_DGF-+O=X/F->RQO!U]ZU:/M""VW79]:=B=\R-?>?3: TZC8'>.Z(A5\L(QG!OH!B MG/>J@,B6Y,-"[VO1X?W!BJ<6'.'69>[&'K>S/5&^NQ%O2S]=.B<.(8]M>B< M"--+K1LUPJ-?#RM/\(2AXY!1* NF I-P)>* /GQFQSMJR:@1'O^2V<(6$MM@ MZ>2IHUT=I0VJ UTF!P77[<?W;#>RA]G<( JX"D06H>%NP MWRU$>S5Z@T'#Z)>^#H\!!_PVJMDZSGYB VJ]&G%IZY6251VQ'NR,7B>9/VI&MSNC_/Q%GLO7EY\ M\B(BP'&$"6QVL1<-[,)J;Y2U!;NAZ/1_74:6Q67Z7$<+Z<09LJ) MJ^,=J7[>VNMT'A2X6YWM3'KUBM+A\8XAE(U;HYRM1B-5FWD0F$EY/3E0KMI M-#J'(Q>.2UTX?6VAUV@-^HUNJVB,\O&.M'D^VN0/RALZPUCT&[TREV4I/0% M)1E.<:2ZD@P'+!F.2V/HG_QJ:36Z@T&CM;>@.B47]H+M;IMN"/VB!P97U!R MX61':BBY<+!RX:BT!;A#Y>172Q_<3[7P.W;.=247$CNBW>]5Y7G<78BOP\M: M9$A[CBG;>=3OZB+4<; O4J0"?E7 +_2B GZ3KE?O=SPLH6=;!Q)N%G+AXV[ M4P@,5C.O H@5(%2@\9J3M"7;5@4?[SM05 4?5\NL38./"]>!/X#!'GSP<;O1 M[ X:?15\OTS !5\?$(CI<)FHWLX08;'=CBH@H]/9Z3Z>4\% M'\2+MQAYX_]7P3/$(93?R 3FJZ??.U3Z39S\R_9FF=^' JLE+ MYEQY$ZKMS31SP@ZU[#! 6DR)=;;,.N K/HRONQ&6X:&&NS9TS ?#\:F3U^4 M6[<#S8S"L>=3N6M!"W801$0S WY8%J@3L75.Q$)O6D3O;4]_%C=>D3.#;F^P MB4\PNSQ7]4IQ,J'0"D/VN%7"2+AA:YCCVQX0"$PRP!5XFAN9ZVM3TM=>E M5S.7LC86\/7H>'BI>%B.A_<^&1'?)Q9C8^7L._F]^7HT(L/0?B5)R3:]AR7; M6KG[#Y)#]R!MZ?YCD8#V9(9T!T%:Z&,7J3G0INF)/->>?GABXFB+\4N9"=?& MYBM!&IX)<:4I/C^T_:EJ5>KZO<8%RB,RY@8V;(MNUSZ=R>>P;@K4K>=Q7/^ M\B$SEY,<_H1F3/V'+J/!]?_CNQP=NN%Y),=#!TOB'SR1-N[=.@SO__G?X"H M^HMX$9AKAZ"H!A>N!9YBJE,0=TAAF?,VU0Q<(.V!C'Y[\]GW)A!Q=-;4Z?^' M'OO<.FOI;WY/<2 >E^28W@.6;N^>KK6^=G7W]>O-T]?KVZ='[>+V$_W[]NGF M]H_KVZN;Z\>ZX8DJY+?>Q>(312(S;1 1'\^.1NZ#&-W-7(9.IX,[1NS!>? M$/STPP['H+9K5]=W#8W$ O=OILOT?6Q=AP@V+WH98R?9^ID=B AR(WX$Q"/ M\$C2 2COVLCF@A&K<$[I0#U+,RD=5$JZ+IQP!8#W='7WQHZAIYBHSYA#71_ M$0]2<>X3,R#G6K:R)\3,S9'&V)+J! GY0:V'MT9?;S2-'B.?L8>P#IW @ZW" MI\T!-TQPSE-VXT"[9EV;FFPE20-L^]8\^?:!9T K@&P?4%$\F$#=.[C?8)V M\4P;F4Y].IV6]CS#1I\]T[> %99-"0@]/SC7Z)2GIZ2;X3,,R"\!"A[3=>CW_I:!WG&3#5\-G\>!KU&OS_ -U=44.WF$-C+$)A+'./" M(@(;VG/$(9I+88O.;Z_;+D)A+X?"09I"I$50:;Z8MEN4D2OI[+0;O8%>A,[! M.91I=5H+N#F=NGL=1O-7A]>91.SE%:#+M$+5(C2L:QHSR^HL6L.AWX4+Q6Z M;AS3'>2>VLTNGJWT>UW\7WZ9Z?5:1C-5H//2S!EHLFA^S=(UVGL%=J@_53A'=-)?SC7'NPA.D^\R->NQC89 M:7=4(IN@0FAWHQ']E;X +\&#;+A]0^_]&N3O(&,3!+00_E3389"ADXAT#&FG MSPR3-BC=.6(C;"4=RR5M$GVQFH+0\.M>^4>RQ1_.Z;R1OV1!:'=JAPYQ$ M,<(Y&<&8ZD&37$#9@D X'4#MYH&I!0!-.]Q8FH><#AV=#&Q'1@?W2I/@5 M;6CMIOXG77PAY342,J4 1OWM^G: BE/=]%PR+:4V#RAVPF;%"#;8CN+/7F. M_( D],."'=-!3,T@U(@5#9%.ND+)3Z":V1ZX5_RT)Y23SHP.0&=;Y0T=K&79 M\(+$$=@3;9ZFRP&_0SFAF^ 6%\6:)E&=/G2'4PS1!DJR=@9RHX!OKO'X\(= MG(@R5.(=$^8IU"V.=90]H[>$M R6C^RI&,A "2-5[M-GY$__4]D!5$G,1% MTT\E$!^VZ3ATPBBE7TVZ0OKR"DG\B'.LT#@;Q&X6!($O, M(-59IK$&+111'F@O9(@9 K'94&(((Y-[KSE/.!I3A&14IX&=D:YFN%[W1 M;O?CC2PNDLY9FR)5WL/:C()TVV"&XWS0K6R)=AJWB#0\+4#"$CFD;4\&(0EE MY1!NLPL$4'L= <1WQ-5"J)18T/)$0G?A.D B-EL+Q5:XA,!PJB?@A&;DI\A M@S,V\W-J/!6X>3EZR?5!$Z\9:@XG,.7M SWBNSA#!Y'D29AN)HH9TA#; M7@5HD5@=D]5BZT_TPY0J6(]S0XY7CLLZ"VP^'>#N O=7>/;#=IQ5%M\=6'Q( M+&S]H3#AY@9/E58!$:0T9'UN31!L:4IB-V35"L>%)Z+BBP',WHYM##L!DS M>D+#H^X 9FOXH E%VNG=(-E"@)B-A8G_/@)9,P9R(?X;3O,EL2FQ=;?1" MM3DQG[GLVXQ4,UGK5-QD"4^$)W\C;MODAW',N@7CE^OH^ ,:J%/3!E<";C : M;\$8'=U!79;]X_""K@1 W'[+8>>UM M(EBYL37QP-E!;3G/_PY/#,VI'9I.8V^D?Q/S%U)1%8S8\87WPR5^,+:G\ >0 MS U%BKY.\Y=D)T@.RV7(OGIH93#IC_8I-40 _(AXH54\4]MV9(>XU?B$0IK: M-/#TL^E^]Z-I. 1%S]\_7T;VB$HN+A9<:IKZ ;>DQ9:P:JW![@>32U617%? M0>Q\B!6S'[3OM[U6H],WF'N@VVZT.D9#D_T"#5G_1#1-S9GO49E%_PM'935A M])VD^NM+MYO$-W.[O@N<2!G]KOWS'3)+HADN^&Z@]IRU):CMARUY6S/:1HY MU(Z1I>"\PU2+G:5(#XB^/XGK$LKJ+^@JE4T+&5R?> O0VA\>G0V7.^<=DYWX M /?OZ1YE6_ ]?>K>]RS[9:;!X:SMD(!Y6K\L\K-F!/1.?!SY?M:8,U_>3BZ MS04>RB\I1T3XP\MQ103Y[DD&]$W]:U\H[UTZ"1?QB5O]SNW!W8ONV&9W\8F]9B(A#N>7Y N[SWC, MV%%?]M ]W3J4J;F>NX9A> H\J-@HX;JD#3)L0KJ%40 M%Z&>?EVI0$]">-;)]JG_0%[,>9/=?LX<,"!Q M(-R&A8PH>C=;O(X@ASJ(" M.?OD6JR8'E!!1E$8@3^4D;M\FK,Z>TK;F\$> MX-.QV#Z3S$%0$\96?G+"_XWA MTPX1G[=>2''SR4QOX L$ 8]FH4ONY]") @QLH3,(@B'Y!G.? G'P-03!0$& MP=2&Q@/;^4X'.AR[GN.]0! D.[% XP'6!-UE ?O81D(S_@V@H M-#"V(\+PC M#Q>@PRI]@1=,H6>^[8E3 7:"R@(=##1JF$GAZ[,<\IH7OA@175-3!&@Y\$<74N/DOPW-A< MCT..0)2"M3#,:G0N GSE<"E@[73ZI)%1F;DT+FC_8%+WJ/S]<)U661T[)I) M"_&1:3NHK U!CN'<\J80!11!@Z9FF3-VAJW]\.V0#HQ"+P1]C!,9Q42FC\]A M5/&0)_$!H?J-C1-9\R-@O KWBO<$E I800I86:U-K+F^-Q,7+2$6L3H':4T]:X8W MRD]P9AKSQ_06GC]8U%QH@E;)6:8"CF2I+OIOOS_[;UM<]LXTBCZ_5;=_\": M,WLJJ9(](D7J)=F=L=Q]G@WB7UL9_;.IRE:A&P^0Y$:DHKC_?6WNP&0($5 ME$2]\ZEG)[)$ MV-1J/?X:(6(3>M>AX0O4NV=A)'G%,^4^+X,CR1H'PC-C$ M#I%3O" 34!'0C4$!'"Z W_ >PZ1@.21OM2,@L>?TD"!JE2LULK KT(R1A M@DDR29!3$<"^B ,;I6RS#--(CD@.K0-JQ6US(482-6+)V#<_:PHTFL]0I M1Z^OP\L$LL+=0FIS?84]QB11297Y+IZ0FS,NE$RD;&7DR+GV<1HF0;F%W0QG M8G%$N)]UOL&$))?&4I+,%6G=4\GF2NVB#V]A$'YT(%O<2;4QV=7Y_E-'3QLA MJ(B7VOTY1E(NK1A5!N!IY-4E7'[)JHX$MB!/> %D]7-;DY%"U;L#CF8R7^ M<-H>+?(X9I3TC.')P;S\17P\3P2NKST@Y/S+^"J0G(NJO!4I )D,0)#O#; M,?>A8NJ%I61>"+>G+6Z8%AACX0#.GWA)RN"6LNJ[T+QP(?CQ/D$ED_HPD8\& M%0$.7^)Y3$/WW:+4!B$7.UU5 RL6?D#L7E=[@[@9@\$O].Q;;LX(8LK,+A"/ M&862V")+\ B#3 [/!Y'Z.I?@IB:3WV<<02)?/36<)99I1?\#V:1Q4F^1@F[ MN&PLCCV6"3#83!%AY<(57$$L4VWJ5!,+Z)8FFQ2N .XBJ\8@513?UTDJ4Y M[=7TVIX& NI4A#*0.5EAGE8RSTDCDUVRF@HK5GS2@$9!A9;KS/KOWH>K#@ M0!)B:5Y>Q",[]%).[>='/?&1D%<3%)L 9K+?Z,M4R9#)L_P-=.6BER5(:[OHKG!2#Q(**M?'5&-A&CZ!#!)GUH? M[L@=H@F&!,-G,<-70,S(^9.@D@^( 13G+>US[$B+E8 H//@2.+52&&EE =6( MU0 C3Z&;@?,T=E%JL5QB<6^B:)QR,"?IBB(JTJL((G! MCBBS!H%<6!7ACM#(0$.%SNLQB\&4D.&/9Q>DDY,4N(E\XD+2)>GIYIS4]/F@ MS,]"YR=B8@_EC 9"6:X$UMHY>#YP%3\A"PJ;69L$5'8\7GA%:&**?< >H6?W MP^> NA0V7>&($F%;1PXS)/1,YDI3BYN6B6$,5_>D:7?N:P?B1)UGJ6]6F>> M'_!\=BH2% 6YDD4ZP@U)J>MT$47V7(/FU)+T2W07025RM/F) B.K#O-% M)1EKY!MD=0438^RPKSJ(7AAVDDEDD(Z4%YEU#])-S=5705T\<=D/X#O_ MB1\8/)FYSS(L-UIR+WT(/CX5JD<_$S91J?KM;IW4>#=LTG,9L7KFB^H.I! M)M.(XA$36T9/8\WH&1WM'BR=9^T^QDU_'P/]0!F\!VN-:;H%['?A XN'CT'8 MTKZX($.?8,N8?;UM)D5#O)03=H$_="=H=%)0 0!XG$8N1@Y -K"9X+EPC7#S MQFKWI4\$C%1&@7U["S(%@9^O19\\Z,ES(PA(Q&6RD@O&'++(UX(S&GP@_!B M#I1\]EH"Z_+YF>1]!1XM)'N XRD@LJW;$)14V1AJG23S%"=&E%,1U]9LOJ MML^MGA;]-<7#8HP6/6^HA@R7\$K,QX_H>,1H72BJR1-NR%68FE8+V#!-\<7, M#@I\O@3T;Q+DM?Z6)ATF3R-/\=.$!PVD)PT=AJ?#"+D2KUX)-_137W:.&Q(B M%SECT_Q"I+9'P24?[2D[$M:A.MU3&+Q$9.^,IQX(JC 7; 4Q(0K(N0O;>Y7B M2_MY "P&_.BG3H<$$/U]XGR8V BX-)47!HN(B_C134TY.BV]PXO@X/1ZC_ M/]'R__1LT3OE05RQ=FC,XA8E;N),I"0M<7!LED'I6)Q;UNB[Z5]'O(/>( 29.S#:/0(D!OWM).O+/)F5R9MMA(+#)4R-J:7SDMLH_G2$K?!)Z22! M1MZ!E")%VA^/0@UQC#'F4(0/C\'+[_8"=]MGV,BL#Q>\T= M#80V2+K)'C,Z4@9% E\/"#,M6=X4'H>+AZN/VNW%W6U3=D>9TDHX35"4L7QEX8J"< 2$$H@[GQN)TTJB<&D0+@?Z\E$X M FAA)$[NO5YK3FVNB6BYV#J.3S+0?ALN]&!I:D_C>%@\!+0_U4#9^MEZ$T M1QJ=2$'+:T=@-\:USZ:W55]\SBT&$N1DA %,8),PUB")(L$DIV-BY:[V] M8$Y6SR\1F1-Q_E5#C2<6F:NICV&KKD:&]TDI@&@GE'V_7Y#_NF37O7G]USIF MJ]?N9Q7C6=>J\$QB6XYM]%\[Q;JE@MY%A48[FA4$RN+V15G;1#7@+V]NU!:4 M:_0UXD)P6_W5BJO^$J_B:KV-C576]372!C!_CLH9'RT$H5;=Y'8]&"G,6=G1;JA-2>=.AHCBL:#RT MJ-0+2UZ1/)^HM>OT%&("%)[+R&A/"W33ZBPG<-ZO82XBG_0S1V.Z.(/([GX M8X4;M?;_TA#5J5;:)4.;VR%CH[=C5HYW2+O29,SKSOBW>5Z]K?ULI78L M%5F33R&;]Q6E=QMEO:J9P(1>E,B0SI0U03N#AP M=56&T?M5)J7)>%,4T17%3PJ9\YY1!.6A<,C<>-B#)TI0T/+@JS=;)H9WD'-/ M]-^G]=1BV8R4Y8M^'23OI4.2T+72'[KRAVQ: PVGS_QF%(R8K?Y7^\D4XIU MX6[5P?MD75574Z_@Q_0.TN1'H^!'_&%.?X( /9"K.W)IE9"\A[9SO)-X>>4L)/QN6 M E';^5L+9=_4Q_8](=Y#2%DH/'+H,) @F/".O0LXT\H@%=4J%.QR'NLH+LKC M 3F>HR+V2>' E(U3/+I=)/%QV($8=KD.!3/Z6IJDI"K/NJE MH,<4^?:W.-,Z"%##,Q4S[# #>.4ES]W+%#"HZ7UT]QAM M,9';3<%X3 A-LOC,+A) M-TQ=_: ><=^9O&&ILKB/'RO3N//Y(TL!D>1TOQRW:$IP2G" S%=MI/R@ M#[HMJ[TM%FZO8YK[7Z R-)GZ72),KBEY>KGDKU5Y7F),D"BD2KY1>0>Y1K7D"S MUVL6,./'X>O$\TE1#"I9TXD4I"L=,ZWLAI76'"Q1,E$OMHB=;9=8;N_Z(AJ M_2V=O_MP_W5__UV]?5!N_H-KP,_M9HE3,IS.#;WNM_1;^3U%A3FEI+!A7^ MPS2!.LV$=41% ;ON]C@V25A ]_RNH 7?A,WNO^YGPAGSN6KM[1 !#% LW X MGV)T@WG!"S=5W%AS D _DY^/A:8A39=VX:8^E110D..6W3#D4XDM9Q,. =Y3_1_^R@KGWM%_'Q9@H$C[#P,64.XSA ML&S#9Y0_3\QWAX6BJE3>Y 73)0\ZI3+H(KH9H00\TPV4.]@ F/_P[?[C3X#! MT!W;7H0I4[_JAM4V34@#<:J.'XBU^:-W^F9NCY_^ OTR-/]5,0?@RFC_%H MZET(C?B.7/T\^6LU -KIY-4FJ@T\H/\VP /V8"DF]'D(G/]]=-/O_8[G8XUT < M5G7 MRVD<]6#; ^4+Z505Z6 .D M1^^8Z"$F_>,R\"DW"G;BK2RM(B)5)8YQH%0IVAKK<0G?-8?)87T.'DN62A+ M;JB_364F,7H=LPW_=Z#D6+AI%I'C1^2^\UWO'S_%X93]I/TRHYIA2_N;D=A[ M-^$=UCY?B4R?6TST27Z,Q^17EF5NBU9%:K+492Z58#8%":6 /CMN!!]>@F-CT!R"&,_ M%A3[B+1EBA>4J)I1N.[\)VR<^QP#Q%RG:PI>/8?OW4EC[7'HJ<(P^5%CWE@ M"X@>@YL#3\%T_#(,00SY%B.CV(,02L_<@0QU+(IOG".A0&$@\1$QFPBE')KGR+N_CLZM,#P>NZH,P2.RJTI0/"[J@S# MX[&K2C \'KNJ#,&]LL^V6[X&W:._Q(^[I$'M:BV-Y2DY3E0M4Z MR8Q;-'G[VI],X^@SYL;I1:NS"T",?0&DLP5 9C2K72U-)4"VL325 %EQ:6Y% M_>FM!V("['#L/TTIH?\,@RBJPB<74Q!JP2,6"!2#D,D2-/5^VTIEV/SIZP-6 MB-[/]B/VVPK"U^35"C /NE:GNWV8)8%YR>,R />,;GMW\-(]7UB!,_Y> ;>W?"QN&?A4Q!27U!)E:/ M/-@&96+QSYT%RZX2,3M^/=-+MDSN^B/2I3?]"=]6%,9_)#T,O%KW8"CJ)* MP^>@,\O"Q@8[?T ,WF]AEPVA?U4J1[O!.IBF SVO7B,T !<>_YYZ:9JI5\5CM0[5LT+6);YN21D5J_6'3V/ M9FNPUA97=H<"\S,6=+$L '=X3X7M/6!3P@)%3QXVO][V?T_G63!0/?.B%(1Y MC:W.BZ)28E++MR4]VW>C,1MFV)I?KVU5H?O(F3VS>BS+1HRK0FDG_]URB> M<269_"I0)1<]F7TMNH=4%N$GN"X#+U-N:5:%I180OJEM4W5"80\V\6L)P M3%X\Z.;V05ORB- '1J<"C-FY5G$G9K4)J]/1%=J4#+\^%,G!B=[8A^";\M97 M%B][G'9,<_= 5P"TJ_=4BVA'@%;;))U.O]W7EP;V(WN,K_TH#JP)63[H>^&=K3Q9Q<&;T!%@ZJE3SP>IN"2P 1==3L'1C_B+JVP++2%D>/R^@ MUG86D7M%.M(K I_-^7K%]J#2NRE4>F\A5-L"RQA(L(Q%'+\]L(PSW4S!TO=" M/A H0IKRLKP]X7@=^$DNHHY9]//E0WMK<,']21<\+F_%W!U\2!LTM @+"@L)%WS>"Y;CMEN[G_K8-K85 MLK;3M>CU>V?'[#XF3Q0+A_"#_532%2R?#7@[#5E1:F:GS%R;-V6MP!:X ?<7 M6'GJRQW]3=[ 2L[=J,H"%^_!G&NI J^"=E'>SR[\4L0U=L[1W2SCI>R!2YU M'NP,[WG^CXVRJ7SVEC>JO9R&(:,LE:^!/^1_K.I3MP:6$D:M,%$]L"WO75U@ M>ZOQB-UAL60411]TK?:. _02M,TK1W MKR_>GYV6KNS"PH;[:7#!YA'< \2 MP [=X%,0LJ$=50G;F(/V'JS2IIWQNUO&-5S@NQ.N:P"]+]M^25EJ= >&OAZ+ MH$D6B>RIDRT)R)IAHR4 R:HL,QDXW!)J=\G?2RX4\;E;IUCX M]5;_O4R+LK1J02T<-_U5/?=6HK\K[>&^649,E^C K 2K=PWG4WKS)RH&S: M=.BE)^TKK0QK;+V5K8G;!GQ+UT!O'\2EBYAW .+R9\?J98 MV0+&5)6MLAZ[OP)>.O>L__V7\DGJ Z.L%6POZV1OTC)XJV2J!O15DE:T- M6UKN[@-#+4E*R%LV)6";; /10'BF6AH7H 2**F MN9ZE6X:D8>T+CFM;RL>&8J&E?61(%EOJ1X;DP1P>.J:S"Y<\_YP@^!E,3W]& MV:^ D[%[:KF5.MJ>YA"G)0[O7!-J7W<155TS;9A[51EIB.P1@LNLC>2K?Z_6,;@5'=:??+W)JW M%X9U!:P^S,=JAT2GH07E:;B'X /C4VT?W)4XTVP MLO7\'9&UHB@:3J[L32O(CNSK76NP$-SLQ)N$5J['A>.X2'O;X\7 '^R(.3?^ MPS-+>F=FC\9O/AB78>3&KS>C\DSJ@IRFOE5AO39'@$VH@/NVSIM6_8HJGK= M'6&[/96O-6MDO39)#>7WEA>5O:R3^ NJ9I6:M"["?@6JZ6'1.W%ZNB.";V, MKI]4.61D!Z9M[;K7/N7]L2-;6^/(+QCL>WZS)&75J\&VL5PB!I!M$KF=[2.Z[:O4MH_D^E>?;1_FM6\JV_ZFJ>=FL?5(G=A4%\[_P"PX:7KU M2&E1O;#::!X$#-+YL+VF;Q6.N6NQJQ(IV##&"@+39EI'2JQ8=OIB1E MW64QNCVKIS05P9J^Z"7IJ'/5%3V^_L(?UF&^J& 7Y\G@??[%OY+.;ZH)_7 MU'252I!\?5;7,O)IS7L ?)5-JP_ZIJ[O'>S5Z&ZT^UVU%^^> %^2,#TC+[MJ MS>&>P%Y66)1WBG8[G?WCFK(JE)F;76:$/8!]K+RE#S?&+T]I'QIW4I>SG>- MRM"K6>1[#9=WEDJZ6M8IU8CU+)"4.J%
$T?$5<. M7+S8H9.JJ%$T'0LV@$F&,7,^NM_Q2@/GKKQVH+:U%?%8CC@=-U"1 MWQ!U(UG)#5DWD0;=4'4#.2!=V0=2-YUPU9Z\[T;BBZ[E%5Y/EJJ+IF M@."KVY@ I52M,T>SH6G]2:$-3=>CZ>D2]+? @V'P7JJ=N53T\[;56^BQKA7/ M R=M91'0D':#[I6&N)MSLC2TW9BKI2'M!ATN#7$WZ'9IB+L9YTM#U\VY8$Z7 MMMMPQ QZ5O<$:;MQ=XQ^;ECZPK2YAK++.V4:RF[$-;,O9'UC/MKNH^].["DL :L3QHLBZ3HZ1;"ZN+&[N4OO1\.MFJC\: MNFZD_J,AZX8J0!H!NZ$:D(:P]5>!-%)@,W4@)TC7K52"&-W\E83'3M=MU(+H MUJ82[8^-JDM96N:FDF6.C:I+,.HN2$K]-S:2XO I"$?,C0';:-<]-K:'Y&&3 M=OON-'0=#,]-TZ- MKMOJNG%B=-U2WXV&JIOHO-%0M?;>&]LGZ=J^G:^P&VFJJ[^F;OQZ[4=Q.,5? MU:L1ODZ1!L5W85 [U\47 %I69V -]%X-[J@E0-X3,LF6PB=,IG_BKF).Q=[+ M2UQANMZ>2P!6B7+MQZ'K1^Z0=F.U]9QM1CSH#09&O[NN5@ X2Y)D5R('CG M#R% J_0C;W<'_?7%YJ$02)PU@C[5.OUW^KWNJ5H6D=^T[1ZYJE2J.H5+V:G MT[=.1A)EB53U'IF3IE&URVIZ>G> %[Z<(HFJ7;'1TP>G2Z&%WGH7;/7.?I# M+;E%9'F]J-/M6>W3(=!>I'5/ED5=2+VH9ULA2JJA<9 [.'B8>G22J>M%) MTZB:7H0'6E\_31)5TXM.FD)5]2SWSMXD?T?AF%SYEQ\9Z']QY^L'#H1NPV M=(?S5,DL86YWX/-;$O!B#V!-@$>+(2=W:G3M\]OGP-?R>.Z540DK'N/2VW< MM)W>6MH"&#M1X\MC/LLM&YPAR&WF[7J\'/0+U3LBRV:4H(TSDENA19,F4, MTSDENA3:+R64Z74&_6YGU)S%).V),ZJY?QO#:$:928I9RL#5T. M0(EY7#S!XRH.I3LVMET?OK\$4H7V,)[:'G:[,ZIZR+ QZ.!+[Z-C:T#NY_T MPL(;2:\%?JY?;_7?>U\,LR%C136J921A%0[C^J_][_H1D/(U0B9 MN2Y _]WXTF\HN1(E<]<)-(1AX^ITS-SK8/UN?C&: M<[NBWCU'CS0;/;(Z&>?ID>:704/'E>B852,;AER=D!DULOV[KC>GS8JDS.B1 M>D/)-2BII(-)=>@9/8&L(:0JQ,RITKJ^Z5SFT-\Y%%P]"ESQNZ %-\H[VX MGJ<],HVE_F8-)KV8/L%X6K^E 7V-E@:(:J,@U&QM0HF46C#2.MHKL\,(7IVX M(: [\YYU+LA=%=>=$TA14I8A4&=% G4/CT"J\K$,B=HKDJAS<"12E8IE**2O M2"%S'RB$,GBE.^0:'EIP#6@CJ!?>_]F(ZH47?RY#(G-%$O5V1J)5._!)ZLA? MRLCSQ0Z'SQK'UR#ZN11WS.,@^.@;D.0)QR)B&:UVNXW_$^]%&MAFVFCJ>:_:=Q9AZR_U77H1OL-7]9E7\07- MCNEQYA/QF0W;-)H.ARR0#>AE: 5&H$NQ]?E7%MRG4O4.;V]>)T[![?.BMVT MUCIW^ZNM,GX92K-;O,X7FOT%UC<,$(!MGGO,%"NQF!?J6OSNXK5?\Q05R\'" M\8;\!G3G0\U@;"R[;8CF0]I#N!(.-:W T, M&?5^1S#4,_W:&MBMT=[%_)G(\$X@45BKQP V7GU8CB')[.1S8)V= E MMS=\]ACYOWWG8AR$L?M?^OXV#.#HBE]O/9@4?L.VJQ/TA%?NM9!O0J%WNMU^ MVGVV+GBVB&>EYJRZH;?-+> IK\?"/LY^M%H#@QSH_6ZWIUSJEYMA>0!R3^+ M >AV!T9[(0#$Z-?CR11(FEP2QHC"MS:0K@Y2G UZ?5/LJ3E3K0'2TL0Y,P=F MKSI(1&'(;,C]I'Q?Z^!Q=C$=IT:&0TO!Q60#JAGX%:K=[G=Z:T,NU M$C'8Z"&X&((X#%DUH5V=\&6-3VH!H KM%@&P?DW13-MTV3EF XW3)=2?@I"Y M3_[E- R9/WQ] &@C>TC:&]",_O0(D>@V\%QX #XX(&N4[G6Z'][\?N)%L6O M'OO'3V,[?'+]=UI[$O_TOY_B]_CC+Q/Z]+_TCOB/^L((9GFGZ?"\]N".6:1] M92_:73"V_1;_HJ7=@_D^>J\E0[_7$XSVP.\WFG_ UJ:.WI-9GO$#V\^O-4$ MYII$G4!YW %0]GCR_G_IW?:6YWUX9IK-A0FZ0CS7?G0]-W;13328/C R07,9G+>TS[%SKKU!CPPRNNV_<@SZAMY['VF_N2SV;8"%:='T,7(= MUPY?WVHOST&$OB?>,OVM$@N^9&Y-U1WOL8^$\M\BW%@O]@![A^'&C?[@D, M)_ \X1CBOILS] VQ'\-GW&L:B"U 8@(_A!J\!(P: >\ZQ,;G&DBZ8,P(9R:. M+C=FXR@_H? ZV3QG1 R_B 4MTE;WQ@BAZ"Z1$"IPG.R!9BCC=_=J3[?J",^ E)B<= M!D^^^U]:#\UGL<;L$'UU$4%!V3CH,W/(XM?&//1UT:SY99)> S5 MJX4S?G:<;)%425A9@>4GX+6(WHRO8'V."ZZ#%V^5;#=!!-D@0 M.C7Q=NV#! !MD39EX2YRR<$.;#F&4Y>@>7'C9^V)^;#CT25M#X=L0J)@. RF M/NU3D"HPT 0E(D#AV_QH1R$6,E(['!0Y8_M/IK&$EY"7[?1:'V!X$"XV;)%A M+%S>$[ NY58>XUPD:DK$LW2H.VXTA,TY#6FED6$!0H2F[+TXX];'ST6$X5# MNR%ZT:9B0B$K(U7.2;@3@7=!N71"SN$>FGJ.$ 9"Y-$QD%"F<$=G-V)^FU[: MT3-L;/P']:7OMH"RR"9Q6&FOBNIST>A"Y YP+ ;L+)6> M&$,(VAB0>H:_0PUV>;)K@!UIUP!T<'X!$\KO@Q\FV95(QL[#$X0'.257OZ4'"<7Z9%YC\^#G1MI'P+X1WLC M%5RC_?[3Q?V'Y$^=DZGPU4LP1T;ND#2YS @7]Y?* &^UK\&Y9G3;+4UY1C(_ M$8,8Y%QY!_7@_&9$4B9?$50\L>@E243B>SM&9=J;.EPA)FE%=.5PPB;GNO8O M4O5& (B2H!8/[2FD6?FAGR4"-]Q\;B-W3-:2%#:ST^#@Q]F2?(&!HC-AFQ+'4BL"Z#%U+V@AA^<$D9E.L!1LE0'!E" M_A>OXPOI/H\LNYKO-D'5B@L74S+$D'E>-+$QVP.]@/3WQ'8<^7<6#&,Q&"^N M$S\CQ.V_O=<>@Q#.X+,A&NB3B+W3Y>?4G@0E%#. T(FAFWM29YX#.(X&=/ MXR%&;SCR#96#A@R]ZT7XQ\Z<(02^9WPR@/W6?$ZK>LC1&KIMWS\NS&K&CO++=19+)AX3[1=:O]R_TR&Z7J>BV[ MKJNOI=%K=4SRMT1"MM#]6QM##;MCN"_2\2&(;>]@.:W?:74Z>( -CI[EDK-Z?50+>.\7LC33KXH-W7+G8>KJ M7."US#LY[UC$4+N_\)V/[#OS LKW$-E"_-W#=G1^>JM)',G-H6"I7091?')1 MO@C=!Q;WM@8?HV MN7U&TQ@#;=.(D7N?$MYH%"\I!.0EZD0&%0\,M+8>.(%KXS[MF1.4!)@2W[E MOBCNB56?+/3_5^#R@N2]8,P>[!]'Y?;_YUN9S &8G5Z$6^5]$:&.B)&YSUF+ MD2@:G._"88J^]JP?_2&8N$.M9[;/]/:98>7]ZNDOJH?]7/N&0VKX #K;DX=: M& W@B=,71J$%B$()95D) )_8HOARQC-8W]->0:)'<>A^SCE_LLX,PN0EF M:T,[#%\I6)&&U=D/-\+P@LB('7I\$?4EIA/!UP MG00AUJBII,'IU9$?>?X.Z(.8I!.[!KGG$ H75,2:3Q5 5-SJ"-B0N:R/%! MJ"6J/$E"32!4$NBN:(4CQ(DA%"-1/$?$XH$^B8=_B-GX:$L7>$T=9[?$7P M$TH][7+5X @^5?P&&$.!L_.4S8S/@G?9P)E+W#^27:DY#K/?DE22WR VF-/ MKLB=HG."$L(BAF%!3_N3O=+3L+@NQOELUI$LL4L.6K2#L0&(B=41Q]C&&] M. A%RIE+<^!P\(^=%F.D.6,R@$>9-,!%SG0HPT0\I!/B!HB9(ON(Z3AC!9JA M_TUP,>[C?]D^K^@DDO9;!SPO,:S'_;V?YA(=DL3>A^S>P'/CG.A;3C+!_) MG9I4E?(M+OFWA;6KSSQV"MK%F)>Z)BEP"2E:6 A+PH-4B6FH?3N_/Z\F8C$\ M"3J0C?L-GXDB>WXVL;XO>?^E[_R2NF",$&%L3%]4N')A!_OKRY1Z(Y&L,FC M3D=\ \EE/MAZF$Q#=_J&-T)#SN'1=9/3W(U9>N04$2AU42GE.Y7DLXGC8F MC?3F_N(##OZV)62DC>$\. @CN9"AD[(MVMJTI5(;KEW":)(U82H[TP NQ5 MS#9]9\!%B3[HAI=0)>34]H],"1+X$9(<=]-D+I 6,ZQ^#-!@=7L\;/V%S G ML 8.R2ELTT1/ 8+V-'4=&\>DK9"2RL5HR"1D(GZ:$?Y);;4/P&NZ(5)<@$ L MR9M)@%#&E R>8\P,GX3L3%5)("EY%.>5LM/'MJ76$[%@,9TBO-0^ +/ZB( M)=HQLJ3$VH:%>HU<8H(19>X@T2GM%^AL<[F%XBC@@/)=S G /%&"Y!%P#)&<YW($715+#3;@Y::LJS93C"14C_AT) ]V2$7 M_2E/H;(WA5]#/$] ]J1J .FK:%S!RB1C##T;0'6%%I ;)Z/H/KYBPB=6W3^J MT@X%['@ZEA<<_$S//@<>-B;0#TQ)/?,I',R$)F/#$\C^ =GS^HQ"S,I4:DC M' (R3D?,H4,4E; X=VHI''R%G0YP.-B/=$K;2U^"(7IZ9VXX\!B1]-P_&6JA<)QL?+W%G2T_()DBA,)C #@!V2X?("O)I M)$3MO#8Q! 2UBJ%Y$A53Z.(Y##-X3GS$CPDSCX5;!NU?8E M:NR"BA3M%'JT+,UOM]I8\\NCUAUZH3$EX1/RH4)$^$YB2./16P&4RR1":) MR?/UIUA]!,(%EX)+0B&_Q8I'6>XBLR'ANU1.<^T@82&GI=ER-_$ MZ["D-4>U4\HFP"QO:BS$2QIHW&M'U3,%E?\<.5<42:+V]81I;+)J9&.EBH) MXE@1+B]>%H'F%B^NI1Y:,DH96((H#(4/)QBQO;T=.;-I+E8+!(%O&-4H9^ZS.E/#%CYLBHBCWQE#HU%L2C M/:'6DMQS68MBM2)G148295ED4(02?<\N:!2YQP,D9"AC+8RHJ6ZK87>SUO MH4NCE9F?I ^!D$@@TC2PKITK,;FR43MJFX3KX0D3;PE:@.RBAJQN%WSX2 M OE-6J"'+V-E3RJNI99&PWUBD!_RXMQL[RK.8VDR"NMKJ3=6LSPE%;I"=Q M1LQFE]MI1>"[U(SY'J#+%=UR<2YWT'!P$H\(GSH1G^2@.?.'K1 0EDJR./ M-(;GCGB4,D%/1ADH/EJZ_H^O"F)P7MB85'#FP?D# $6F<./G^+MA6"T,-,> ME1>E'#KDHL'\ZJO PPZ=!'Z%"1+S#Z0W&/^B58/T3WR1U8!&O)0QD@PH- MZWV_"VOQ C9I$1#"0T0P.0%,E"=@!IOTKV:>0$/7D%_JE)6=KXF=KV ]6T! MDRO6:L+OH1QY6.Q<$ZP@7-,A5'_9B>E#0 M^UR8H+X3)?XB7L D^/A,QQ:YH ZZ9$',JEBT.<0PL.J^(P)JB M=?B!6@@=/X'FCE$G4RWWU.!$N0 "U439P^9TH2#'\ 1+"ZEB^!D27)!/$L(..-L/"=)-@[AN$)!F5 ZIWDO6B$> MMAM).'P]5[3;(!&OA;(K;(RBHB9/:0R)X13T'@1)IR6)P#@"(?I8#HB4E2 M.$]^ G41(L5W_HA6NZ@UI$W%'!$+03I'4] 8%QXY7[Z&!-AK;9U9L%9Q=M& M\4VM4)9_+6S,6P6KCA0<^5;G;>]2:OP0OEMPZO#UZIZUC59FIX"TI_YVD7H6<$[IFT:2 M0C!F4KHED4F76AJ-1=:4?6MY#2(@9/,!,X1F%H3B9,O\2=&7/9.;-Z3,8- MB;=#F:8QQG,EY)!;4W=UKPE2QKFA!^Q@P7C.5F4(7X6C,ZP6ED][>YNLJ>L MFOF!L!$TF00OSIN/MD>$B)XQ[$:!"!!F'D?'"T#5%7LT23A0?1.2!"VEC4TT MDW_.3[)'J#DM'("PE>=9FY3"1[9>8J\=+!\4N9@\ M<2KI(&;'F'K,M8CL@SA2%B5ZH(+DU+8G@D5LH),BK TS0M]V E;EV5)#53C M@Y)(Q?D;LC@,TA3)-%>$PDWV\+G%BZ8(:M#]E:#O-S4)0Y&M2!.=/<35Z@CO93J/9)AA+:<3+EIG&RXI^0%3 M7\V>R6"GCD6^.$=DNSI)6RAY(HKL@AS->1:+)P+2]IOVVKFA&/<$8N/L:ZC(.!=J17RQTG"B<9B;$4JH]><9O%9;TZ M,^UYR[KQ'I4WZ%]OM02Q4W/[J#H&#T4AF]BI MX)@?C$@"2&Z8ACY [(#XF(V \,06&PY]<660T&I'(H5F"C9?\(B=;D]$R!0$ M#B0 69R(]WGC?#'?@B/$S5I MD!]I6A7FD9I&!,AY0X,RM&!B:>DH40R3XX?[")%)J.$ZTDX4<5 @%5VM#0 MC7B/033"@F@ $+ZDJ)4\'98@A!I].E<^Z3D=B%SJPT50>L93D7/X72H%L4= M9,PW"?"F\8D.C%R/\DXFH)"GL/$QY(EOJ(9.(F5LHIBA)(R58 ME.DYR3W)!?W,2IM!5CU79_J^ VR_(8OBA6L!0RPN65U&FFWIC';&(&A;UR3A GSU%FS=5YB* M0[5":E[+W(Z1>! );W)/.8S4_I'I G]1JE#4EI+IN93/^!$^.P-K'6=3?]1? M41BNREZYDI$BOBS"^86;-=7L:&Q)3TVGH?3X;\BD];U)U/NB4J3/'E6_%^H M)$TCZ>HB^#,'WL.S,H/VA!F PI9]>L;T#S'5T_FEBF.!,I?TX Z,X<4IJ:E M((N BVA1.R@H3M,UIYZWBJ.OC>?L;Y]%8'C&.D4,'5$)6^^.+3QV+-= M3@HL-DW%':AMA,$J?0$GJ>F3R&Y3BK.@Y"&/NU_!YAG203X4^G8-=G-,> MKG':;1,#DR3:NH,<^-2.&G"8,-M)&&H.M0\""ZA,;!I$('1,.<_%BU&5[Z M;H5V.GS\0;%^QGTY1"Y^\%K-H5BEOSN@ S">'UB'_>46WS]VAW-%'UHB0 MGRA)AKS6[#_H9?)<]IW[++,R"+>+5R <::@FAE"I\X4%!TZEC/> M@1RHS<8XO8W1=D8>6:,IA,12,(4 1<+3WD80"J$J%:ITEKZ6I!TD!_TQF M;#$SX@&1=!IP^+VJ/ 6>^[5(9P_A2UGNJ(:%?'Z= 1P66R;Y+ZGBCPW304- M> A0%H850"EI91=WSYAB]OU_^>$58N!-D$\MZOCZ^Y>K_T]8)"A$%$AEX)1V MZ'[,-\WK]$"Y^_H%3I9SNW>7=Y??-VVZ.N-O >MTNFK4/LE :_^!O1'1/TL MY\FQZMO+N?6D)5 UXU?YO; >BM/]D> WD%IUH^5>WL73N%F[79F_6J21"LW1E;&X5,:S;)EF69W;93;^AQ/[= MR LIH9[&^[=-O?N[YT$1[9>#26V=HO/EK9;!#=US'#<-D2.P3B@W)U.F$].5PQ%%W2COSO5!/OI_1J9 (MX MYA\FT7R\OL3(VC2D3!O/Q2&<^VB6@@MG\WOJ($Y[U7[F;_W<[NE]$GBMQ M8)S&TLG+JQ>F\_%,29'2ER7]8Q#\R9R4WKQ4)@^QIC2+-M@%-$72XA9MIM M#9^9,_5 %WXL2LO)KU/;C6]XG>E.BA,+M,;66]&^\1J[IMM[IL]OL7]\:SUMPWV]PWNUL.W%_? M[E;6H;EOMB;>J\\[6[]OI+3N\G.:E;2; M;&'Q<(O?F2QR;:(F+::20&X\:.MZT/A-SIO,HVE(GB/YC'#8;TWK\2OX8FZ M2+K>+DF9XW=XF'JKW[9V19:&H ?HXK&IDP_V[,OV #_$V/2@V[(ZW5T:%8>$ MYN:%?%6$;D8C3 P[? ;LM8SN\2>#U8/EWDA O-&#F@M?\VL.TP;+A\B"?:O5 MZ1]_;DY-:.Z/#/S,HN@=MI/F5]PP]!>("R;P;J)#9<KG5<;;M8DEW8!AL?K2Z^U!:V#N-%5W MO^BA]UH=HVIR5)"O#[7]V(/==ZG30K%91#%VTQ]W(PCF]]V)B]M'"VH%B9@ M$I?W"U: !Z!2N=3/,U(2LM3Q" MNM6R^E5E^"%ZA-9CA,,]C08MO8:S>7\,BI)U3.^QU]]K(>.F!EX5\GKTZRW M!L;ZZ4 ;U39=(?R;AA4M_$!6V;?VJ^HEER\V%#Q6RB_C)IK7V!UZGP[PY? M,[E1+D_'2#JI'&I;$GG]/QREMR<&ZQC0.\76[XC-O"H )._)]&==O\OCFU M^86X32);Q H/8;6WKEO8:H._2E=+9/<4;X;/PN_8JY] "%%A"O'".VSF$8@: M6>I?D^OX_;/1T@?]EJF#1L6;HD\GXAJ?#QB$/ ,N"#P$F 8Y0\!PNX\#AWGR MPA]YG?13"X_YD&R7VUWQG>O91YFAY% &4!K[PD7)" 7P6_[;V'%G^ M[P'>]8F7).S(5U#KF%8Y\O5C>[#$M:@=B:+B#=)'.SR=?B9M2_FP-I;BYHN MCO!$32XBP?M[#G9]]'-KJ0#XL6TN4&9&S,7K#0\W4KE4"+GN!=RC6VMV;2#I M\PVD[LKV$3;#6L8^TA+;B&!9:!]U#8#-[U@':6+4F8F:89$6Z$+OY9TD>%$ MK^L)U>2K^(\/A[PQ-F8#?9,-7;"+%I(BX#462$UQ'2"918801&14M,+['$ MVK.66/[=SB(KC."H:(FU^ZUNWVCLL,8.:^RPQ@YK[+#&#FOLL.SPW:JQN]Z M::8;KL-5I+F(J-)U[PRN2%TRL:8'JGTVIW.QLRP+K]UH+1T?['NHN-,J,G MC3("9+WP6+?5U3N-3=;89(U-UMADC4W6V&3++E^WLGWT<[.)C34V66.3 MS;/)[MDDY@TW0"$NN-5,6&6]+JC+W1[7_[G=Y?J8+^GCA7)X@94;/_/[LNSH M&:R=+7 1,E#&@EZ$3?'@.7@:Q?3)X!(T\UYL[<&W5ZKW].%S4=@+#M_?W;^ M'>KV&UM00<_^''+:FC$_%72-3%##& PV%^DT@ VLGEEG'FAJ2Q,(:^2!JI1' MN[/(R.T4&+F9]TQ."27T2,%0;MDNN/Q1-6Z)3KNQ;M>16^I8I5]6-XRTQDYK[+3&3FOLM,9.FX?%H=0(-G9:8?V@V6SQDYK M[+3=Q=/TO;73=+W?ZA]UVF.GEK1'0:?&3&O,M,9,:\RTQDP[4HWPH,VT)IQV MR&9:$TYKS+3&3&O,M,,VTTI:L&RI.JTQTQHSK3'3&C.M,=..6R-LS+0#V9- MF78ZF[(QTQHS;2MFFF'59Z3Y2:/.]0PTL]6W!INQSW+YCKLH^4S'E>RSP29 M&ONLL<\:^ZRQSQK[[#A5P<8^.Y MV=AGI[,I&_NLL<\.SCZK,XC6;?6,5:Y2 M6-Y&._#>(69+M_J-E=98:8V5UEAIC95VK IA8Z4=R)9LK+33V92-E=98:1NR MTJ+#,-/Z+<-L;]],.[S6(4;+Z.F-F=:8:8V9UIAIC9EVK!KA09MI3>N00S;3 MFM8AC9G6F&F-F59DI@U:%H"V=3/-6,Y,,UT:DJ7AN?8?"5B)D99Y M?E#=2%/? UN0H%BW:0A1J< ^2X@K##2Z5![HY&F6,B!($<=VCX:2#!L-WLE MO&2D_/H"2I_88SBUP]>$>G N 1S 5_X3!^3G+@V%%]"#Y?XZ9GY\KEW[&IIA MN'B)C2K!L+TH2#&T$QR!=Z9#F; K(9,H2]\ _!2GK"51LO&UQD9M;-3&1FUL MU/U5E@:]M9E,V)NI63-1BQ311-RC>S3&/J#9=,OU[0M0AYU[M.5$].DWL+)()[X Q7[, MOWM 0!Z BA\\>/#7__?_0OL% MVN"L#= 9!!K_W%D,FGC@2_AOYOLL?O[,$ICT]6%JPTI: K")#[WY92?@0!@ M!>8 JF=>XN8S@^85GQ?/:[1K0+A_UC;/#-I5^!D03OCC+GBUO?CUPG?N6,30 MK9",%M7-" F/#O:+1Y$>9SH7.O39J"!T$A[]5^#;\;/MW]T!8'7RB]%.20:? M.;LKT5D(= ;']$,ZT/@ M3R-\?CYREL+:5E76SCS 6%64C+9 :0Z,$A=YH%]Z=A3=C(0S\B:\0ZWFZQ0G MA#,>2!NZLI=-2/!AE4+Z @?AN[BAB\][]<0ESBS=G<"$](IK! M1C=[@Y[1ZZ>JQYJ0;@WQ0;)\^. J/A/G45:'YQ+3671DN^&09;C 3M=]"!6E/W-CV MY@ [%YXS:] !D)3+C/H?!9&S^ZDQ!K=$-U+#%%+4?\JPULSHO6NV280I<46SKTO M-H:Q?$PD^<2' DK.";GG(OQ6"4 3DKB#+@R/\DO,=+\L[5!>[C P!UPP M>=[E^O\U)33=8B8;/$K?%?#J\EY7Q9QLL2>S>!7?63^S&+L!@AF(RB?,62P8)$'_'"4.%F)9H=IVS#W0=#U_;<"$:= M3!\]=W@S^LUEL6^/B\Q6:<]K%D_ZG8B=H'DXAY8,ILG1<-G%>)B\ TN-:;CP M!-FP9LOJ@L;3TZ_IBC\QPR,>_H%$TM92[SBQGS\B#Z-6DAT7_05IX &'!R MP9;Q7K6?3:NE6VW[B88 Y\1-\8O ?U+O@6T8V_::X(S1/(\]R+N6EI_#? M8/KTK(W<[VC5ERJ>E86F52N[$#AUODK6[)B/GM!$E!"O5@NQ#5^=B--%#OS M11@%09PNK.MKGT'P60M[%M>5(F3HF"P[\P+)N3[>6:V@Y @]1+<0PNWHQ@\>A/2ST M&%!F@]&IN(509[H%/#"S-PVA]W^?#W06BGK@WM#6IP#MMG'I(;/K%=< 4Q9V M0^]E-N2,-+1D7TPNH-QKT3MP,(8?L9=M #(>?IC1^]8XB0K!V=UJ'/)&K5! M;?0ZE:&6JP/[&32ZD/&TL]\"?D@V+4EA9'/S_,"06\"L>BAPU7'NA3A_^4. MX;26"0[$B<2!>X=3UBM';D9OEO4V5=V0(/<"O^(W'>^Z_WC)U"8P:#^97;] M@B%C3H3 ?0Y@JI+<.O0JB-PZ_)R 3&@^!YY3D/8QRV)6UJZ:F7PEZ&:C"_W5 MH-/;&P(/-F@[M2O2S;HD>-9FH#,%-XK/RZML2':=<$.D]!U%7_B?M .(.HK MT WV"[J>5(CY9VN_5G8@1FBG)QG6]#EU?>Z#!D5Y";I< M6OR\5PH>N:BYGQ1M2',>>'^(D?^XGSY&8)^@8?6]6E1N$WN:V[]&1\(.GU<4 MUALA+8$JRW!@\^K:EB; J\CO,GB\[; ^SAE#X'(0[FUPS6R?)1!7BM :G9Z MNA+!K A'?>#GO31+@F^! =M9&WP1GZOLH5F'X%W+&"@Y2-FIEP9LGL-K%C"C M-QAT!WUS?0 =YK[[& PI9O?P.JD&NZ,L__[]U_RK^?QOA@.PRES^-SI(LYA M_V50AE]=2 J)7NM!D0Y1Z]#%,W+;-;:<^O!4PEHI@=/'#;JP CBXH^,O[O MM5\1O#GL.5]3,WMJLLY'#>#[L7:-GU 2[>I9]#6(6W=JOO"'.^C3N MS#DWU;G6@&EYVLTQ(.;!=,=$UR38#9CD4 L/9AU+^2E6 "%OH^K 5@;4%:TR%@95!-+8)XE?79P\\B^+A!49Y?<#$BLJPUK[CY\&Z2G+I M<@!>.-BSA!YX""Y$SG;N[5=Y]H7^=DW\3,+ZQ"7@UY?$3B5IZX3YJ4WMSDP M>SN&>?Z&"T$UN,B&14OX>%&LLFZZ[AN,\^BH'IX$WWZ1< _ JTB]#_M-O5V! MMYAZ!)A884JB> @^,)Z8N8_4W"MP"ZDK]>2L2J:AS.Q;; MH<.7Y/F896]>!6;G&VE72^, M_(@?WGQ^JPD,-05%@N9Q!W#MJ+7X,GVIU2[2'-Z^H??>8W(RT3'27EC(M"?F M8_H@WN 4PI8.7>^55UQ34VF>))IDE7\[OS_7_AE\9Z&/&^%<4[.Q)RP$8 MQ@W"/X%['<8SL F081#%9Q,/N'7D_F#.V4C4QN'XY]HW\3"CQN+:A!J@4RVV M':=@J%7P."9+H M.0CBB0T; @9B7H1(!#!=_GM.'H=Y[G?LD"Z;6.=(H/%SC(42"=L7_<]E;8B- M??Z &]#O)BY_7VM?@7.NVNUJR8SW MB6PASI>IRA%G_$NQPI%<8F60V0[P()G^RY)-Q@?$9ZBN(,2D=,Z%ML=;'7!& MC@%QC^QSW-])KXB("@B&"3R/KU@0XKU(3 /"]XP;^BF$VB=]H;_:U&&?M M(S&MNH?MA%WYVKPQ,,22M,)G>)_Y0&/V\+ED\MFYD29OK+.K MJ"!+DDFYA%+IDI.G'1YHN9(I.G5+#_>1^XBU=%3Y!FQM.W2NU&Z/&).60/G MI)5J>OD%_/[SP-!;>J?-;]?@[]#])RVL\VH/#'YUB8.[2#?D MKA(J0CX,^7-8#AP! (; 4L#]\!A'HG>P'2>,]ZZ)BTJ$P2&L^QQ&N@0 [-D MR(5ILHQR2BI[I;:21!Z7RSXK7P4U,I(+L5K[@!YQ;D$QL>!!+ALKP' >7; M3[QKTB.P!&Q_+%U$D0%CV]HDB"7VKJ\4ETE]=#"\U,.8KNZ)0/XI;2LQ026'2TZ MEW&U(H'A(\.K4\>BWO,C&Z&3OI7[^@H$Y-,KEU1D8SXELA6F 1KY0QCXO@% M]4+#,%/;E#:LIMJ9;Q%\NH@B%N=:41^B-4D8X4)-4>@34J003,=H]^#A!DP6 MO+S;!%3'=_O,O#;V M@S_B1,?&[)%5^B>_R:HP!:0$3_'S\9"<4$ZG+ 1[RV MB@^K1; IG"SO8+,2%E9N69\X[)J5D-0DOZ[9;9KWH3S3)DV?3])>ORR,%> M8F'11=W[PL]H6RB=78@%1MY; MO\73ZK1,TS@5A3J[_ >KL77U5J\_V!>%K6Z=^D@6J=/IM]K]O;%\]E>MWLX] MIR#H.GI507<(>P;;C+W#C(TPYEYT!BW+[!^$E3O/8"VQ<9,;DS"%8,M6;F/P[=3@R^(D MQUK?T)>F(+]420M&.2MPLN%Y)4L73KOI=3C:U?P/0[')G"TOY@7L1_N);7E6 MT11\V]-2[_^&;8^';;4[-K9=K"?8\OPR>1:[N7YV1]MFY#>NK_V.+<[?;H>; M5]"/2]7@.HU&94/4/?;IPK!Y SCG930'U7V]'VP/LYU;L^4@2UHLNW3HFNLY M=U69V"U!GK5@.X^H+P18AT(!KMB%..\MPD6J4D^K.TL^2=:(4+S.$2'Y=F. M(-\>ALHL^'TC,D;^AX;!3GTBD6+4)RX=MWF#0,BJ7?.PI!^_QWMO(T5-[;'U^H'Q! M=/UF&D>Q[>.>._PT\LJM#%H$2+9#QDMRR2_6#P;Y.Y?ZA9R?L13"N M-E'-BM:[HB)RKQ7' MTK>XQH7!]&:AZR+OQ=-3R)[L>.NG0)$ILS\)"NO%K#=?1V^TUPK^M<_;[:JE M"?L0ZESY36.]\BAL=-1NX_].@EC&6L32S\T#)-,&]^AZY.RTNCUK0ZQ7DT1< M.TJ_/4\22#SKP+U(E7AF.7%UN)CJYYV=+N=>,7?'JF?1-Z\H[1_M0#"LWT5C MWW>+T>JZF83KC;S??'<,B<'-RC<)Q U#-(G&RY23;9M MDWR\ZT31)OEXL\1:-_FX:QT>F3:X1]M?I-\7%<,H$D^/B),0=BL M[_0^%F=?I]]K=?/7RKH+;/3:?5K4(=/5%]H),/Q8&HTDF&/)<-A:0Q-DN'Q8-K(!?4X MT+NM@;&1.P!/05]HY,(18=K(!54N#/9)+AR4MM D'Q\5IM;Y;HVEO>)NO45E M"=M)/D[_XZW7V;BT2;%L;CR-SIYL>_+NTHZ>K_Z:NM]MCV%'Y/@21GB%URB[ M)=/2^"Z&6%F\)EN8!MC;>J[_(=O]Q]_TGY$[CO?]8#4X93]I/VR]D1)O^05 M)OKFNWXT#9ES,0:A&B^!AL.&[MCV(LP/_K7]]U_FC+K:Q&5HK3$QWMW.V,V$ MA78,!,W>''UKOXZ1X!^G["M \O#"O._L2T"-G@O(TCMK V4ZF4P?/7=X,_K-9;%OC[]0UOM<=$U+ MMPX+W>R@%T\A8S0:1_88B((7DCZ\!*MRL D,O +T8M8- +T'_+HUY/:7.W,D MH+/U#GZ[]H MXQE=2V6\PGGJ!$82[XYY=LR<6SN,7ROL#T/O]9>$\M9VG6O_WZX/_XU9R**X M#GH->GTS!61VCI6@0#Z54.#GA5"8 [.W#!1?@YA%(#=XD5FAP.O _')QO@$Y MAZB^W0)X;A0%X2N.D&5_^"9D'^TQJ[)\7O=\VC 7PT.Z4YDERWUV!FIRNH7G6-B0GP6=+PG@9C,>!?Q^#.9/< MY.([-Y/8#?PJX';I\)\'4)Z(]\]VR#[ YG!@;MP>-LYU@>\^DD._ OI5 MLTBZ1K>MNF$: B8$K&:0Z)U.N[O%8YB'GM>VOU5[6TXFVWV(;A^RWQ"U&UK) M[7B[R&.2(K,Q5)DE,![#HFD8XG20>2!A>/UP;?&K]WO_0^RIC_+F#-4$O^ M1J.61.)Z9X8YGVG;AMX>& IS)"9R2X&KG>D$[!D[+R@N!@. M@6><>]NS0Y=%E],P1)KZ2-$A_V-.HH'K2EXE MT^SU=@!W/I2RH9W>U;O=?G>O\3NDG9['"G0,?^A.;(]4L?\3> XK"$/OY;JL M(ZMZ':MO[!KXPY-5>>Y97E;U![L@>U[&KLSU->@=\MG_@.))-@]GVDC5:TN< M(3T1:A2?.QL23=U=6(B%)GXUV:C'ZT=3#;5Z"I'C ]JMXS[H[ M0]%"8T>@2)]3%"NLX[] ;X^?;?_N#B:K(BB,W2UFES#M$;\L[E)3,W5,26[ MZ,J9#FUN&(FDH,0_Y;73T^S-PH G$G]NPH2O+B;\([M'._3G&:F]$]IN6 MZ0=RRL;DCP^O5_;P.?MLD?"L!4OYX[]L?VJ'KP\OP<-S,(W 'H>U^>2.8L9\ M 4K5Y AB;77)U\9^6^2TSHQ^/>3\8M="RLYADK+.<_"XFS&P[-B:M+!T73 MT5^?B&#YHO]PQU/9S/6CTOHUWS.6C35"'>X%].(>].Q8Q.QP^?V)%@084 MKM(QSS^G)M1G0,57TN K16QZB2XS,_T6@)O+HT6^^G9%<#%6X/H$B&G_,BB M8>A.RG1CX#VF<%#V_QS?P%E?WUX9AHJK[;_J@UM7XO%K(RN+K'EX]IT E/: MVJ"M.?:K]@)<$3-?\X,8HTG1]/%_V##6XD";\"B)%HS@Z3A%01L!O>'+GRTL M_]7<$8VO/A#;?X)N//%L&/#%C9]=7S/H=I5(LT'["#4WCC0V&L%$[G?FLRAJ M:3_K[26&,^ M/7\VE[\"JJ:9>R4IE#%I],,"<]&H@ M5Y&34?P1Z(?X_.?9341))&1)I%P246+(=Q1#?KTS]U=99& L$(?589ZM^\: M'EP3/T[,JR6K4A84"'TN05)[SK5Q&5'[RCY/84 KHI%4ITEL<@Q MSPNW&RRB&UUQU]A& (&4?W(&"JN[$CNM$VK,\@X!%>"?8,TR+-I_330]6ZG M7Q\-2(:)H/UU%,&+GX+PGH7? 9X5JD>W+BF:9BRAJYLICK!2:H#&;JD+F # MC1C@[)#_N<3S/#=WHR9X>!H.B=(+@F4O0/FP%Z 0$((TI(_!!\8'WH'H(G- M]4>:O<$+]R[MB0NBM%+P KA>WRK72Z#O6 PJ"7.N[!#3;)9D>"E7KJ0>.T/ M@S%[L'_U6]^"\_^>Y_F0./? "M=P1:,$\7DP6_'QG_=_$!OU(+D[5A4 PT M^+P2#C)?@Y S_/O;8_!F70118Q2!>G#-5A#;HCJR27LT>53X3U72&V02IS[TRUMC@;+W5]06I$;0>'GWN&%T M>_U:2E3+XL[@UF9H&(>:%ERS25=+6"WN)U7^[$N+MQJAB!XK%4F"9P>7#2^^K'3ZMH_]20@8D%(QM^VU9_L[TQX9 M\[5)R"; CH[F^C1>Z&"O /++T=]@V.'H$YY! X>A]@2 2@VWBO^SB8Q?Q?A M^>;3_CR,%J@BS'@,[3)?1<_,X(BG.(@^$W(GJ8>-S[Q873JI6YM>N+JQ_ 9 M]PWZ0;&U!'DK@Q#FBV'@<8H?? /?CVFP<^V"\ "PO5>ZY_E55/S&2B[D1V^TBRVAN0-V3,0$[0])%7";@AP.OLDB$A)%VBA-XM0 M"A+K^OPTN/:O+'PKLV%'8>C;^B]]T"0"8BO (9]#EX8R#0@OQTG:P%+ -, M,6T'1^1\^@9X&38[L2#0T\>5\H#"Z$' [Y1GWRI,/;8=ACU&A\##(9M9UA%H M;\KJI?N"@%&7^9SX6J[H2%PL+MEO0KH'GPX2T[CPM9P01_ Y(WO3+V'"0. M $:-_9B #8%;5+FL_$28Y-^A[3YI']Q@&-JC6/ML/P:P2P+TE+0TT.3.M3=( M$SH()S@"4',DH_3T[-?4JF""XQ__.LLHRTX;! ^V60X8(YPY>,-&>X4 &DH3,?XJ?6X); M@IB!_/S')@%)B6-HUP%C2GQH_(9K'V\>L%T&/X[ =>\ 12"9<=?AWC88\\ M/YEX[E#(0AB-ATQ^Q['29$P"TNAA'X#,A>0%"DV/E,N\S%&D"VBCIKCFK MSV:;:QZBXO!);\86S9H8]YBD &7.-H7C,5H'1TYP&CSU<1'1X'G!2_$)IP@ MV@N#'1ZD9'FW;_LTYF$9YN&=QD. $!U ]+>XE)?^SL)F+(9-WD_9QBMLQ>W( M0Z"./8G8.TU^^BG3\W51-^C".WD++F-6B;'BK=$['J)!Z@B1JM!2.;%5\K>Z MYTR4U=H[;^([77WY#)$D:Z8[1#C8'A%G+T-51JJ+1X@@Z>($B= K^$KSL MV:!EZN<6J"81JQ.5B=:E5[D]5V95D#2H D\,H!6XU-C#RSFBL& T-I3= M:<5!W%!ZHY16_.S:9W>T6W)O2:V;8W=NYWJ7!KX#@6\%AESRAC@YF'1#_WR M%E[V_APQ@X%^#I5:R]X4I>O6:C-+W):0M#M\T[#6HM/92=#(6(M&AM$RNKU6 MO_+%3'N \NZ(U3GOF!N@4X&(J_UJT5.]YDK CII#Q+XV(:/PW/3 M,6O,X:L(]_Z0JYCS]IQ<5>_Y6O5:1LL:6-T%W%\T'\#Y]U]^/(:>^P[_"W_^ M_U!+ P04 " ZB)50O5A9I3L1 !2R $0 &MB;&(M,C R,# S,S$N M>'-D[5U;<^,VEG[>K=K_P'75UF8?9%EVNI/V=,^4?.OUC&TYECN=SCX]. MCWX^/?[I]X:-ABB,>-;HT:?T9^CY]7+V1^_C+\>_?[E-F[R M(W?G>($<<#_EGPYR)GT^.0S8K _6&/1_N[T92[Z#F/'TQ2?TFXY]\.'#A[ZD MIJPY\N$^6G5)WU!GB".LYJ!2@S\A/(04;? [X690)[Y73\F%EB)EO5]S$I2 M5@^7^#AV#V?!4Q$P#_XT#L:]$X&7O$>S.$EIG(%/&)K#HA]$78"(L\#'7 MRDB1HBS4.6'0CUK+UPM=0UD)(T8#2B-%GK[>R'K"[D^,/6 "S/B9G+U0D4! MT+("7DK1H!.]-!/XQA"9^6@B^ORBG_9;R%L^7F :7@5L<8&G/+!9G]$R"=3 M@KT#)T1LAD/1H?@2N;BNNK1;(DH#Z+V0M)(24;9<$NB>4/ O'T4)U?1QWZYBES%$B/Y5_EXRS$**70#!8E@PE(AY"+?C?QV M,FLH6I&D(#7R9F8_0[Y('^,YQB&/35TL,IOW&&PJLCA.['L>4 ]3@"A^\< G M'M $ZG2B>O<6YK?(P:S7%( [&[$6ZV0M?29<%G2G$.HDV_025K<^S'?>\X1GU_YP;.F M8ZU)9A^]WZ1?B'^-HL4!L-9J.R8S"T,]%-!RZ;A#!.(C.[L&"+L%\ M2+T1FR%_LP-O383-?OS)S$6@^F;'_"(8>'+S!;^+AL82'J)+[:4W#G#E^']PHHQ% M+!0GEB!HR-(P/Q% ,4S$.B\UM8C";_<>RV7-5R'E+1?=&CNJ$.VK9LFPXPV;_7F[$9_'&\XNQ8[ MJKOM+\WLHY#/LEF?RA3;.T49==MO\G#X@'B/C\#C&Q!?>$7_'<4:HR^U29 MU+_J"90T[F2M[X.@N>=ZXC27%_EX-!T"GT?\2)APC-V( 5[,1]-+Q"A4P.\Q M&\\1PXF]7Q$NKVC4'%CJ>L8K @ND$YA"/ _462,5I!2K V =B38+RGTH?H^H MT!PIZ12!.4B5U9_.@W1_(F8;07N%"),G^A(U#0%^-.0"4-<'- J!,W3N_G=?. QZ^ MSN_Y&LPN5Y8,7^-RT>RN>]MTZDW_V&XE8?:FLDY7=VYN_YS6G73N\G$8/: MLC"5/VNW]X!AHZMBZ4!H]DCZ@J-?O-K[YIU^0>.:.E:!V>%=%BF=NUJG16 M U&S^]2#4%KW%1]1<5/.NJU=?U9/?-5A+PX@NE"W)<'HIN)FIVJ'I-JX-2T M2=M:^_4)IX91:&XXT'J)Z/:N#;7W-Z[]].K(ZY!.Q9TVGPXX$5=@'21EW MH3($;EN5003[;ZCKC:A_JTI"]+55LA2P;Z3J^;J5K2H,7:>MPL7>]D;Z7F2- MY-5-KG3JK^]T2OXNW_OT$10/6.A0Y08ITV5E\35K-X$KJS(B+]ZJ5Q/%/4& MQ[V3P>$+]]9(VX!8FZ$=B%1N Q#&]-T'B5D/C16TLW!6"\@W"#+)]K6 ? M^R%/2WKKJC9!HUYMMCD<6=<&>!K<7HGXOOCUZ2!DD4C[XB[)4W@?14/S MY\Y-)G-[863L705LC-D3<=>.:,9JJZ)C'(9^Y7:F:U61K-8HS7]SO MKNGEBROOGH,>6')3,86VEFJA_YLDUJ: VRIHLVN;O^)7\(S'SI?]J!I)]/: MK?&5QZ=A6L&]1-CTN7Y8D;DO5X9HH!#82<]Y#SXO=JK'TX0RP#W87VNK3I'3Q)E;THZ+L,!N'$ ME09XM2F;M;'Q7,?2:-5J_16+Y(^]X1-F:(8O7R "",?W,,E_(SO7M-AV,I:$ MK03P/:S+ZY7]+!/?-;V7J+=BX6VWNFEVL,G,J4[?W=)M&[;>V%OKO]\C3[=J MW_9LTCC8A!9WT6"V1:MJJN[X\4P"7E2K]5DDUAYP M$:/SV9\B0&T;(?\1L M<5RP:1>M;SJ&3TJWNX:'>"C7J+4!>8N(\L8@+@6L>_Z3J Z,NS+:@6@QF M3L$72KJW_?5B&87Z&6JV,QB[7+$-84&H+-+I1^L,#X+:,0%2%4-,TO'^).<&B])7D6^O_H5NCWV2LLK.GK'3_!S'W&> MG18>,=E5X^'%:+J^/.4<^3[VSE;9J>8D1=&CENJR]9=R\N7$%,/>\4E/XT$N#DLD6PWK0;Z!P]J]B,I+'.1-G,KF5@M^&S:XJBXHJ%.NAMLNU4\EU9('49:KAPMQ7'\!%+)UB;!UR]M MYG9$M[H]\!8M6[$_\+U7/3M=X!&$C M3AL&MZ:7_>L&\ TDK% 1FL-\"+Z88@8!(K395PPO$4&-K&[%R MY7LHL17A5Y-M0GYF1GYF)7()K&L79Z#,YPG+5TFC1AMT"SW/AK/2PKZV-F MZER+PCG?6DCI'?![Q,%A@-BQ96BGN'.D-F@300L!6V0W,1+:#05,SPQ=!N+=RV+6C1A[%X;FJYUEL"KY9UC?7P.M%@UY9UC'0?B M,PE$G)M91A,8G(VFOQ(< N!2,JGGZUR7_X$)',0#1#)8N@A?3[("\>,<)F@ M[(H\816TEMHY[O)[47>X<.ZJJ$939ANUJM7$:O00\;4Y'DLTB';T6H86K7\ MENK61!_;=3"$615;YYH4M\#3Y_PZ@: ML=55$#$8>SS.@X@CZMT1BD.,:5&OAKR=Z_0%S.U&#&S-@@7A'&9 XKJ&HC)U M3)UK 6@8O@"L1=QJ<>=(KPCCX9B\W 8TG)>R5 6M<\QC_(2I^$22>!CH@)L8 M.D50"'3],ET-3^0),P[SIM&T8I1B9NE< ^-+D)4)T,!J MMT9CVW,;;=>2N]NS&VY7FHF:,%OMVYB$-="M0[Y9HI2^3-V>W63,S?FBN6 MY[9<+S'':Z-9@=]NW>)Y:W/=BOQVZR8FM2U4[#;K=ECJWA\M"D:$WAJ?M<1 MK$&KY&P=P1:T2A[6E%N#5./K!.3K"?H5'!.#)>C+HT6EM'.V#GJ9%40%;:N MI':..[D5 F(Y?;$I UE:?FO$V;D^YS 8C_Q0Z;J:\LZQWC)()8LE#V@YP)7R MSK$F]B-T5A'B)H;.T1?/@51%>"U7YWJ(R^M\'\NW<._CKXC%GT<8E;AEW8B MG6N8^_BIYBV%$J%SM(83AU:>,8J/\.MGA6TSC'+)?7DX(18"Q"GGR2^RZ\4&3IYWC7;UGISTL8Z)UC/Y\3/+U\P6XD MOBD;]SPF/D(LRI/'D-C_BPFE!^UFLMWK;%@_;;4M:E6O,0%MM2GZ?V9/M+E M]NASSPAUR1+Y$NA_Q]]6+YT.,[)TKH%$I3T6H:5TCOG\4HH&GWLJJ]EQ#J%#1^ BO:B+5#!3_VXR^# MPL__!5!+ P04 " ZB)50"2Y-ZX$- !8H@ %0 &MB;&(M,C R,# S M,S%?8V%L+GAM;.U=ZV_CN!'_7J#_ ^M#B[T/CNUDG[E-#]D\#D;3))=D[XI^ M.3 2'0LKDUY2RJ-_?4E9LD51$BE;$IFBB[O=Q.8,YSS=#@"+(/9A2# Z&F R^/GO?_X3X'\^ M_V4X!.C-=LYU'T?)P-'IZ>MK#Y!$^$?J-[7G$ MC-TMB:F'UKS^\>7B"_CK_BG8'^^/QP<'$S 9_PI^G8#3\\N]YQG'<@HCWDY\ MS9N-W__]B=W^^/#\0(< M MA-GA,PN.!CFH3P=[A#Z,N)23T;_^>7'KS=$"#@,L+.6A048EN)3133Y]^C1* MOLV:BV?[VF8]7$PRL19<^;?!C7M^$EBY'X=L0M%"\0 MCLYP%$0OPE9TD8CQ4]XS2F:'0V^W8?WP\PU1(<_: FCER4?,RP0+C\ HVT% M_ )#HJJV1;N:G&CAFKE+6O;DAAGW^-@6RHDT%IV)( -\'#/+HC7QDZ9HQ' M#Z[U"\3#_T4 [X.0!UZ=8,8,6A8.PJ-D3_%$:(1<,;%/)AX/.HIY?5A+8E M,2])A[A"[P77.JEFG:6EC9(OYU'>MXC;H(HB1N<5_APTH,>EX9\R&O$\Z MMUAD?.,.PHQ@YY1JM/1M1:6[QGZ'HOJZ%%H0Q]QR]O;S!+9QYUDBR)SFT#O MQ,CN!J;,NNV<9"9X1?.>\A-/,&9B-F;470PV= @=H4V?/D41#$)V":FHYA^U M.:[53FP"'XKE #\.T=7LF+?S@S 6HMTB+Z;8Q+VAK:K,4N+("6O^@ #FDIM M0-K=35QF6_.HCNA<]YYM125!_?B>+',S2BV@&'.M!=@OPMUBF4PC^O4/(KM MQ+178%=QE.R,\[JK56S5?'MTR-;1:=EVOW;;-%1LP:KCM=W&E5Y#/G7B\YFB M%X?)/.F"_RY1H.<(81_Y&1\!8J<==_ZQX)">C)B (E4M6\(KF10 Y+SFF'B"4A["CP23C"ZDG M^89Z+"5M,6)BU2%920BX#V3T,TH6=?I,=4=,1,_KF?U<"F;2Y:ISS3+%TF '(35:%Y"%D+)@%R->:MQ$3VUG8V+Q;J,8Y\\K9 M:KTXK[6HCLYVBC8VHID"G+/;!8$X\SU]QBAK;#MO&UNH!JIS9DGC^PUY@:%I MXBLG,#//._OFT4!VSD2G,;HCA7"MLU(=C9FAWMLWE!ZX<[;83.JAYVJ#:O" MV>NI_2X(?KA#=)&/P'59IJRU0]5<97ZI1NF<22KE4N"O2U+MCRI0U5;LW)- MQ>^ T#?XI/X#(-J?C2R97502VY[[&WJ^![)R);L2Q%8S\[D& M/CF,%W$RY2@\"I:RX36]JS8V'#FBG#.AKDB[!C[3
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�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end XML 53 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 R6.htm IDEA: XBRL DOCUMENT v3.20.1

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Cash Flows From Operating Activities:

Net Loss $ (3,051,339) $ (477,746)

Adjustments to reconcile net loss to net cash used in operations

Depreciation expense 7,379 6,665

Imputed interest - related party 9,784 4,947

Fair value of options issued for services 2,544,215

Changes in operating assets and liabilities:

Decrease in prepaid expenses 19,075 1,713

Operating lease right-of-use, net 28,728 10,737

Increase in accrued expenses and other payables - related party 174,705 162,725

(Decrease) Increase in accounts payable (78,513) 76,003

Operating lease liabilities (26,647) (10,090)

Net Cash Used In Operating Activities (372,613) (225,046)

Cash Flows From Investing Activities:

Purchase of Fixed Assets and Leasehold Improvements

Net Cash Used In Investing Activities

Cash Flows From Financing Activities:

Proceeds from Notes Payable - related party 300,000 120,000

Principal payments on debt (15,000) (1,000)

Proceeds from issuance of common stock 1,000,000

Net Cash Provided by Financing Activities 285,000 1,119,000

Net Increase in Cash (87,613) 893,954

Cash at Beginning of Period 125,024 13,697

Cash at End of Period 37,411 907,651

Supplemental disclosure of cash flow information:

Cash paid for interest

Cash paid for taxes

Supplemental disclosure of non-cash investing and financing activities:

Settlement of accounts payable with note payable 265,244

Settlement of accounts payable with stock issuance 281,659

Adoption of lease standard ASC 842 $ 167,867

X

- Definition
Adoption of lease standard ASC 842.
+ References
No definition available.
+ Details

Name: KBLB_AdoptionOfLeaseStandard

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Fair value of options issued for services.
+ References
No definition available.
+ Details

Name: KBLB_FairValueOfOptionsIssuedForServices

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Imputed interest - related party.
+ References
No definition available.
+ Details

Name: KBLB_ImputedInterestRelatedParty

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Operating lease right-of-use, net.
+ References
No definition available.
+ Details

Name: KBLB_IncreaseDecreaseInOperatingLeaseRightofuseAssets

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Settlement of accounts payable with note payable.
+ References
No definition available.
+ Details

Name: KBLB_SettlementOfAccountsPayableWithNotePayable

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Settlement of accounts payable with stock issuance.
+ References
No definition available.
+ Details

Name: KBLB_SettlementOfAccountsPayableWithStockIssuance

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586
+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableTrade

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R2.htm IDEA: XBRL DOCUMENT v3.20.1

Condensed Consolidated Balance Sheets - USD ($)

Mar. 31, 2020

Dec. 31, 2019

Current Assets

Cash $ 37,411 $ 125,024

Prepaid expenses 12,670 31,745

Total Current Assets 50,081 156,769

Property and Equipment, net 109,942 117,321

Operating lease right-of-use asset, net 444,514 473,242

Security deposit 3,518 3,518

Total Assets 608,055 750,850

Current Liabilities

Accounts payable and accrued expenses 482,435 560,948

Note payable - related party 942,000 642,000

Royalty agreement payable - related party 65,292 65,292

Accounts payable and accrued expenses - related party 4,320,170 4,145,465

Operating lease liability, current 113,764 110,678

Loan payable 60,000 60,000

Total Current Liabilities 5,983,661 5,584,383

Long Term Liabilities

Loan payable, net of current 170,244 185,244

Operating lease liability, net of current 339,548 369,281

Total Liabilities 6,493,453 6,138,908

Commitments and Contingencies

Stockholders' Deficit

Preferred stock, value

Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively 22,000 22,000

Additional paid-in capital 4,966,968 2,412,969

Accumulated Deficit (32,849,245) (29,797,906)

Total Stockholders' Deficit (5,885,398) (5,388,058)

Total Liabilities and Stockholders' Deficit 608,055 750,850

Series A Preferred Stock [Member]

Stockholders' Deficit

Preferred stock, value 5,217,800 5,217,800

Common Stock Class A [Member]

Stockholders' Deficit

Common stock, value 16,757,079 16,757,079

Common Stock Class B [Member]

Stockholders' Deficit

Common stock, value

X

- Definition
Common Stock Issuable.
+ References
No definition available.
+ Details

Name: KBLB_CommonStockIssuable

Namespace Prefix: KBLB_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AccruedRoyaltiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 210
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840
+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_DueToRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_LoansPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermLoansPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a)(5))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_NotesPayableRelatedPartiesClassifiedCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (g)(2)
-URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8,17)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details

Name: us-gaap_SecurityDeposit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 report.css IDEA: XBRL DOCUMENT / Updated 2009-11-04 / / v2.2.0.24 / / DefRef Styles / ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } / Report Styles / ..pl a, .pl a:visited { color: black; text-decoration: none; } / table / ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } / Top labels / ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; / word-wrap: break-word; / } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } / Header rows... / ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } / Calendars... / ..report .rc { background-color: #f0f0f0; } / Even rows... / ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } / Odd rows... / ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } / styles for footnote marker / ..report .fn { white-space: nowrap; } / styles for numeric types / ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } / styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 57 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) - shares
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Antidilutive Securities 83,335,919 58,595,919

Stock Warrants [Member]

Antidilutive Securities 55,995,917 58,595,917

Stock Options [Member]

Antidilutive Securities 27,340,000

Convertible Preferred Stock [Member]

Antidilutive Securities 2 2

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=KBLB_StockWarrantsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=KBLB_StockOptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R27.htm IDEA: XBRL DOCUMENT v3.20.1

Equipment (Details Narrative) - USD ($)
3 Months Ended

Mar. 31, 2020

Mar. 31, 2019

Property, Plant and Equipment [Abstract]

Depreciation expense $ 7,379 $ 6,665

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

Stockholders' Deficit - Schedule of Options Outstanding (Details)	3 Months Ended
	Mar. 31, 2020 $ / shares shares
Equity [Abstract]
Exercise Price \| $ / shares	$ 0.115
Options Outstanding
Options Exercisable	22,267,800
Weighted Average Remaining Contractual Life	23 years 4 months 2 days

Stockholders' Deficit (Details Narrative) - USD ($)								3 Months Ended		12 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Feb. 19, 2020	Sep. 26, 2019	Aug. 14, 2019	Aug. 08, 2019	Mar. 20, 2019	Mar. 09, 2019	Mar. 20, 2018	Mar. 31, 2020	Mar. 31, 2019	Aug. 08, 2020	Apr. 05, 2020	Dec. 31, 2019	Dec. 31, 2018	Mar. 08, 2019
Number of shares issued		766,667	7,967,871		4,052,652
Share price					$ 0.0695
Proceeds from issuance of common stock									$ 1,000,000
Warrants to purchase up share		1,000,000	8,000,000
Warrants exercise price								$ 0.001	$ 0.001
Number of shares issued, value					$ 281,659				$ 1,000,000
Number of warrants cancelled
University of Notre Dame [Member]
Number of shares issued, value					38,500
Accounts payable					$ 243,159
Common Stock and Warrants [Member]
Number of shares issued						14,797,278
6 Cent Warrants [Member]
Warrants to purchase up share														14,797,278
Warrants exercise price														$ 0.06
8 Cent Warrants [Member]
Warrants to purchase up share						7,398,639
Warrants exercise price						$ 0.08
Warrant [Member]
Warrants exercise price						$ 0.06		$ 0.001				$ 0.001
Warrant expiration date						Mar. 08, 2021
Warrant One [Member]
Warrants exercise price						$ 0.06		0.056				0.056
Warrant expiration date						Mar. 08, 2022
Warrant Two [Member]
Warrants exercise price						$ 0.08		0.04				0.04
Warrant expiration date						Mar. 08, 2022
Warrant Three [Member]
Warrants exercise price						$ 0.08		$ 0.06				$ 0.06
Warrant expiration date						Mar. 08, 2023
Common Stock Warrants and Options [Member]
Number of shares issued	20,000,000			2,000,000
Share price	$ 0.0115			$ 0.2299
Warrants to purchase up share							600,000
Warrants exercise price							$ 0.001
Warrants term							4 years
Fair value of adjustments of warrants							$ 19,915
Warrants cancelled amount											$ 6,000
Option term	20 years			2 years
Fair value of options	$ 2,198,411			$ 267,574
Common stock warrants and options, description	Options will be exercisable on February 19, 2025, and for a period of 15 years expiring on February 19, 2040.			Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2024.			Warrants will be exercisable on March 20, 2019, and for a period of 3 years expiring on March 20, 2022.
Share based compensation								$ 2,198,411				$ 267,574
Warrants expenses													$ 19,915
Number of warrants cancelled											600,000
Common Stock Warrants and Options One [Member]
Number of shares issued	6,000,000
Share price	$ 0.00115
Option term	10 years
Fair value of options	$ 626,047
Common stock warrants and options, description	Black-Scholes option-pricing model on the date of grant and 2,000,000 options are fully vested on the date granted and 1,000,000 options vest at the end of each successive year for four years. Options will be exercisable on February 19, 2021, and for a period of 10 years expiring on February 19, 2030.
Share based compensation								208,682
Common Stock Warrants and Options Two [Member]
Number of shares issued	1,340,000
Share price	$ 0.0115
Option term	7 years
Fair value of options	$ 133,063
Common stock warrants and options, description	Black-Scholes option-pricing model on the date of grant and 268,000 options are fully vested on the date granted and the remaining option vest equally over the remaining 4 years at the end of each successive year. Options will be exercisable on February 19, 2021, and for a period of 6 years expiring on February 19, 2027.
Share based compensation								26,613
Common Stock Warrants and Options One [Member]
Number of shares issued				2,000,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 267,574
Common stock warrants and options, description				Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025.
Share based compensation								66,528
Common Stock Warrants and Options Two [Member]
Number of shares issued				2,000,000
Share price				$ 0.2299
Option term				3 years
Fair value of options				$ 291,842
Common stock warrants and options, description				Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026.
Share based compensation								36,331
Common Stock Warrants and Options Three [Member]
Number of shares issued				1,000,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 118,874
Common stock warrants and options, description				Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023.
Share based compensation												118,874
Common Stock Warrants and Options Four [Member]
Number of shares issued				1,000,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 118,874
Common stock warrants and options, description				Options will be exercisable on August 8, 2021, and for a period of 3 years expiring on August 8, 2024.
Share based compensation												118,874
Common Stock Warrants and Options Five [Member]
Number of shares issued										125,000
Share price				$ 0.2299
Option term										2 years
Fair value of options										$ 14,859
Common stock warrants and options, description										Options will be exercisable on August 8, 2020, and for a period of 3 years expiring on August 8, 2023.
Share based compensation												$ 14,859
Common Stock Warrants and Options Six [Member]
Number of shares issued				125,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 16,723
Common stock warrants and options, description				Options will be exercisable on August 8, 2022, and for a period of 3 years expiring on August 8, 2025.
Share based compensation								4,158
Common Stock Warrants and Options Seven [Member]
Number of shares issued				125,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 18,240
Common stock warrants and options, description				Options will be exercisable on August 8, 2023, and for a period of 3 years expiring on August 8, 2026.
Share based compensation								2,271
Common Stock Warrants and Options Eight [Member]
Number of shares issued				125,000
Share price				$ 0.2299
Option term				2 years
Fair value of options				$ 19,525
Common stock warrants and options, description				Options will be exercisable on August 8, 2024, and for a period of 3 years expiring on August 8, 2027.
Share based compensation								$ 1,621
Purchase Agreement [Member] \| Investor [Member]
Number of shares issued						14,797,278
Share price						$ 0.06758
Proceeds from issuance of common stock						$ 1,000,000

Right to Use Assets and Lease Liability - Schedule of Lease Liability (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Jan. 02, 2019
Total	$ 453,312
Less: short term portion	(113,764)	$ (110,678)	$ (531,462)
Long term position	339,548	$ 369,281
Right to Use Liability Net - Related Party [Member]
Total	53,442
Right to Use Liability Net [Member]
Total	61,789
Right to Use Liability Net One [Member]
Total	$ 338,081

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Preferred stock, par value
Preferred stock, shares authorized	Unlimited	Unlimited
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock issuable	1,122,311	1,122,311
Series A Preferred Stock [Member]
Preferred stock, par value
Preferred stock, shares issued	2	2
Preferred stock, shares outstanding	2	2
Common Stock Class A [Member]
Common stock, par value
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued	844,468,378	844,468,378
Common stock, shares outstanding	844,468,378	844,468,378
Common Stock Class B [Member]
Common stock, par value
Common stock, shares authorized	Unlimited	Unlimited
Common stock, shares issued
Common stock, shares outstanding

Summary of Significant Accounting Policies and Organization (Details Narrative) - USD ($)		3 Months Ended		12 Months Ended
	Jan. 02, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2017	Jul. 24, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash equivalents
Income tax rate, percentage	21.00%
Income tax, uncertain tax positions
Impairment losses on equipment
Revenue
Additional contract award						$ 921,130
Contract award						$ 1,021,092
Cash excess of FDIC insurance limits		0		$ 0
Doubtful accounts		$ 0	$ 0

Going Concern (Details Narrative) - USD ($)	3 Months Ended
Going Concern (Details Narrative) - USD ($)	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital	$ (5,933,580)
Stockholders' deficiency	(5,885,398)	$ (3,650,363)	$ (5,388,058)	$ (4,459,223)
Cash used in operating activities	$ (372,613)	$ (225,046)

Stockholders' Deficit - Schedule of Warrants Activity (Details)	3 Months Ended
	Mar. 31, 2020 USD ($) $ / shares shares
Equity [Abstract]
Number of Warrants, Beginning balance \| shares	55,395,917
Number of Warrants, Granted \| shares
Number of Warrants, Exercised \| shares
Number of Warrants, Cancelled/Forfeited \| shares
Number of Warrants, Ending balance \| shares	55,395,917
Number of Warrants, Intrinsic Value \| $	$ 9,799,286
Weighted Average Exercise Price, Beginning balance
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Cancelled/Forfeited
Weighted Average Exercise Price, Ending balance
Weighted Average Exercise Price, Intrinsic Value
Weighted Average Remaining Contractual Life (In Years), Beginning balance	2 years 9 months 7 days
Weighted Average Remaining Contractual Life (In Years), Ending balance	2 years 6 months 7 days

Stockholders' Deficit - Schedule of Option Assumption (Details)	Feb. 19, 2020	Aug. 08, 2019	Mar. 20, 2018
Common Stock Warrants and Options [Member]
Expected dividends	0.00%
Expected volatility	125.19%
Expected term	3 years
Risk free interest rate	1.56%
Expected forfeitures	0.00%
Common Stock Warrants and Options One [Member]
Expected dividends	0.00%
Expected volatility	125.19%
Expected term	3 years
Risk free interest rate	1.50%
Expected forfeitures	0.00%
Common Stock Warrants and Options Two [Member]
Expected dividends	0.00%
Expected volatility	125.19%
Expected term	6 years
Risk free interest rate	1.46%
Expected forfeitures	0.00%
Common Stock Warrants and Options [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options One [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options Two [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		3 years
Risk free interest rate		1.54%
Expected forfeitures		0.00%
Common Stock Warrants and Options Three [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options Four [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options Five [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options Six [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		2 years
Risk free interest rate		1.62%
Expected forfeitures		0.00%
Common Stock Warrants and Options Seven [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		3 years
Risk free interest rate		1.54%
Expected forfeitures		0.00%
Common Stock Warrants and Options Eight [Member]
Expected dividends		0.00%
Expected volatility		105.73%
Expected term		3 years
Risk free interest rate		1.54%
Expected forfeitures		0.00%
Common Stock Warrants and Options Nine [Member]
Expected dividends			0.00%
Expected volatility			97.56%
Expected term			4 years
Risk free interest rate			2.65%
Expected forfeitures			0.00%

Right to Use Assets and Lease Liability - Schedule of Lease Cost (Details)	3 Months Ended
	Mar. 31, 2020 USD ($)
Operating Lease Expenses [Member]
Lease expenses	$ 15,582
Operating Lease Expenses One [Member]
Lease expenses	9,142
Operating Lease Expenses - Related Party [Member]
Lease expenses	$ 1,923

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows From Operating Activities:
Net Loss	$ (3,051,339)	$ (477,746)
Adjustments to reconcile net loss to net cash used in operations
Depreciation expense	7,379	6,665
Imputed interest - related party	9,784	4,947
Fair value of options issued for services	2,544,215
Changes in operating assets and liabilities:
Decrease in prepaid expenses	19,075	1,713
Operating lease right-of-use, net	28,728	10,737
Increase in accrued expenses and other payables - related party	174,705	162,725
(Decrease) Increase in accounts payable	(78,513)	76,003
Operating lease liabilities	(26,647)	(10,090)
Net Cash Used In Operating Activities	(372,613)	(225,046)
Cash Flows From Investing Activities:
Purchase of Fixed Assets and Leasehold Improvements
Net Cash Used In Investing Activities
Cash Flows From Financing Activities:
Proceeds from Notes Payable - related party	300,000	120,000
Principal payments on debt	(15,000)	(1,000)
Proceeds from issuance of common stock		1,000,000
Net Cash Provided by Financing Activities	285,000	1,119,000
Net Increase in Cash	(87,613)	893,954
Cash at Beginning of Period	125,024	13,697
Cash at End of Period	37,411	907,651
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Settlement of accounts payable with note payable		265,244
Settlement of accounts payable with stock issuance		281,659
Adoption of lease standard ASC 842		$ 167,867

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 37,411	$ 125,024
Prepaid expenses	12,670	31,745
Total Current Assets	50,081	156,769
Property and Equipment, net	109,942	117,321
Operating lease right-of-use asset, net	444,514	473,242
Security deposit	3,518	3,518
Total Assets	608,055	750,850
Current Liabilities
Accounts payable and accrued expenses	482,435	560,948
Note payable - related party	942,000	642,000
Royalty agreement payable - related party	65,292	65,292
Accounts payable and accrued expenses - related party	4,320,170	4,145,465
Operating lease liability, current	113,764	110,678
Loan payable	60,000	60,000
Total Current Liabilities	5,983,661	5,584,383
Long Term Liabilities
Loan payable, net of current	170,244	185,244
Operating lease liability, net of current	339,548	369,281
Total Liabilities	6,493,453	6,138,908
Commitments and Contingencies
Stockholders' Deficit
Preferred stock, value
Common Stock Issuable, 1,122,311 and 1,122,311 shares, respectively	22,000	22,000
Additional paid-in capital	4,966,968	2,412,969
Accumulated Deficit	(32,849,245)	(29,797,906)
Total Stockholders' Deficit	(5,885,398)	(5,388,058)
Total Liabilities and Stockholders' Deficit	608,055	750,850
Series A Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	5,217,800	5,217,800
Common Stock Class A [Member]
Stockholders' Deficit
Common stock, value	16,757,079	16,757,079
Common Stock Class B [Member]
Stockholders' Deficit
Common stock, value

Summary of Significant Accounting Policies and Organization - Schedule of Antidilutive Securities of Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities	83,335,919	58,595,919
Stock Warrants [Member]
Antidilutive Securities	55,995,917	58,595,917
Stock Options [Member]
Antidilutive Securities	27,340,000
Convertible Preferred Stock [Member]
Antidilutive Securities	2	2

Equipment (Details Narrative) - USD ($)	3 Months Ended
Equipment (Details Narrative) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 7,379	$ 6,665